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The aims of the work described in this thesis are to examine the impact of 
physical activity/exercise and energy balance on metabolic control and 
inflammation and specifically whether exercise has independent benefits on 
various health-related outcomes above a role in energy balance. 
 
Chapter 3 examined whether a lifestyle intervention combining dietary advice 
with increased physical activity would further improve inflammatory markers 
compared to dietary advice alone and usual care in 494 patients with newly 
diagnosed type 2 diabetes. Motivational unsupervised diet and diet plus physical 
activity interventions led to reductions in inflammatory markers. Interestingly, 
there was no greater benefit from adding physical activity advice to dietary 
advice. Chapter 4 investigated whether daily vigorous-intensity exercise would 
counteract the metabolic changes induced by short-term overfeeding and 
reduced physical activity independent of any net attenuation of energy imbalance 
in healthy young men. The overfeeding and reduced activity model induced a 
state of insulin resistance, hyperinsulinaemia and altered expression of several 
key genes within adipose tissue. The inclusion of a daily vigorous-intensity 
exercise bout largely prevented these changes from taking place independent of 
any net effect on energy imbalance. Chapter 5 examined whether caloric 
restriction combined with vigorous-intensity exercise would further improve 
metabolic control and inflammatory markers compared to moderate-intensity 
exercise in middle-aged, overweight/obese men and postmenopausal women. 
Three weeks of caloric restriction combined with either vigorous or moderate-
intensity physical exercise improved insulin sensitivity, lipid profiles and 
markers of inflammation. These results confirm the positive effects of combined 
caloric restriction and increased exercise in sedentary overweight men and 
women, but that exercise intensity does not seem to be so important.  
 
In conclusion, this thesis presents reasonable evidence that exercise per se has a 
positive impact upon metabolic control and inflammation independent of energy 
balance during an energy surplus but that a role in contributing to the health 
benefits during an energy deficit are less convincing.  
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Review of Literature 
 
1.1 Introduction 
The human genome was selected in an environment where high physical 
activity and periods of restricted food intake were the norm. As a result, 
metabolic pathways that conserved energy for future food deficiency were 
favoured. There is strong evidence that people who are active have a lower risk 
of developing both cardiovascular disease (CVD) and type 2 diabetes (T2D) 
(Department of Health and Human Services, 1996). Today, various machines 
and technologies have replaced much of the physical activity that led to optimal 
gene expression for energy metabolism (Booth et al., 2008). One of the most 
dramatic changes in the environment during the past 40 years has been the 
broad availability of relatively inexpensive, highly palatable food (Schrauwen, 
2007). It is likely that most individuals intermittently experience brief periods of 
positive energy balance when exposed to the modern Western diet. The latest 
Health Survey for England (2008) suggest only 39 % of men and 29 % of 
women in the UK are meeting current minimum physical activity guidelines 
suggested by the government. Worryingly, the same survey (2011) identified 65 
% of men and 58 % of women as either overweight or obese according to their 
Body Mass Index (BMI). 
 
A sedentary lifestyle and a high intake of calories are conditions that can lead to 
a state of positive energy balance. As a result, healthy humans respond 
primarily by storing excess energy as triglycerides (TAG) in adipose tissue. Our 
ability to store excess energy as fat within the adipose tissue is impressive but at 
the same time can also be problematic. Excess adipose tissue increases the risk 
of developing a number of diseases and disorders such as T2D, CVD and the 
metabolic syndrome (Schrauwen, 2007). Metabolic dysfunction and chronic 
low-grade inflammation are likely to play a critical role in the aetiology of many 
chronic diseases (Duncan et al., 2003). It is estimated that in England alone, 5.9 
% of the population (3.1 million) is affected by T2D (Health Survey for 
England, 2011) while there are also thought to be around 850,000 people with 
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undiagnosed T2D according to the NHS. Individuals with T2D are 2-5 times 
more likely to develop CVD than individuals without T2D (Garcia et al., 1974). 
Furthermore, individuals with T2D who develop CVD have a significantly 
poorer prognosis than individuals without T2D who develop CVD (Stevens et 
al., 2004). According to estimates, up to 80 % of diabetic deaths are due to 
CVD (Biondi-Zoccai et al., 2003; British Heart Foundation, 2004). 
 
Numerous studies have achieved a reduction in body weight/fat mass through a 
dietary intervention which resulted in an improvement in metabolic function 
and markers of inflammation (Esposito et al., 2004; Forsythe et al., 2008; 
Nicklas et al., 2004; Shai et al., 2008). Conversely, other studies have 
investigated the effects of an exercise intervention on body weight/fat mass 
through an exercise intervention and found similar health benefits (You et al., 
2004; Giannopoulou et al., 2005; Cho et al., 2011) while others found no 
improvement in markers of inflammation (Marcell et al., 2005). Although there 
is reasonable evidence that weight loss alone improves inflammatory markers 
and/or metabolic control, the evidence base to demonstrate whether physical 
activity has the potential to elicit changes in chronic inflammation  and/or 
metabolic function over and above those gained through weight loss alone is 
weak. 
 
It is generally accepted that regular physical activity and exercise are an 
important part of a healthy lifestyle and that physical inactivity increases the 
risk of disease over the long term (Booth et al., 2000). It is well established that 
both an acute bout of exercise (Hagobian & Braun, 2006) and chronic 
endurance exercise training can have beneficial effects on insulin action in 
insulin-resistant states (Henriksen, 2002). The potential mechanisms through 
which physical activity leads to improvements in metabolic function and 
inflammatory−related benefits have yet to be elucidated. Whether it offers 
additional benefits compared to diet alone still remains unclear which makes 
interpretation of findings difficult. In order to understand and isolate how 
exercise exerts its effects on metabolism and whether these benefits are weight 
loss dependent or not; it is critically important to conduct studies that will tease 
Chapter 1                                                 Review of Literature                                         
17 
 
apart the effects of energy balance and weight loss from exercise/physical 
activity while carefully controlling energy status (Braun & Brooks, 2008). 
 
1.2 Energy intake, energy expenditure and metabolism 
Obesity plays a key role in the aetiology of chronic diseases and is 
fundamentally the result of an imbalance between energy intake and energy 
expenditure. This section aims to highlight recent changes in energy intake and 
expenditure and the resultant effects on macronutrient metabolism.  
 
1.2.1 Energy intake  
1.2.1.1 Caloric intake and diet composition 
It is highly likely that access to food was irregular and restricted in prehistoric 
times while daily activities would have been dominated by outdoor physical 
activity consisting of hunting and foraging for food (Cooney, 2000). If the 
human genome evolved to support a physically active lifestyle with restricted 
access to food, then it is logical to presume that these individuals developed a 
“normal” gene expression profile (Booth et al., 2008). Evolution via the 
survival of the fittest principle selected the genome that we still carry today. 
Genes predisposing to storage and energy preserving pathways would have been 
favoured in order to offer a better chance of survival. A modern Western diet 
combined with physical inactivity superimposed on these genes may have led to 
the current chronic disease epidemic. Even recently, there has been a noticeable 
increase in the proportion of fat in the British diet, while the proportion of 
dietary energy from carbohydrate has declined (Figure 1.1).  
   
Figure 1.1: Changes in fat and carbohydrate contribution to the British diet. 
Taken from Prentice and Jebb (1995). 
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 in 2000 according to the National Food Survey (DEFRA). 
Unfortunately, the reliability of the National Food Survey findings is limited as 
it does not include the contribution of food consumed in restaurants for 
example.  Paradoxically, trends in the United States appear to be different; the 
mean daily energy intake amongst adults has steadily increased over the course 
of 30 years (Table 1.1) while the relative proportion of energy from 
macronutrients has changed (Figure 1.2) according to the National Health and 
Nutrition Examination Survey (NHANES). Current research is inconclusive on 
potential changes in energy intake and diet composition; these discrepancies 
highlight the difficulty in collecting these data and possible variations between 
countries. However, there is no doubt that the prevalence of obesity continues to 
rise in affluent societies.  
 
Table 1.1: Mean daily energy intake (in kcal) for the U.S. population, 1971 to 
2000
a











Figure 1.2: Trends in the percentage of energy from macronutrients, U.S. adults 
age 20-74. Data source: NHANES; age-adjusted to 2000 population. Taken 
from Briefel & Johnson (2004). 
 
1.2.1.2 Carbohydrate metabolism 
All carbohydrates absorbed in the small intestine must be hydrolysed into 
monosaccharides prior to absorption. The digestion of carbohydrates begins by 
the action of salivary alpha-amylase followed by the further action of pancreatic 
amylase in the small intestine. One of the resulting products, glucose, is stored 
as a multi-branched polysaccharide (glycogen) within skeletal muscle (~500 g), 
with alternative sources found in the liver (~100 g) and in the blood. Glycogen 
serves as an energy reserve that can be quickly broken down into glucose by 
myocytes own requirements, while hepatocytes convert glycogen into glucose 
to be utilised by various cell types including the central nervous system. Hepatic 
glycogen accounts for approximately 14 % of total stored carbohydrate while 
around 7 % circulates as blood glucose (Sherman, 1995). The capacity of the 
human body to store glucose as glycogen is limited. Glucose oxidation is 
assumed to be proportional to the level of glycogen stored at a given time 
(Schutz, 2004). Physiological pathways such as de novo lipogenesis (DNL) 
occur in order to deal with surplus dietary carbohydrate, once glycogen 
saturation has been achieved, by converting these into fatty acids where Acetyl 
CoA is the principal building block. This process takes place in the liver and, to 
a lesser extent in adipocytes (Hellerstein, 1996). Recent work is challenging this 
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within adipose tissue in the fed state in healthy humans who are in energy 
balance. This pathway is believed to be thermogenically costly using 
approximately 28 % of the energy content of carbohydrate (Flatt, 1987; 
Hellerstein et al., 1996). The excretion of glucose in the urine (glycosuria) does 
not usually take place as the glomerular barrier of the kidneys is able to 
reabsorb all of the filtered glucose back into the bloodstream. It is usually a 
consequence of elevated blood glucose levels often seen in untreated diabetes 
(Ballantyne et al., 1977).  
 
1.2.1.3 Fat metabolism 
Triglyceride digestion occurs almost exclusively in the small intestine. The 
major digestive enzyme in this process is pancreatic lipase which breakdowns 
triglycerides (TAG) into fatty acids and monoglyceride. Following the 
emulsification process, micelles are formed containing the products of fat 
digestion. The content of micelles become available to diffuse across the 
intestinal lining where fatty acids and monoglycerides are resynthesized into 
triglycerides before being released into the systemic circulation as chylomicrons 
via the lymphatic system. The fatty acids of plasma chylomicrons are released, 
mainly within adipose tissue capillaries, by the action of endothelial lipoprotein 
lipase (LPL). The released fatty acids then enter adipocytes, hepatocytes or 
myocytes and combined with α-glycerol phosphate (synthesised in the 
adipocytes from glucose metabolites) to be stored as TAG. The liver acts as a 
major organ for fatty acids, processing chylomicrons into various lipoproteins, 
in particular very low-density lipoprotein (VLDL) and low-density lipoprotein 
(LDL). Glucose entering the liver can either be stored as glycogen or 
transformed into α-glycerol phosphate and fatty acids, which are then used to 
synthesise TAG, as in adipose tissue. Some of the fat synthesised from glucose 
in the liver is stored there, but most of it is released as VLDL. The liberation of 
fatty acids or fat mobilisation takes place in adipose tissue when other tissues 
require it, for instance during exercise or following an overnight fast. The 
process of fat mobilisation is catalysed by the enzyme hormone-sensitive lipase 
(HSL) and the resulting non-esterified fatty acids (NEFA) enter the plasma only 
from adipose tissue. NEFA are not water-soluble and are carried in plasma 
bound to albumin. NEFA are taken up by, among other tissues, skeletal muscle 
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and the liver. In each of these tissues, they may enter the pathway of β-
oxidation, or they may be used for the synthesis of TAG. An excessive intake of 
fat can be stored as TAG; this is by far the biggest and most efficient store of 
energy within the human body.  
 
1.2.1.4 Protein metabolism 
Proteins are broken down to peptide fragments by pepsin in the stomach and by 
trypsin and chymotrypsin, the major proteases secreted by the pancreas, in the 
small intestine. These fragments are further digested to free amino acids by 
carboxypeptidase and aminopeptidase. The free amino acids then enter the 
epithelial cells before being released into the interstitial fluid and then into the 
systemic circulation. Most amino acids are sufficiently water-soluble to 
circulate freely in plasma except for tryptophan which is bound loosely to 
albumin for transport. Amino acids cross the cell membrane via specific 
transporters. As well as being one of the building blocks of body tissue, protein 
can also serve as a fuel source. Amino acids can provide gluconeogenic 
precursors for hepatic glucose production (Butterfield, 1990). Only the branched 
chain amino acids (BCAA) along with glutamate, asparagine and aspartate are 
available for oxidation within skeletal muscle (Rennie & Tipton, 2000). Some 
studies suggest that adipose tissue is also capable of oxidising significant 
amounts of BCAAs (Rosenthal et al., 1974; Tischler & Goldberg, 1980). In fact, 
very little amino acids are lost from the body intact and most of the amino acids 
we ingest are ultimately oxidised. Amino acid oxidation contributes around 10-
20 % of the total oxidative metabolism of the body under normal conditions. All 
other amino acids must be transaminated into either glutamate or alanine before 
subsequent deamination in the liver, at which point the resultant carbon can be 
oxidised and the amino group disposed of as urea (Felig and Wahren, 1971). 
Although protein represents a source of energy that can be drawn upon during 
starvation, there is no specific storage form of protein. All proteins have some 
function other than storage of energy. In evolutionary terms, we can expect that 
other sources of energy such as glycogen and TAG will be favoured. Amino 
acids can be oxidised just as glucose and fatty acids can; however, unlike fatty 
acids, amino acids can be converted into glucose. This gives the body’s protein 
store (muscle mass) a special role during starvation, when the body must 
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maintain the availability of circulating glucose despite the absence of external 
carbohydrate supply. On the other hand, an excess of amino acids might 
stimulate muscle protein synthesis to a small extent over a short period of time 
(Bennet et al., 1989). However, this increased muscle protein synthesis will then 
be inhibited (Bohe et al., 2001). Overfeeding protein does not increase the size 
of the lean body mass long term and amino acids supplied in excess are simply 
oxidised (Motil et al, 1981; Price & Mitch, 1994) and their carbon skeletons 
used for fuel or stored as fat.  
 
1.2.1.5 Alcohol metabolism 
The average human digestive system produces approximately 3 g of ethanol per 
day through fermentation of its content (Zakhari, 2006). As a result, catabolic 
degradation of ethanol is essential to humans. Alcohol is primarily absorbed 
from the small intestine; however, alcohol cannot be stored and therefore, the 
body must metabolise it to remove it. Alcohol can only be oxidised in the liver 
where enzymes are found to initiate the process. Ethanol is oxidised into 
acetaldehyde which is itself further oxidised to acetate and finally CO2 and 
water through the citric acid cycle. A number of metabolic effects from alcohol 
are directly linked to the production of an excess of NADH and acetaldehyde 
(Zakhari, 2006). Excess NADH may be used as a reducing agent in two 
pathways; one to synthesise glycerol and the other to synthesise fatty acids. 
Acetate is also metabolised to Acetyl CoA, which is involved in lipid and 
cholesterol biosynthesis (Lieber, 1976).  
 
1.2.2  Energy expenditure  
 
1.2.2.1 Changes in physical activity  
Humans evolved in an environment where survival necessitated a large amount 
of physical activity and as a result, the cardiovascular system and 
musculoskeletal systems evolved to meet the requirements of these 
surroundings. The unique ability to expend large amounts of energy in order to 
sustain prolonged periods of physical activity is an achievement that no other 
primate and few other mammals are able to perform (Archer & Blair, 2011). 
However, this is only feasible because our physiology has evolved to favour 
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metabolic pathways that conserve energy for future requirements. The shift 
from hunting and gathering to agriculture during the Neolithic era facilitated the 
transition to a less energetically way of life (Weisdorf, 2005). Nevertheless, this 
was still enough to maintain health and prevent chronic diseases. For most of 
human history, infectious diseases were the leading cause of death rather than 
chronic diseases. Yet, with time, the demands placed on the body diminished 
resulting in the current chronic disease epidemic we are now facing. 
 
 Hippocrates observed that “sudden death is more common in those who are 
naturally fat than in the lean” in 400 B , this observation remained unexplained 
for many centuries. Although the work of Dr WA Guy on the health benefits 
from physical activity was conducted over a century ago, the main body of 
evidence came from the work conducted by Professor Jerry Morris. In a 
landmark study, he showed that sedentary bus drivers had a higher death rate 
due to CVD compared to conductors, whose job specifically required them to be 
more physically active (Morris et al., 1953). Systematic research on the 
relationship between physical activity and health only began in the second half 
of the 20
th
 century, and until the mid-1980s studies relied on self-reported 
physical activity questionnaires. Because of this, there are few baseline data on 
physical activity patterns against which to compare secular trends. Durnin 
(1992) presented some indirect evidence that energy expenditure amongst UK 
adolescents must have declined over time by highlighting the decline in energy 
intake from the 1930s to the 1980s, with no parallel change in body mass. 
Television viewing is one exception for which we have historical data available. 
According to the General household survey (1994), the average person in 
England watched over 26 hours of television a week in 1994, compared with 13 
hours in the 1960s.  
 
The latest Health Survey for England (2008) suggest only 39 % of men and 29 
% of women in the UK are meeting current minimum physical activity 
guidelines suggested by the government which involves 30 minutes or more of 
moderate or vigorous activity (20 minutes, 3 times a week) on at least 5 days a 
week. Conversly, Westerterp & Speakman (2008) suggests that physical activity 
energy expenditure has not decreased since the 1980s while the obesity rates 
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have continued to soar suggesting that an increase in energy intake must be to 
blame. Whether changes in physical activity patterns, dietary habits or a 
combination are to blame for the current obesity epidemic and the associated 
rise in chronic diseases remains disputed.   
 
1.2.2.2 Exercise metabolism 
During exercise, large quantities of fuel are metabolised in order to meet energy 
requirements to support muscle contraction. Various substrates can be utilised 
such as plasma glucose, skeletal muscle and hepatic glycogen, fatty acids as 
well as amino acids.  
 
Skeletal muscles convert chemical energy into mechanical work and therefore 
use the majority of energy during exercise. During submaximal steady-state 
exercise, the proportion of carbohydrates and fat being oxidised depends on a 
number of factors such as substrate availability, training status, exercise 
intensity and gender (Arkinstall et al., 2004). During high-intensity exercise, 
glycogen is the main source of fuel (Romijn et al., 1993). A low-glycogen state 
leads to an increased fat metabolism and amino acids are released in the 
circulation from muscle protein breakdown (Blomstrand & Saltin, 1999). 
Interestingly, muscle glycogen levels do not majorly decrease during short-term 
fasting (Vendelbo et al., 2012). 
 
The liver plays a key role by supplying additional plasma glucose during 
exercise trough the breakdown of its own glycogen into glucose 6-phosphate in 
order to supply glucose to other tissues. Fasting dramatically affects hepatic 
glycogen levels and after 24 h, liver glycogen has decreased by ~65 % 
(Magnusson, 1992). The increase in glucose utilisation by the muscle during 
exercise challenges glucose homeostasis and the liver is the main source of 
systemic glucose when fasted (Wahren et al., 1971). Glucose requirements are 
met during the early stages of exercise through glycogenolysis (Ahlborg & 
Felig, 1982). Gluconeogenesis mainly takes place in the liver by producing 
glucose from non-carbohydrate carbon substrates such as pyruvate, lactate, 
glycerol and certain amino acids (Coggan, 1991). Prolonged exercise, restricted 
carbohydrate intake as well as increased exercise intensity will increase the rate 
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of gluconeogenesis. Towards the end of prolonged exercise, the production of 
glucose through gluconeogenesis can account for up to 20-50 % of total glucose 
release (Ahlborg & Felig, 1982). 
 
Triglyceride stores are a major source of fuel for low- and moderate-intensity 
exercise and daily physical activity. The large increase in adipose tissue 
lipolysis provides glycerol available to the liver as well as non-esterified fatty 
acids (NEFA) which is used as an additional source of energy to the exercising 
muscle. The availability of NEFA to the muscles also reduces glucose 
oxidation. NEFA oxidised during exercise comes from 2 sources: triglyceride 
stored within the adipose tissue and within skeletal muscle. NEFA 
concentrations increase 2-3 fold during exercise compare to resting values, but 
the overall contribution of NEFA towards energy expenditure is limited to ~60 
% (Frayn, 2010). 
 
The liver plays a key role in amino acid oxidation as it is the only organ capable 
of eliminating the nitrogen from amino acids by synthesising urea. Amino acid 
catabolism predominantly takes place in the liver with the exception of BCAAs 
(leucine, isoleucine and valine) as well as glutamate, aspartate and asparagine 
which are largely catabolised by the skeletal muscles. Sustained exercise 
stimulates amino acid oxidation, especially of the BCAAs. As a result, ammonia 
production is proportional to exercise intensity (Rennie & Tipton, 2000). 
Although the contribution of amino acids/protein towards the energy needs 
during exercise is not as important as either carbohydrate or fat, it contributes 
significantly towards total exercise calories (Lemon & Nagle, 1981). 
 
1.3 Metabolic health and inflammation  
 
1.3.1 Link between adipose tissue and inflammation 
The global obesity epidemic currently taking place in many Westernised parts 
of the world is fast becoming a serious public health problem due to the 
resulting increased risks of developing chronic diseases such as type 2 diabetes, 
metabolic syndrome, cardiovascular diseases and certain cancers according to 
the World Health Organization. Exercise and physical activity make a major 
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contribution to total energy expenditure and therefore energy balance. Western 
lifestyles are characterised by chronically low levels of physical activity and 
excessive caloric intake, resulting in positive energy balance (Hill & Wyatt, 
2005; Uauy & Diaz, 2005), and an accumulation of triacylglycerol (TAG) 
within adipocytes. Adipose tissue has evolved to store energy efficiently for 
periods of reduced caloric intake. The adipose tissue capacity to store excess 
energy as TAG is tremendous, it can increase manifold to >80 % of body 
weight in obese people (Thompson et al., 2012) but the adipose organ is badly 
equipped to cope with this increased load. Although adipocytes typically 
constitutes 80-90% of adipose tissue volume (Thompson et al., 2012), they only 
constitute 60-70% of the total cell population. The remainder constitutes the 
stroma-vascular fraction (SVF) which includes endothelial cells, fibroblasts, 
pre-adipocytes and immune cells such as macrophages, more so in obese people 
(Langin et al., 2009). 
 
Long-term whole body energy balance is reflected in the storage of TAG within 
the adipose tissue as the two are tightly linked. The body’s ability to store 
glycogen within the liver (~100 g) and skeletal muscle (~500 g) is limited, as a 
result, long term imbalances between energy intake and energy expenditure will 
be reflected in the variation in TAG stored within adipocytes. Adipose tissue 
plays a key role in lipid metabolism; it is a key site of absorption of TAG from 
the circulation and is the only organ capable of realising large amounts of 
NEFA in the circulation as a source of energy for other tissues such as skeletal 
muscle and liver. The coordination between fat storage and mobilisation are 
tightly controlled (Frayn et al., 1995; Evans et al., 2002) and post-prandial state 
involves the whole tissue, not just adipocytes, as shown by the dynamic 
regulation of adipose tissue blood flow (Summers et al., 1996; Summers et al., 
2001). Adipose tissue is a highly vascularised tissue; in a preprandial state, 
adipose tissue blood flow is greater than the blood flow in resting skeletal 
muscle (Bickerton et al., 2007). The regulation of these processes must be 
regulated in reflection of whole body energy balance. Catecholamines regulate 
fat mobilisation and this process seems to be blunted in obese people (Horowitz 
& Klein, 2000) and weight loss does not appear to improve this impaired 
lipolysis (Blaak et al., 1994). This blunted response in fat mobilisation in 
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reaction to catecholamines is also a characteristic of childhood obesity 
(Bougneres et al., 1997; Enoksson et al., 2000) which also occurs in adipocytes 
among first-degree relatives of obese subjects (Hellstrom et al., 1996). Jocken et 
al. (2008) showed that the beta-adrenergically meditated lipolytic response of 
obese men was blunted systematically and in abdominal subcutaneous adipose 
tissue compared to lean men. This could have an impact on the development or 
maintenance of TAG stores and obesity. 
 
 Other factors such as glucocorticoids have also been shown to up-regulate 
lipolysis and thus the release of fatty acids (Samra et al., 1998). Interestingly, 
insulin has been shown to increase lipogenesis in both differentiated and 
undifferentiated adipocytes (Gathercole et al., 2011). It is likely that insulin is 
mainly responsible for diurnal variations in lipolysis which is elevated 
following an overnight fast and blunted in a postprandial state. The increase in 
lipogenesis following feeding is achieved via the increase activity of lipoprotein 
lipase (LPL) in adipose tissue capillaries following the increasing levels of 
insulin. This results in the hydrolysis of circulating TAG (Wang et al., 2009) 
which produces an excess of fatty acids, some of which will be taken up and 
stored within the adipocytes (Saleh et al., 1998). The amount of fatty acids 
taken up by the adipose tissue for storage varies (Evans et al., 2002); this leads 
to a proportion of fatty acids called the “spillover” which has not been taken up 
by the adipose tissue. Research suggests that these metabolic responses are 
more tightly regulated in lean healthy individuals compared to obese, insulin 
resistant individuals or people who suffer from type 2 diabetes (Coppack et al., 
1992; Tan et al., 2005; Tan et al., 2006). This has been described by Frayn, Tan 
& Karpe (2007) as impairment in “metabolic flexibility” or in other words a 
reduction in the normal response of the adipose tissue in response to nutrient 
intake leading to a “fat overflow”. As a result, other tissues might be exposed to 
an excess of fatty acids, especially following feeding (Frayn et al., 2002).  
 
While this lack of “metabolic flexibility” might partly explain a decrease in 
insulin sensitivity in skeletal muscle or liver, a glucose transporter type 4 
(GLUT 4) knockout mouse model suggest there might be other mechanisms 
involved. Abel et al. (2001) created a GLUT 4 knockout mouse model where an 
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adipose-selective reduction in GLUT 4 was achieved. Interestingly, this resulted 
in a state of insulin resistance in skeletal muscle and liver despite GLUT 
expression being preserved in muscle. The knock-out of GLUT 4 within 
adipocytes would have resulted in an impairment of fatty acids absorption by 
the adipose tissue as glycerol 3-phosphate resulting from glucose metabolism is 
required for fatty acid esterification. Surprisingly, the insulin resistance reported 
was not associated with an accumulation of TAG within the liver and skeletal 
muscle.  
 
A positive energy balance resulting from an excessive caloric intake and lack of 
physical activity results in hypertrophy of the adipose tissue, which is common 
in patients with type 2 diabetes in an attempt to store the energy surplus. A 
possible explanation is that larger, “triglyceride-filled” adipocytes are less 
metabolically “flexible” or have an impaired response to nutrient intake. In 
humans, large adipocytes are linked with an increased risk of developing type 2 
diabetes (Paolisso et al., 1995; Weyer et al., 2000). The lack of adipose tissue 
“flexibility” is also apparent in obese people where adipose tissue blood flow 
appears to be disturbed and this appears to be closely linked with insulin 
resistance (Karpe et al., 2002; Virtanen et al., 2002). 
 
Frayn, Tan & Karpe (2007) propose that a stimulus such as expansion of the 
adipocyte beyond its normal range might result in a metabolic “stress” which 
would induce the release of chemical signals that would attract monocytes (i.e., 
the initiation of an inflammatory process). Adipose tissue is not just a site of 
energy storage and acts as an endocrine organ capable of secreting growth 
factors and adipokines (Rajala & Scherer, 2003), which might act as a signal to 
alter the metabolism of other tissues. The authors conclude by suggesting that 
an increased fat mass might result in a metabolic inflexibility of the adipose 
tissue, compounded by inflammatory changes and the release of various 
adipokines resulting in the altered metabolism observed in other tissues. 
 
1.3.2 Link between inflammation and chronic diseases  
Adipose tissue is an endocrine organ capable of secreting a number of proteins, 
collectively called adipokines. These include various hormones and cytokines, 
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such as adiponectin and leptin, all of which can have an impact on energy 
homeostasis, metabolism, immunity and inflammation. As a result, the adipose 
tissue is capable of responding to signals from other organs by regulating the 
secretion of these adipokines. An increase in adipocyte size results in an altered 
secretory profile of some of these proteins, which can negatively impact other 
systems (Bluher et al., 2002). Almost all known adipokines are dysregulated in 
conditions such as type 2 diabetes, obesity, metabolic syndrome and 
atherosclerosis. Many adipokines involved in the aetiology of insulin resistance 
and inflammation (e.g., TNFα, IL-6) are up-regulated with increased adiposity 
while other insulin-sensitising or anti-inflammatory adipokines (e.g., 
Adiponectin) are down-regulated as fat mass increases resulting in metabolic 
complications (Maury & Brichard, 2010; Figure 1.3). 
 
 
Figure 1.3: Adipokines involved in the pathogenesis of the metabolic syndrome. 
ApN= Adiponectin; PAI-1= plasminogen activator inhibitor type 1; AGT= 
angiotensinogen; TNF-α= tumor necrosis factor-α; RBP-4= retinol-binding 
protein-4; MCP-1= monocyte chemoattractant protein-1; IL-6= interleukin-6. 
Taken from Maury & Brichard (2010). 
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Adipose tissue is unusual as a secretory organ as different fat depots 
(subcutaneous versus visceral) have different metabolic profiles and also differ 
in their adipokines secretion patterns. An increase in abdominal fat is usually 
linked with negative effects on metabolic function and mortality (Pischon et al., 
2008) while an increase in lower-body fat is linked with protective effects 
(Manolopoulos et al., 2010). Differences in secretion may have a local impact 
on the adipose tissue and intra-peritoneal fat may directly impact the liver. It is 
worth remembering that other organs might contribute to the systemic 
concentrations of certain adipokines. 
 
Enlarged adipocytes secrete some adipokines such as monocyte chemoattractant 
protein-1 (MCP-1) in excess, resulting in an infiltration of 
monocytes/macrophages. Obesity has been linked with an increase in 
macrophage infiltration (Weisberg et al., 2003; Xu et al., 2003); both BMI and 
adipocyte size have been shown to be correlated with macrophage infiltration in 
humans (Weisberg et al., 2003). Cancello et al. (2005) showed that following 
bypass surgery, morbidly obese patients experienced a drastic weight reduction 
(∆ 22.1 kg), a significant decrease in macrophage number (~ -12 %) with the 
remaining macrophages staining positive for the anti-inflammatory protein 
interleukin-10 (IL-10). Adipose tissue of obese patients shows that the majority 
of macrophages gather in “crown-like structures” which surround dead 
adipocytes (Figure 1.4; Cancello et al., 2005; Cinti et al., 2005). The 
accumulation of macrophages within adipose tissue is partly responsible for 
some of the complications linked with human obesity. It is linked with fibro-
inflammatory lesions in the liver, arterial dysfunction and reduced insulin 












Figure 1.4: Macrophage infiltration of subcutaneous adipose tissue in obese 
subjects before (T0) and 3 months after (3M) weight loss surgery. A–D: The 
morphology of subcutaneous adipose tissue of one representative morbidly 




) is shown. Infiltrating macrophages formed 
a typical crown. Immunopositivity for HAM56 (B; X100) and CD68 (C; X100). 
D: Lack of immunostaining for IL-10 (X100). Adipocytes tested negative to all 
these markers. E–H: Immunomorphology of the subcutaneous adipose tissue 
sample obtained 3 months after surgery. Routine Mayer’s hematoxylin and 
eosin staining (E; X100): absence/disorganization of macrophage crowns. 
Immunopositivity for HAM56 (F; X100) and CD68 (G; X100). H: 
Immunostaining in resting macrophages for IL-10 (X100). Percentages of 
macrophages were estimated in subcutaneous adipose tissue specimens 
before/after weight loss and in lean subjects, ***P<0.001 (I). Individual 
decreases in percentage of macrophages in 17 morbidly obese subjects 3 months 
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1.3.3 Inflammatory markers/Adipokines 
 
1.3.3.1 CRP 
Of the inflammatory measures that are readily available, serum concentration of 
C-reactive protein (CRP) is commonly used and appears to consistently predict 
the risk of cardiovascular disease. CRP is a hepatic protein which increases in 
response to trauma, inflammation or infection. It is secreted in response to 
systemic concentrations of IL-6, which is mainly produced by the adipose tissue 
(Mohamed-Ali et al., 1997), and is a useful indicator of the inflammatory state 
of the body as it has a relative long half-life compared to other inflammatory 
markers (Vigushin et al., 1993). Research suggests that CRP is the most 
accurate inflammatory marker to predict future risk of cardiovascular events 
(Schillinger et al., 2003; Rutter et al., 2004; Schulze et al., 2004), risk of death 
(Stehouwer et al., 2002), atherosclerotic progression (Kang et al., 2004) and 
development of peripheral vascular disease (Yu et al., 2004). A meta-analysis 
by Kaptoge et al. (2010) investigated whether CRP concentrations were 
associated with risk of vascular and non-vascular outcomes (cancers and 
respiratory diseases) under different conditions. The authors concluded that 
CRP concentrations were associated with future risks of cardiovascular disease, 
ischeamic stroke and deaths from vascular and non-vascular disease. Higher 
BMI has been shown to be linked with higher concentrations of CRP in young 
adults (17 to 39 years old), thus confirming that low-grade chronic 
inflammation is a feature of obesity (Visser et al., 1999). Bariatric surgery in 
morbidly obese patients has been shown to significantly reduce CRP 
concentrations (Vazquez et al., 2005) but less so in insulin-resistant patients 
(Holdstock et al., 2005), indicating that CRP might be primarily dependent 
upon insulin sensitivity rather than energy supply. Circulating CRP 
concentrations increase continuously across the spectrum of fasting glucose 
concentrations, beginning at the lowest quartile of normal fasting glucose 









Interleukin-6 (IL-6) is a pleiotropic cytokine with both anti- and pro-
inflammatory properties which is primarily secreted by white blood cells but 
also by endothelial cells and myocytes (Fischer et al., 2004). The adipose tissue 
is also a particularly important source of IL-6 secreting up to 30 % of 
circulating levels of IL-6 in healthy subjects (Mohamed-Ali et al., 1997). 
Visceral fat has been shown to produce substantial amounts of IL-6 in obese 
individuals (Fontana et al, 2007). Like CRP, IL-6 is secreted in response to 
trauma, inflammation or infection. As stated earlier, IL-6 stimulates the hepatic 
secretion of CRP and other acute phase proteins (Frayn & Stanner, 2005). There 
is growing evidence that IL-6 is also a valid predictor of future cardiovascular 
events as well as potentially playing a direct role in the progression of 
atherosclerosis (Ridker et al., 2000; Madan et al., 2008). It has been suggested 
that IL-6 might be linked with insulin resistance (Lee et al., 2009); the adipose 
tissue of insulin-resistant moderately obese women has been shown to express 
significantly more IL-6 than their insulin-sensitive counterparts (McLaughlin et 
al., 2008).  
 
1.3.3.3 Adiponectin 
Adiponectin is dramatically reduced in obesity (Baranova et al., 2007) as 
increased adiposity is associated with lower serum concentrations of 
adiponectin (Rajala & Scherer, 2003). This adipokine has direct anti-
inflammatory effects (Rajala & Scherer, 2003; Pischon et al., 2004; Shimada, 
Miyazaki & Daida, 2004; Schulze et al., 2004). Adiponectin is synthesized in 
substantial amounts exclusively by adipocytes (Baranova, 2008). In patients 
with type 2 diabetes compared with subjects without diabetes, low adiponectin 
concentrations correlate strongly with insulin resistance (Weyer et al., 2001). 
Adiponectin has been shown to increase both hepatic and peripheral insulin 
sensitivity (Fasshauer & Paschke, 2003). In insulin-resistant rodents, the 
administration of recombinant adiponectin has led to increased insulin 








Soluble adhesion molecules have a non-adipose origin, being derived primarily 
from endothelial cells and leukocytes. These molecules promote the attachment 
of leukocytes to the vessel wall in the early stages of atherosclerosis and 
subsequent migration. Soluble adhesion molecules, mainly shed from the 
surface of the endothelium are an indicator of cellular expression (Price and 
Loscalzo, 1999). Such markers provide information on inflammation within the 
vasculature (Pradhan et al., 2002; Blankenberg et al., 2003). It is noteworthy 
that soluble Intercellular Adhesion Molecule-1 (sICAM-1) independently 
predicts the risk of cardiovascular disease (Shai et al., 2006) and the risk of 
stroke in people with Type 2 Diabetes (Kanai et al., 2008). Following 3 weeks 
of caloric restriction and increased physical activity, sICAM-1was significantly 
reduced in obese men (Roberts et al., 2006). The analysis of ICAM-1 in the 
plaques obtained from coronary artery bypass suggests that it is increased with 
smoking status and altered in diabetes.  
 
1.3.3.5 Leptin 
Leptin is an adipokine that is predominantly expressed in the adipose tissue and 
is involved in the regulation of feeding behaviour. Leptin levels are correlated 
with adiposity, decreased following caloric restriction and increased with re-
feeding (Das, 2001). The primary effect is that adipocyte-derived leptin acts on 
the hypothalamus to centrally suppress feeding and fatty acid metabolism 
(Baranova, 2008). Interestingly, obese patients tend to have higher circulating 
levels of leptin explained by a relative resistance of their neurons to the effect of 
leptin (Sahu, 2003). Leptin and insulin compete for the same signaling 
molecules, in particular, JAK2/STAT-3 and phosphoinositide 3-kinase (PI3K; 
Baranova, 2008). As a result, an increase in leptin reduces insulin efficiency 
(Benomar et al., 2005). The relationship between leptin and insulin sensitivity is 
complex as it appears to have an impact on insulin action in peripheral tissues, 
pancreatic β-cells and blood vessels (Ronti et al., 2006; Seufert, 2004). 
Overfeeding studies consistently showed an increase in serum leptin 
concentrations (Joosen et al., 2006; Brons et al., 2009).  
 
 
Chapter 1                                                 Review of Literature                                         
35 
 
1.4 Metabolic control, inflammation and physical activity 
 
1.4.1 Epidemiological studies 
Many epidemiological studies have investigated the effects of physical activity 
on metabolic outcomes and markers of inflammation. A selection of these 
studies is discussed in this section. In 2003, Rennie et al. published data from 
the Whitehall II study of civil servants that included 5153 white European 
participants (age 45-67 years). Cross-sectional relationships between the 
metabolic syndrome and moderate and vigorous physical activity were 
examined. Cardiovascular fitness and BMI were examined as possible 
mediators of the observed association. Measures of HDL cholesterol, systolic 
blood pressure, 2-hour glucose values following an oral glucose tolerance test 
(OGTT), fasting TAG and waist-hip ratio were collected. Self-reported leisure-
time physical activity was categorised into separate moderate and vigorous 
activity categories. Resting heart rate and BMI were used to estimate 
cardiovascular fitness and body fatness, respectively. Participants in the most 
adverse sex-specific quintile for 3 or more of these risk factors were classified 
as having the metabolic syndrome. The odds ratios (95 % CI) for having the 
metabolic syndrome in the top categories of vigorous and moderate activity 
were 0.52 (95 % CI: 0.40, 0.67) and 0.78 (95 % CI: 0.63, 0.96) respectively, 
adjusted for age, sex, smoking, alcohol intake, socioeconomic status, and other 
activity. Adjustment for BMI and resting HR substantially attenuated both of 
the above associations. The authors concluded that vigorous and moderate 
physical leisure-time activity are each associated with decreased risk of being 
classified with the metabolic syndrome independently of age, smoking, and high 
alcohol intake. Both activities (moderate and vigorous) may be beneficial to the 
metabolic syndrome cluster of risk factors among middle-aged populations. 
Increased cardiovascular fitness and reduced BMI may be key mediators of this 
association for both intensities of activity. 
 
Demakakos et al. (2010) examined whether there was an association between 
small amounts of low-intensity physical activity and reduced risk of developing 
T2D in 7466 individuals aged 50 or over (56 % women). Participants were 
followed for a mean of 45 months. Physical activity was assessed at baseline via 
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interview. Vigorous/moderate-intensity physical activity at least once a week 
was associated with reduced risk of developing type 2 diabetes but low-intensity 
physical activity at least once a week was not after adjustment for all covariates. 
However, age-stratified analysis showed that low-intensity physical activity at 
least once a week was associated with reduced risk of developing type 2 
diabetes for those aged 70 years and over. The authors concluded that any type 
of physical activity reduced the risk of developing T2D compared to physical 
inactivity in adults aged 70 years and over. Interestingly, in adults aged 50 to 69 
years, physical activity needed to be moderate/vigorous (as opposed to low) to 
reduce the risk of developing T2D. 
 
Fischer et al. (2007) interviewed 84 healthy non-diabetic men and women on 
the amount of leisure-time physical activity they took part in. Adiponectin, CRP 
and IL-6 were measured. Participants were separated into 4 categories; active 
and non-obese, inactive and non-obese, obese and inactive or obese and active. 
Participants with a waist-hip ratio greater than 0.90 for males or 0.85 for 




 were classified as obese. CRP and IL-6 were 
associated with leisure time physical activity independent of obesity and vice 
versa. Adiponectin was associated with obesity independent of leisure time 
physical activity but not with leisure time physical activity independent of 
obesity. The authors concluded that the benefits of leisure time physical activity 
on inflammation are independent of its impact on obesity and that they might in 
fact be additive.  
 
On the whole, epidemiological studies seem to suggest that physical activity is 
beneficial in reducing markers of inflammation and reducing the risk of 
developing chronic diseases such as the metabolic syndrome and T2D. 







Chapter 1                                                 Review of Literature                                         
37 
 
1.4.2 Physical activity intervention studies and metabolic 
control/inflammation 
Many intervention studies have attempted to investigate the effects of 
exercise/physical activity on several metabolic/inflammatory markers. Some 
studies have looked at the effect of exercise per se, others have looked at 
exercise combined with caloric restriction/weight loss. Improvements in 
metabolic and inflammatory markers seem to be increased with greater 
weight/fat loss whether this is induced by increased physical activity, caloric 
restriction or a combination of both. Although there is reasonable evidence that 
weight loss alone improves metabolic and inflammatory markers, it remains 
unclear whether physical activity has the ability to improve metabolic function 
and chronic inflammation independent of changes in weight/fat mass. Current 
findings seem to suggest that lifestyle interventions combining caloric 
restriction and increased physical activity are most beneficial. Studies looking at 
the effect of exercise alone or exercise combined with caloric restriction, 
including participants who overweight/obese, are summarised in Table 1.2. 
Exercise studies including participants who are insulin resistant or suffer from 
type 2 diabetes are summarised in Table 1.3. Studies combining exercise and 
caloric restriction, including participants who are insulin resistant or suffer from 
type 2 diabetes are summarised in Table 1.4. Only recent studies are presented 
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Table 1.2: Interventions investigating the effects of exercise alone or exercise and caloric restriction on metabolic control and inflammation in 
overweight/obese participants. CR= Caloric restriction, VLCD= Very-low calorie diet, HR=heart rate, AUC= Area under the curve 
 
Author Duration Study population Intervention Body mass change Outcome 
Arsenault et al. (2009) 6 months 267 overweight/obese women   xercise 3-4 times week,  0  
   2max 
-1.4 kg 
 
Lipid profiles and inflammatory markers did not 
improve 
Brochu et al. (2009) 6 months 107 overweight/obese 
postmenopausal women 
2 groups: 1/CR 
2/CR + resistance exercise 
1/-5.1 kg 
2/-5.8 kg 
↓ in TAG, fasting insulin,  RP, no difference 
between groups     
Campbell et al. (2009) 12 months 202 sedentary, middle-aged, 
overweight/obese men and 
women  
2 groups: 1/moderate to vigorous 




No reduction in CRP 
 
Imayama et al. (2012) 1 year 439 overweight/obese 
postmenopausal women 
4 groups: 1/CR  2/aerobic exercise 




Compared to control 
CR weight loss diet with or without exercise 
reduces markers of inflammation (CRP & IL-6) 
Izadpanah et al. (2011) 2 weeks 22 overweight/obese adults High-fibre, low-fat diet + daily 45-
60 min of exercise, 70-85 % max 
HR 
∆ in average BMI 






↓ in TAG, cholesterol, HDL cholesterol, glucose, 
insulin, HOMA-IR & leptin 
Kohut et al. (2006) 10 months 97 older adults 2 groups: 1/flexibility and 
resistance exercise 2/ aerobic 
exercise 
No change in body 
weight  
↓ in  RP & IL-6 in aerobic exercise group. TNF-
α↓ in both groups. 
Olson et al. (2007) 1 year 28 overweight  women Resistance exercise at least twice a 




No changes in BP, lipids, glucose or insulin. 
 RP↓, Adiponectin↑ in resistance group. IL-6 did 
not change. 
Thompson et al. (2010) 6 months 41 sedentary middle-aged men 2 groups  1 30- 0 min exercise,  0-




↓ in IL-6 & ALT 




↓ in glucose, TAG, BP, insulin AU ,  RP & IL-6 
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Table 1.3: Interventions investigating the effects of exercise on metabolic control and inflammation in participants with IGT or T2D. IGT= 
Impaired glucose tolerance, NGT= Normal glucose tolerance, NS= Not stated, IR= Insulin resistance, BP= Blood pressure. 
 
Author Duration Study population Intervention Body mass change Outcome 
Balducci et al. (2010) 1 year 606 participants with T2D 2 groups: 1/supervised exercise 
(150 min over 2 sessions/week) 
2/counselling 
↓ in BMI ↓ in HbA1c, BP, LDL, IR. ↓ RP from 3mg l to 
2mg/l.  
 
Balducci et al. (2010) 1 year 82 participants with T2D  4 groups: 1/control 2/ low-intensity 
exercise 3/high-intensity aerobic  
4/ aerobic + resistance 
No change in fat mass ↓ in HbA1c in all exercise groups. 
 RP ↓ in aerobic and aerobic plus resistance 
(independent of changes in weight). ↓ in IL-6 
and ↑ in adiponectin 
Bloem et al. (2008) 7 days 12 sedentary older participants 
with IGT 
Supervised exercise (1h/d of 
aerobic exercise). 
No change in body 
weight 
Improvements in IR. Neither CRP or 
Adiponectin were impacted. 
Brooks et al. (2007) 16 weeks 62 participants with T2D 1/ strength training + standard care  
2/ standard care 
NS ↓ in IR, ↓ in  RP and ↑ in adiponectin 
Dekker et al. (2007) 12 weeks 24 middle-aged men (8 lean, 8 
obese, 8 obese with T2D) 
performed 60 min of aerobic 
exercise 5 times/week 
Lean: -0.4 kg 
Obese: -0.4 kg 
T2D: +0.4 kg 
↓ in IL-  in all groups,  RP wasn’t affected 
Jorge et al. (2011) 12 weeks 48 participants with T2D 4 groups (3x/week, 60 min session): 
1/control 2/aerobic 3/resistance 
4/combined 
No change in body 
weight  
↓ in BP, fasting and postprandial glucose, lipid 
profile and CRP. No difference between groups. 
 
Kadoglou et al. (2007) 6 months 60 overweight participants with 
T2D 
6-month aerobic exercise training 
programme (4 times/week,  
45-60 min/session) 
↓ in body weight   
(1.3 kg) 
Improved glucose control, lipid profile, 
decreased IR. ↓  RP, no change in adiponectin 
or TNF-α 
Kadoglou et al. (2010) 1 year 100 overweight/obese 
participants with T2D 
4 groups: 1/control 2/rosiglitazone 
3/exercise 4/exercise + 
rosiglitazone 
↓ in fat mass 1 -0.4 % 
2/-0.5 % 3/ -1.6 %  
4/-2.4 % 
Effects of exercise and drug on glycaemic 
control and various inflammatory markers were 
additive 
Marcell et al. (2005) 16 weeks 
 
51 middle-aged, overweight 
participants with IGT 
1/moderate-intensity exercise 
2/ intense exercise  
3/ no exercise 
1/ -4.7 kg  
2/ -5.6 kg  
3/ -1.1 kg 
Insulin sensitivity improved in the intense 
groups. No improvement in CRP or adiponectin  
 
Oberbach et al. (2006) 4 weeks 60 participants (NGT n=20, IGT 
n=20, T2D n=20) 
exercise program NGT: -1.4 kg 
IGT: -3.2 kg 
T2D: -1.6 kg 
Improvements in glucose metabolism and IS in 
IGT and T2D groups. CRP ↓ in all groups, IL-6 
wasn’t impacted, adiponectin ↑ in the IGT and 
T2D groups.  
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Table 1.4: Interventions investigating the effects of exercise combined with caloric restriction on metabolic control and inflammation in 
participants with IGT or T2D. IGT= Impaired glucose tolerance, NGT= Normal glucose tolerance, IR= Insulin resistance, BP= Blood pressure, 
MS=Metabolic syndrome, PA= Physical activity. 
 
Author Duration Study population Intervention Body mass change Outcome 
Belalcazar et al. (2010) 1 year 1759 obese participants with 
T2D 
2 groups: 1/ intensive lifestyle 
intervention  2/ usual care 
1/-9.0 kg 
2/-0.8 kg 
Reduced adiposity, improved glucose control and 
fitness all seemed to partially explain changes in 
CRP 
Bo et al. (2007) 1 year 335 participants with IGT 2 groups: 1/intensive lifestyle 
program 2/usual care 
1/ -0.8 kg 
2/ +1.7 kg 
↓ in most of the MS components and  RP 
Giannopoulou et al. (2005) 14 weeks 33 middle-aged women with 
T2D 
3 groups: 1/diet alone  





 RP ↓ by 1   in all 3 groups. No difference in 
adiponectin 
 
Haffner et al. (2005) 1 year 3234 participants with IGT 3 groups: 1/lifestyle intervention 





In men,  RP ↓ by 33  in the lifestyle arm,  
-7 % in metformin arm and +5 % in placebo. In 
women,  RP ↓ by 29  in the lifestyle arm, 
-14 % in metformin arm and no change in placebo 
Herder et al. (2009) 1 year 406 participants with IGT 2 groups: 1/intensive lifestyle 
program 2/usual care 
1/-4.7 kg 
2/-1.2 kg 
↓  RP and IL-6. Moderate to vigorous PA 
predicted decreases in CRP and IL-6 
Lindahl et al. (2009) 1 month 168 participants with IGT 2 groups: 1/intensive lifestyle 
program 2/usual care 
1/ -5.0 kg 
2/ -0.7 kg 
Improvements in BP, lipid profile and IR. CRP 
was not affected 
Monzillo et al. (2003) 6 months 24 obese participants with IGT 
or T2D 
combining hypocaloric diet + 
moderate physical activity 
-6.9 kg Significant improvements in IR and ↓ in leptin. 
IL-  significantly ↓ while adiponectin ↑ 
significantly amongst diabetic participants 
Schafer et al. (2007) 9 months 181 participants (133 at risk of 
T2D and 48 with IGT) 
Lifestyle intervention -2.8 kg 
 
IGT was reversed in 24 out of 48 individuals, IR 
↓ in both groups. Adiponectin significantly ↑ in 
both groups more so in the IGT, IL-  wasn’t 
impacted,  RP ↓ in both groups 
Yokoyama et al. (2004) 3 weeks 40 participants with T2D 2 groups: 1/ diet alone   
2/ diet + exercise 
Similar small 
decrease in BMI in 
both arms 
Diet + exercise improved IR further than diet 
alone. Adiponectin wasn’t affected in either group 
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1.5 Metabolic control, inflammation and diet 
 
1.5.1 Epidemiological studies 
Animal studies have shown that caloric restriction slows ageing and reduces 
the incidence of malignancies. Such studies are difficult in free-living 
conditions with participants. Evidence so far seems to suggest that caloric 
restriction reduces risk factors for type 2 diabetes and atherosclerosis. The 
Comprehensive Assessment of Long-Term Effects of Reducing Calorie 
Intake (CALERIE) is a research program involving three research centres. 
Three pilot work studies examined whether investigating the impact of 
caloric restriction in free-living humans was feasible. Preliminary data 
following 6-12 months of caloric restriction (~ -25 %) in a variety of 
participants resulted in a 10 % reduction in body weight, fat mass and 
improvements in insulin sensitivity. More recent work by Redman et al. 
(2009) focussed on investigating the metabolic and behavioural adaptations 
to caloric restriction in free-living conditions. For the study duration of 6-
months, 48 overweight participants were randomised to 4 groups: 1/ control 
group provided with 100 % of energy requirements, 2/ 25 % caloric 
restriction, 3/ 12.5 % caloric restriction plus 12.5 % increase in energy 
expenditure by structured exercise, 4/ low calorie diet (890 kcal/d) until 15 
% weight reduction was achieved followed by weight maintenance. Similar 
weight loss was achieved through caloric restriction alone (-10.4 ± 0.9 %; 
mean ± SE) and caloric restriction combined with structured exercise (-10.0 
± 0.8%) while the low calorie diet led to a weight loss of -13.9 ± 0.8 %. 
Interestingly, the total daily energy expenditure was significantly reduced in 
the caloric restriction group (-454 ± 76 kcal/day) and low calorie diet group 
(-633 ± 66 kcal/day) but not in the control and caloric restriction and 
structured exercise groups. These data potentially explain why caloric 
restriction causes large inter-individual variability in the rates of weight loss 
and how lifestyle interventions combining diet and physical activity might 
be more successful in maintaining weight loss in the long term. 
 
A study by Hu et al. (2001) followed 84 941 female nurses from 1980 to 
1996. Participants were free from cardiovascular disease, type 2 diabetes 
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and cancer at baseline. Information about their lifestyle and diet was 
regularly updated. A low-risk group was defined according to five variables: 
BMI<25; physical exercise for at least 30 min per day; a diet high in fibre, 
polyunsaturated fat and low GI, non-smoker and consumption of half a 
drink of an alcoholic beverage per day. During the intervention, 3300 new 
cases of type 2 diabetes were documented with overweight/obese being the 
single most important predictor of developing type 2 diabetes. Smoking 
status, lack of physical activity, a poor diet and complete abstinence from 
alcohol were all associated with an increased risk of developing type 2 
diabetes. Of the 3300 new cases of type 2 diabetes, 91 % of these cases 
























Chapter 1                                                 Review of Literature                                         
43 
 
1.5.2 Dietary intervention studies and metabolic control/inflammation 
Many intervention studies have attempted to investigate the effects of 
dietary restriction on several metabolic/inflammatory markers. Recent 
intervention studies suggest that lifestyle interventions have the potential to 
reduce the risk of developing type 2 diabetes through a targeted reduction in 
body weight. Improvements in metabolic and inflammatory markers seem to 
be increased with greater weight/fat loss following caloric restriction. The 
improvements are similar to those reported with increased physical activity 
suggesting that weight/fat loss seem to be the main contributor whether this 
is induced by increased physical activity, caloric restriction or a 
combination of both. A systematic review by Selvin et al. (2007) concluded 
that for each 1 kg of weight loss, the mean change in CRP level was -0.13 
mg/L. Future studies carefully manipulating energy balance trough either 
caloric restriction and/or increased physical activity are required to further 
elucidate the mechanisms by which both stimuli potentially improve 
metabolic function and inflammatory markers. Studies looking at the effect 
of diet alone including participants who are overweight/obese are 
summarised in Table 1.5. Dietary studies including participants who are 
insulin resistant or suffer from type 2 diabetes are summarised in Table 
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Table 1.5: Interventions investigating the effects of diet on metabolic control and inflammation in overweight/obese participants. CR= Caloric 
restriction, VLCD= Very-low calorie diet, EI=Energy intake, EE= Energy expenditure, SVF= Stromavascular fraction, AT= Adipose tissue, 
EX= Exercise, IR= insulin resistance 
 
Author Duration Study population Intervention Body mass change Outcome 
Clement et al. (2004) 4 weeks 29 obese women 2 groups: 
1/28 days VLCD 




↓ in fasting insulin, IR, TAG, cholesterol 
following 28 days of VLCD. Decrease of pro-
inflammatory factors and increase of anti-
inflammatory factors within the SVF of the AT. 
Fontana et al. (2007) 1 year 46 middle-aged overweight 
participants 
2 groups: 
1/CR (-20 % EI) 
2/Exercise (+20 % EE) 
1/-8.2 kg 
2/-6.6 kg 
Similar reduction in fat mass and CRP between 
groups. Improvements in lipid profiles, HOMA-
IR.  
Heilbronn et al. (2001) 12 weeks 83 obese women Low-fat (15 % of total energy) -7.9 kg Improvements in lipid profiles, significant 
decreased in CRP 
Larson-Meyer et al. (2006) 6 months 48 overweight participants 4 groups: 1/control 
2/25% CR 
3/12.5% CR+ 12.5 % EX 
4/15 % weight loss through VLCD 





Improvement in insulin in all 3 intervention 
groups.  
Nicklas et al. (2004) 18 months  316 older overweight or obese 
sedentary men and women 








Diet-induced weight loss resulted in greater ↓ in 
CRP. Exercise training did not have a significant 
effect on the inflammatory biomarkers. 
Tchernof et al. (2002) ~14 months 25 obese postmenopausal 
middle-aged women 
1200 kcal/day until achieved target 
weight 
-14.5 kg Improvement in lipid profiles, significant 
decreased in CRP 
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Table 1.6: Interventions investigating the effects of caloric restriction on metabolic control and inflammation in participants with IGT or T2D. 
IGT= Impaired glucose tolerance, NGT= Normal glucose tolerance, NS= Not stated, IR= Insulin resistance, BP= Blood pressure, 
MS=Metabolic syndrome, PA= Physical activity, CR= Caloric restriction, VLCD= Very-low calorie diet 
 
Author Duration Study population Intervention Body mass change Outcome 
Brinkworth et al. (2004) 8 weeks 66 obese participants with T2D 2 groups: 1/ low-protein diet   
2/ high-protein diet 
8 weeks of CR followed by 4 weeks 
of energy balance. Maintained diet 
for 12 months 
1/-2.2 kg 
2/-3.7 kg 
Data at week 64 
38 participants completed study.  
↑ in HDL cholesterol ↓in  RP 
Esposito et al. (2004) 2 years 180 participants 
 (99 men/81women) with MS 
2 groups: 1/ an intervention group 
(Mediterranean diet)  




Participant in the intervention group significantly 
↓ their  RP, IL-6 and IR levels compared to the 
control group 
Hammer et al. (2008) 16 weeks 12 obese, insulin treated 
participants with T2D 
VLCD, insulin was stopped during 
the study 
∆ in average BMI 
from 35.6 to 27.5 
Improvements in HbA1c, Adiponectin 
significantly increased (∆2. ug l) and  RP was 
drastically reduced (∆11mg l) 
 
Jenkins et al. (2008) 6 months 210 participants with type 2 
diabetes treated with anti-
hyperglycaemic medications 
2 groups: 1/high–cereal fibre diet  




In patients with type 2 diabetes, 6-month 
treatment with a low–glycaemic index diet 
resulted in moderately lower HbA1c levels 
compared with a high–cereal fibre diet. 
Petersen et al. (2005) 3-12 weeks 8 obese participants with T2D liquid diet formula which was 
supplemented with fruits and 
vegetables to ~1200 kcal/d 
until achievement of normo-
glycaemia  (3-12 weeks) followed 
by 4 weeks of weight stabilisation 
8 kg Fasting hyperglycaemia was normalised. Neither 
IL-6 or Adiponectin were impacted by the 
intervention. 
Wolever et al. (2008) 1 year 162 participants with T2D 3 groups: 1/high CHO, high GI diet 
2/high CHO, low GI diet  
3/low CHO, high monosaturated fat 
diet  
Fell over the first 8 
weeks then rose 
steadily 
CRP decreased similarly in the high GI and low 
GI diet but increased in the low CHO diet group. 
CRP values were significantly different between 
groups at baseline. 
Xydakis et al. (2004) 4-6 weeks 80 men and women, 40 with 
metabolic syndrome 
VLCD (600-800 kcal/d) 




 RP ↓ in participants with MS. Adiponectin was 
not affected. 
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1.5.3 Potential mechanisms for independent benefits of physical activity 
Although it appears that regular physical activity is effective in preventing several 
chronic diseases (e.g., hypertension, cardiovascular disease, diabetes and obesity) it is 
still unclear whether physical activity per se improves makers of inflammation and 
metabolic health. Several biological mechanisms may contribute to the reduction in the 
risk of developing chronic diseases. Regular physical activity has been shown to improve 
body composition and improve lipid profiles (Warburton et al., 2001). It is possible that 
one of the mechanisms by which regular exercise impacts health is by maintaining a 
metabolically healthy adipose tissue. A positive energy balance will ultimately results in 
an increase in visceral and subcutaneous adipose tissue followed by the infiltration of 
pro-inflammatory T cells and macrophages leading to chronic low-grade systemic 
inflammation (Gleeson et al., 2011). 
 
A series of changes take place as a result of regular physical activity including a turnover 
of liver and skeletal muscle glycogen stores. This results in an increase in glycogen 
synthase (Christ-Roberts et al., 2004), hexokinase activity (Mandroukas et al., 1984) and 
GLUT4 mRNA and protein expression (Dela et al., 1994). This regular turnover might 
be one of the mechanisms by which regular physical activity benefits health.  
 
Pedersen (2007) suggest that the increase in IL-6 released by contracting muscle during 
exercise results in a net anti-inflammatory effect. This is followed by an increase in anti-
inflammatory cytokines such as IL-10. Therefore, it is possible that the anti-

















This review has demonstrated that reduced physical activity and excess 
weight/fat resulting from long term positive energy balance are associated with 
increased concentrations of inflammatory markers as well as a reduction in 
insulin sensitivity. This pro-inflammatory environment and increased 
concentrations of these markers are associated with increased risks of developing 
chronic diseases such as type 2 diabetes, the metabolic syndrome and 
cardiovascular diseases. A reduction in weight/fat mass through an energy deficit 
appears to be associated with improvements in markers of inflammation and 
metabolic control. Whether this is best achieved via caloric restriction, increased 
physical activity or a combination remains unclear. Therefore, the aim of this 
thesis is to investigate the impact of physical activity/exercise and energy 
balance on metabolic control and inflammation and whether the potential 
benefits of exercise are specific to its characteristics (such as duration and 
intensity) 









This chapter outlines the generic methodologies that were used throughout the 
Chapters 4 and 5 of this thesis. The methods in Chapter 3 were specific and are 
described therein. All human experimental investigations were conducted within 
the Applied Physiology Research Laboratory at the University of Bath. Each 
study received ethical approval from the Bath NHS Research Ethics Committee 
prior to commencement.  
 
In Chapter 4, subjects were habitually active males aged 18-40 years. 
Participants described in Chapter 5 were sedentary, overweight/obese (body mass 




) males and postmenopausal females aged 45-64 years. 
Volunteers were recruited via advertisement within the local community. Prior to 
taking part in any study, participants were provided with an information sheet 
detailing the requirements of the research. All subjects gave written consent to 
participate and were asked to complete a medical history questionnaire 
(Appendices 1 & 2) and a Physical Activity Readiness Questionnaire (PAR-Q; 
Appendix 3). Individuals who smoked, suffered from a condition known to 
interact with the study measures or took regular medication that may have 
interfered with the results were excluded from the study. 
 
2.2 Anthropometry 
Height was measured and recorded to the nearest 0.1 cm using a fixed 
stadiometer (Holtain Ltd., UK). Body mass was measured and lean and fat mass 
estimated and recorded to the nearest 0.1 kg using biological impedance enabled 
electronic scales (Tanita Corporation, Japan). All subjects were required to wear 
the same light clothing for this measurement on every occasion. BMI was 
calculated for all subjects as BMI = weight (kg) / height (m
2
). Fat Mass Index 
(FMI) was calculated for all subjects as FMI = fat mass (kg) / height (m
2
). Waist 
and hips circumference were measured in triplicate using a metallic tape measure 
(Lufkin, US); the mean value was calculated. Lean and fat mass were also 
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estimated using Dual-energy X-ray absorptiometry (DEXA). After descriptive 
details were entered into the QDR for Windows software (Hologic, Bedford, 
UK), subjects were asked to lie supine on the DEXA scanning table (Discovery, 
Hologic, Bedford, UK). Participants were positioned centrally on the scanning 
table with feet spaced evenly either side of the mid-point of the body with arms 
placed mid-prone with an equal gap to the trunk on both sides. Participants were 
requested to remain still whilst the scan was performed by an individual trained 
in ionising radiation regulations (medical exposure). Scans were analysed for 
total fat mass, abdominal fat mass (L1-L4), lean mass, bone mineral content and 
fat percentage following the guidelines described in the QDR for Windows 
manual (Hologic, Bedford, UK). 
 
2.3 Blood Pressure 
Blood pressure was measured using an automated blood pressure monitor 
(Dinamap PRO Series 100, GE Medical Systems, Germany) in a seated position 
after subjects had rested for at least 10 minutes.  Three readings were taken; the 
mean value was calculated. 
 
2.4 Blood Sampling 
All participants reported to the laboratory in the morning after an overnight fast 
(no food or drink except water for at least 10 hours). Following the application of 
a topical local anaesthetic (1.5 ml Ametop gel, Smith & Nephew, Hull, England) 
an 18-gauge 1.3 x 45 mm cannula (BD Venflon Pro) was inserted into an 
antecubital vein. Participants remained in a supine position for 15 min prior to all 
blood sampling. Venous blood samples were obtained using a stopcock and 
syringe at several time points throughout the trial. The cannula was kept patent by 
periodic flushing with 0.9 % Sodium Chloride solution (B.Braun, UK). All blood 
samples were collected using syringes. For the Oral Glucose Tolerance Test 
(OGTT), participants were required to drink 113 ml (75 g) of a glucose 
(maltodextrin) solution (Polycal, Nutricia, UK) within 5 min. Blood samples were 
collected every 15 min for 2 hours. A 5 ml waste sample was drawn and 
discarded before collecting each sample. Blood was dispensed into collection 
tubes (Sarstedt Ltd., Leicester, UK) containing ethylenediaminetetraacetic acid 
(EDTA) as the anticoagulant for plasma samples or serum-separator tubes for 
serum samples.  
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2.5 Blood Analysis 
Whole blood differential leukocytes counts were obtained using an automated 
haematology system (SF-300, Sysmex Ltd., Milton Keynes, UK). Plasma tubes 
were centrifuged straight away (Heraeus Biofuge Primo R, Kendro Laboratory 
Products Plc., England) at 5000 rpm (3500 g) for 10 min at 4
o
C. Serum samples 
were left to clot for 15 minutes at room temperature before being centrifuged 
(Heraeus Biofuge Primo R, Kendro Laboratory Products Plc., England) at 5000 
rpm (3500 g) for 10 min at 4
o
C. Serum and plasma were transferred to separate 
tubes before being stored at -80
o
C. All blood analyses were performed in 
duplicate. Immunoassays for serum triacylglycerol (TAG), total and high-density 
lipoprotein (HDL) cholesterol, alanine transaminase (ALT), plasma glucose 
(Randox, Crumlin, Co. Antrim, UK), non-esterified fatty acids (NEFA; 
Wakochemicals GmbH, Germany) were performed using a Cobas Mira (Cobas, 
Roche Diagnostics Limited, UK). Low-density lipoprotein (LDL) cholesterol was 
calculated using the Friedewald equation (Friedewald et al., 1972). Homeostasis 









) / 22.5 (Turner et al., 1979). 









) - 3.5 (Matthews et al., 
1985). The Insulin Sensitivity Index (ISI comp/Matsuda Index) was calculated as 








) x (mean 
OGTT glucose value x mean OGTT insulin value) (Matsuda & DeFronzo, 1999).  
 
Commercially available enzyme-linked immunosorbent assays (ELISA) were 
used to measure serum Adiponectin, Leptin, C-Reactive Protein (CRP) 
(Quantikine, R&D Systems Inc., Abingdon, UK) Interleukin 6 (IL-6; Quantikine 
HS, R&D Systems Inc., Abingdon, UK) Insulin, C-peptide (Mercodia AB, 
Uppsala, Sweden). Absorption was determined using a microplate reader (HTIII, 
Anthos Labtec Instruments Ltd., Ringer, East Sussex) at the wavelengths 
specified by the kit manufacturer. Coefficients of variation and minimal 
detectable concentrations provided by the manufacturer for each ELISA are 
summarised in Table 2.1. 
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Table 2.1: Reported sensitivity, intra and inter-assay precision for all ELISAs 
used. 


















 5.5 % 6.5 % 














 3.6 % 3.3 % 
 
2.6 Sub-maximal and Maximal Oxygen Uptake     2max) Testing 
In Chapter 4, participants’ preliminary visit to the laboratory comprised two 
exercise tests following a method adapted from Taylor et al. (19  ). The first of 
these tests determined the oxygen uptake (   2) of each participant at a variety of 
sub-maximal running speeds on a treadmill ergometer (Woodway, ELG 70, 
Weiss, Germany). Typically this test was completed within 20 min, with the 
treadmill speed increasing at 5 min intervals such that a range of at least 4 
intensities could be monitored. For most participants, treadmill speeds of 




 were sufficient to encompass all the relative exercise 
intensities employed during subsequent exercise sessions (nominally spanning a 




). During the final minute of each 5 min stage, 
expired gas samples along with ratings of perceived exertion (RPE; Borg, 1973) 
and heart rates (HR) were recorded. HR were recorded throughout all these 
investigations via short range telemetry (Polar RS200, Finland). Gas samples 
were taken at the end of every stage to determine the relationships between    2, 
exercise intensity (speed) and HR in order to calculate the correct speed re uired 
to obtain  0  and 70     2max. 
 
Approximately 20 min following the sub-maximal oxygen uptake test, 
participants completed a second test to assess their    2max. This test involved 
incremental continuous treadmill running until the point of volitional exhaustion. 
The speed at which this test was conducted was dictated by the data recorded 
during the sub-maximal test with a speed initially eliciting approximately 75-85 
% of age-estimated maximum HR was selected. Participants ran at this speed 
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against a 2.5 % gradient which was increased by 2.5 % after every 3 min stage. 
One minute expired air samples, RPE and HR were measured in the final minute 
of each stage and also at the point of volitional exhaustion, defined as when the 
participant indicated that only 1 min remained until fatigue. A number of criteria 
were applied to determine whether this endpoint was reflective of a valid    2max 











 in response to an increased gradient; and an RPE= 20. Each participant 
met at least two of these four criteria. While progressive incline protocols may be 
less likely to fulfil all 4 of these criteria in comparison with level running 
protocols, the resultant    2max value is not thought to differ significantly 
between the two methods (St. Clair Gibson et al., 1999). 
 
In Chapter 5, participants underwent a graded walking stress test according to a 
modified Bruce protocol to assess their    2max. This test involved incremental 
continuous treadmill walking until the point of volitional exhaustion. For most 




 was chosen. Participants walked at this 
speed against a 0 % gradient which was increased by 2.5 % after every 3 min 
stage. One minute expired air samples, RPE and HR were measured in the final 
minute of each stage and also at the point of volitional exhaustion, defined as 
when the participant indicated that only 1 min remained until fatigue. The same 
criteria described above were applied to determine whether this endpoint was 
reflective of a valid    2max value. Gas samples were taken at the end of every 
stage to determine the relationships between    2, exercise intensity (gradient) 
and HR in order to calculate the correct gradient and speed re uired to obtain 
either  0  or 70     2max. 
 
2.7 Expired Gas Analysis 
Expired gases were collected into Douglas bags with participants wearing a 
respiratory valve (mouthpiece) and nose clip throughout gas collection. The 
respiratory valve was worn for at least 30 s before gas sample collection in order 
to flush the respiratory valve and associated tubing of atmospheric air and settle 
any initial hyperventilation. The percentage of oxygen (O2) and carbon dioxide 
(CO2) in expired air samples was determined using paramagnetic and infrared 
gas analysers, respectively (Series 1400, Servomex Ltd., Sussex, UK). These 
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analysers were calibrated within 1 hour of each test with gases of known 
composition within the physiological range (British Oxygen Company, UK). 
Expired air volume was determined using a dry gas meter (Harvard Apparatus, 
Kent, UK) and corrected to standard temperature and pressure (dry gas). The 
total volume of expired air was taken as the sum of the volume used for gas 
composition analysis and that evacuated by the dry gas meter. Room temperature 
and pressure were recorded.  xygen uptake (   2) and carbon dioxide 
production (    2) were calculated for each expired air sample as determined by 
the Haldane transformation. R R was calculated (    2 /    2) for each expired 
air sample.  
 
2.8 Assessment of Physical Activity 
Habitual physical activity was determined using a physical activity monitor 
(Actiheart, Cambridge Neurotechnology Ltd., Cambridge, UK). This is a 
combined heart rate monitor and accelerometer. The monitor was worn for seven 
whole, consecutive days, recording data every minute over the time period worn. 
Participants were not informed of the function of the monitor so as to minimise 
changes in behaviour. This data was then downloaded and a software program 
(Actiheart 2.0, Cambridge Neurotechnology Ltd., Cambridge, UK) was used to 
produce a plot of the heart rate and accelerometry data (Figure 2.1), as well as an 
approximated Metabolic Equivalent of Task (MET) level at each time point, 
calculated from these two variables. The software was used to estimate Activity 
Energy Expenditure (AEE) (Figure 2.2) using branched-equation modelling, 
providing precise estimates of energy expenditure in minute-by-minute epochs 
validated by Brage et al. (2005) and Thompson et al. (2006). 
 




Figure 2.1: Example of an output from the Actiheart software. The top plot 








), against time, 
over a 24 h period. The bottom plot shows number of METS against time.  
 
 
Figure 2.2: Example of an output from the Actiheart software. The figure shows 
the estimated Resting Energy Expenditure (REE), Activity Energy Expenditure 
(AEE), Diet Induced Thermogenesis (DIT), Total Energy Expenditure (TEE) and 
Physical Activity Level (PAL; TEE/REE) as well as the average for the seven 
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2.9 Assessment of Dietary Intake  
Participants were asked to record their food and fluid intake for a “typical” whole 
week (7 days) prior to taking part in the study. Each subject received a set of 
weighing scales (Model 3001, Salter, Kent, UK) to accurately fulfil this 
requirement. Subjects were asked to consume their habitual diet and not to eat 
less than usual during the recorded week. Diets were analysed using the software 
CompEat Pro Version 5.8.0 (Nutrition Systems, UK), which is based on food 
composition tables for UK foods. Energy intake was estimated using the software 
and DIT was estimated pre-intervention as 10 % of energy intake (Westerterp, 
2004).  
 
2.10 Adipose Tissue Biopsy 
After cleaning the skin with an Iodine-based solution (Videne Alcoholic Tincture, 
Ecolab, UK), a subcutaneous adipose tissue sample was obtained from the 
abdominal wall, 4-7 cm lateral of the umbilicus. Once the Iodine-based solution 
had dried, ~5 ml of a 1 % Lidocaine Hydrochloride solution (Hameln 
Pharmaceuticals Ltd., Gloucester, UK) was injected using a 27 G needle in a fan-
like pattern into the biopsy site. After waiting 5 min for the area to become 
anaesthetised, a 50 ml syringe was filled with 5-10 ml of a 0.9 % Sodium 
Chloride solution (B.Braun, UK) and fitted with a 14 G needle. The needle was 
inserted through the skin and into the fat. Suction was applied by pulling the 
plunger of the 50 ml syringe out; a piece of rigid plastic was then inserted 
between the end of the barrel and the end of the plunger to create a vacuum in the 
syringe. Adipose tissue was obtained by rocking the needle back and forth until 
enough tissue was obtained. After removing the needle, pressure was applied for 
at least 15 min until bleeding had stopped. Follow-up biopsies were taken from 
the opposite side.  
 
2.11 Adipose Tissue Sample Processing 
The sample was cleaned with isotonic saline and any clot was manually removed. 
After weighing the sample, it was homogenised in 5 ml of Trizol (Invitrogen, 
UK) and stored at -80
o
C. Samples were defrosted and spun for 5 min at 2500 g, 
4
o
C. The top layer and pellet were removed. 200 µl of Chloroform was added per 
1ml of Trizol. After shaking the mixture vigorously for 15 s, samples were 
incubated at room temperature for 3 min and then spun for 5 min at 2500 g, 4
o
C. 
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The aqueous phase was removed and used for gene expression analysis (Chapter 
2.12) while the organic phase was used for Western Blot analysis (Chapter 4.2.7). 
 
2.12 Gene Expression Analysis 
The aqueous phase was mixed with an equal volume of 70 % Ethanol before 
being loaded on an RNeasy mini column (Qiagen, Crawley, UK). Total RNA 
was then extracted using the standard protocol supplied with the columns. Each 
sample was quantified using spectrophotometry. 2 µg of total RNA was then 
reverse transcribed using a high capacity cDNA Reverse Transcription kit 
(Applied Biosystems, Warrington, UK). Pre-designed primers and probes were 
obtained from Applied Biosystems for each gene tested. Real-time PCR was 
performed using a StepOne
TM  
(Applied Biosystems, Warrington, UK). 
Peptidylpropyl isomerase A (PPIA) was used as an endogenous control. The 
comparative Ct method was used to process the data where ΔCt = Ct Target gene 
– Ct Endogenous control and where ΔΔCt = ΔCt Sample – ΔCt Reference. Fold 
changes were calculated using the following formula; Fold change = 2 
–ΔΔCt
. The 






















Diet or diet plus physical activity provide similar positive 
changes in inflammation in patients with newly-
diagnosed type 2 diabetes compared to usual care: The 
Early ACTID randomised controlled trial 
 
3.1 Introduction 
Epidemiological studies indicate that a variety of systemic markers of low-grade 
inflammation are related to risk of future cardiovascular events in people with 
diabetes (Stehouwer et al., 2002; Pearson et al., 2003; Ridker, 2003; Rosenson & 
Koenig, 2003; Schillinger et al., 2003; Rutter et al., 2004; Schulze et al., 2004; 
Kanai et al., 2008). Of the measures that are readily available, high sensitivity 
serum concentrations of C-reactive protein (CRP) is probably the most widely 
used and appears to have consistent predictive value. In patients with Type 2 
Diabetes, CRP is an independent risk factor for cardiovascular events 
(Schillinger et al., 2003; Rutter et al., 2004; Schulze et al., 2004), risk of death 
(Stehouwer et al., 2002), atherosclerotic progression (Kang et al., 2004) and 
development of peripheral vascular disease (Yu et al., 2004). Circulating CRP 
concentrations increase continuously across the spectrum of fasting glucose 
concentrations beginning at the lowest quartile of normal fasting glucose 
(Aronson et al., 2004).  
 
Measures of inflammation capture additional information to conventional 
cardiovascular risk factors (Biondi-Zoccai et al., 2003; Sattar et al., 2003; 
Ridker, Wilson & Grundy, 2004) and therefore represent an important adjunct to 
existing procedures (Pearson et al., 2003). Since it appears unlikely that CRP per 
se actually causes cardiovascular disease (Wensley et al., 2011), it has been 
argued that other inflammatory molecules are more likely to represent direct 
mediators and thus should also be measured (Brunner et al., 2008; Wensley et 
al., 2011). In this context, it is noteworthy that increased hepatic secretion of 
CRP is generally thought to be triggered by an increase in systemic Interleukin-6 
(IL-6; Heinrich, Castell & Andus, 1990). Since IL-6 is pro-inflammatory and 
adipose tissue is a particularly important source of IL-6 (Mohamed-Ali et al., 
1997), it is possible that IL-6 represents a mechanistic link between adiposity or 
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adipose function and hepatic secretion of CRP (i.e., with IL-6 playing a direct 
pro-inflammatory role and CRP acting as an excellent surrogate marker partly by 
virtue of considerations such as a relatively long half-life (Vigushin et al., 1993). 
Increased adiposity is also associated with lower serum concentrations of 
adiponectin (Rajala & Scherer, 2003) and this adipokine has direct anti-
inflammatory effects (Rajala & Scherer, 2003; Pischon et al., 2004; Schimada, 
Miyazaki & Daida, 2004; Schulze et al., 2004). Thus, measurement of IL-6 and 
adiponectin provide information on pro- and anti-inflammatory pathways, 
respectively, and these may be heavily influenced by adipose tissue accumulation 
and dysfunction. In contrast, other markers of inflammation such as soluble 
adhesion molecules have a non-adipose origin being derived primarily from 
endothelial cells and leukocytes. Such markers provide information on 
inflammation within the vasculature (Pradhan, Rifai & Ridker, 2002; 
Blankenberg, Barbaux & Tiret, 2003) and it is noteworthy that soluble 
Intercellular Adhesion Molecule-1 (sICAM-1) independently predicts the risk of 
cardiovascular disease (Shai et al., 2006) and the risk of stroke in people with 
Type 2 Diabetes (Kanai et al., 2008). Thus, the measurement of multiple 
measures of inflammation will provide more information about these complex 
inter-related biological processes than a single measure alone. 
 
Increased physical activity and dietary advice implemented by healthcare 
professionals is recommended by international consensus in the management of 
type 2 diabetes (Nathan et al., 2009). The impact of diet and/or physical activity 
on markers of inflammation in patients with type 2 diabetes has been poorly 
characterised. Although there is reasonable evidence that weight loss alone 
improves inflammatory markers in patients with type 2 diabetes (Hotta et al., 
2000; Brinkworth et al., 2004; Hammer et al., 2008), the evidence base to 
demonstrate whether physical activity has the potential to elicit changes in 
chronic inflammation over and above those gained through weight loss alone is 
weak. Several studies confirm that intensive interventions designed to reduce 
weight and/or increased participation in supervised exercise can lead to profound 
beneficial effects on inflammatory markers in people with type 2 diabetes (e.g., 
Xydakis et al., 2004; Jorge et al., 2011; Kadoglou et al., 2013). One larger study 
confirmed that supervised exercise can reduce CRP in people with type 2 
diabetes (Balducci et al., 2010).  It is critical to answer the central question of 
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whether physical activity has relative benefits in established diabetes over and 
above those induced by dietary restriction alone in order to better inform clinical 
practice and patient guidelines. 
 
The aim of this study is to investigate the impact of diet and diet plus physical 
activity on inflammation in the Early ACTID randomized controlled trial 
(Andrews et al., 2011). Early ACTID is a large study that was designed to 
evaluate the impact of physical activity over-and-above the impact of dietary 
intervention whilst controlling for overall contact time with patients. The 
physical activity was unsupervised and community-based in order to increase the 
potential relevance of the findings for clinical care given that the provision of 
supervised physical activity will be unlikely in most healthcare settings because 




Early ACTID was a multicentre, parallel-group, randomized controlled trial. The 
study was approved by the Bath Research Ethics Committee (05/Q2001/5), and 
all participants provided written informed consent. This study is registered 
(number ISRCTN92162869) and has been described in detail previously 
(Andrews et al., 2011). Early ACTID is a large study and represents the work of 
many investigators. The unique results reported in this thesis represent the 
biochemical and statistical analysis of four inflammatory outcomes (CRP, IL-6, 
sICAM-1, and adiponectin) at each time point during Early ACTID 
(approximately 600 unique samples and thus ~1800 measurements in total for 
each analyte).  
3.2.2 Patients 
Briefly, eligible patients had been diagnosed within the previous 5–8 months and 
were older than 30 years at diagnosis. Exclusion criteria were: age older than 80 
years, HbA1c concentration greater than 10 %, blood pressure higher than 









, mass greater than 180 kg, use of weight-
loss drugs, taking a sulphonylurea at the maximum dose, unstable angina, a 
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myocardial infarction within the previous 3 months, inability to increase physical 
activity, and pregnancy or planning to become pregnant. 
 
3.2.3 Randomisation 
As described previously, patients were assigned using a computer-generated 
allocation in a 2:5:5 ratio to usual care, an intensive diet intervention, or the 
intensive diet intervention plus activity (Andrews et al., 2011). Allocation was 




The usual care arm was designed to serve as a control group and consisted of 
standard dietary and exercise advice after randomisation, with reviews by a study 
doctor and nurse at baseline, 6 and 12 months.  
 
The intensive diet intervention arm aimed to enable patients to lose and maintain 
a 5-10 % reduction of their initial body weight (Andrews et al., 2011). The diet 
was not prescriptive; goals were negotiated individually with each participant. 
Participants saw a dietician at 3, 6, 9, and 12 months and this was supplemented 
by dietary advice and goal setting by nine 30 min appointments with study 
nurses; approximately one every 6 weeks over the course of the study.  
 
Patients in the intensive diet and physical activity group received the same 
dietary intervention as the intensive diet group but were also asked to undertake 
at least 30 min brisk walking on at least 5 days per week over-and-above their 
existing physical activity. Each patient was given a pedometer (Digiwalker 
CW200, Yamax, Japan) and a folder containing motivating literature and pages 
for recording daily physical activity (pedometer readings). Activity targets were 
gradually increased over 5 weeks and maintained for the remainder of the study. 
Activity was discussed during the same nurse appointments in order to keep the 
total contact time the same as in the intensive diet intervention group. 
 
3.2.5 Clinical management of patients 
Management of type 2 diabetes, blood pressure, and lipid profile was undertaken 
by the study team for the period of the trial. Any changes in treatment of these 
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features were made by a doctor unaware of treatment allocation and according to 
a strict trial protocol to keep the risk of performance bias to a minimum. Diabetes 
treatment was only changed in the first 6 months in exceptional cases whereas, 
during the second 6 months, patients were treated to achieve pre-determined 
clinically-relevant targets.  
 
3.2.6 Inflammatory Markers 
Serum C-reactive protein (CRP) was determined using an automated high 
sensitivity immunoturbidimetric assay and RX Daytona clinical chemistry 
analyser (Randox Laboratories Ltd., UK). Serum was analysed for IL-6 
(Quantikine HS, R&D Systems Inc., Abingdon; UK), sICAM-1 and Adiponectin 
using commercially-available solid phase ELISAs (Quantikine, R&D Systems 
Inc., Abingdon; UK). Average intra- and inter-assay coefficient of variation (CV) 
was established from the repeated analysis of 20-60 samples at different 
concentrations.  
 
3.2.7 Statistical analysis 
The primary endpoint was the difference between arms in the change in CRP 
from baseline to 6-months, adjusting in an ANCOVA model for the minimisation 
variables (age, sex, fitness, route into the study, blood pressure), the baseline 
value, and study centre. Importantly, in the first 6 months of Early ACTID 
medication was not adjusted. Planned comparisons were conducted between diet 
plus activity vs. usual care, diet vs. usual care, and diet plus activity vs. diet, with 
no adjustment for multiple comparisons (Perneger, 1998). The same analysis was 
conducted for the secondary outcome variables; IL-6, s-ICAM-1, and 
Adiponectin, and repeated for the 12-months timepoint for all variables.  Mean 
effects are presented together with their 95 % confidence intervals. Outcome 
variables were natural log-transformed prior to analysis, to normalise residuals 
and stabilise variance. Resulting effects are therefore presented as percent (ratio) 
differences between arms in change from baseline, derived from back-
transformation of the differences on the log scale. Analysis was according to 
intention-to-treat using a full information maximum likelihood method (Enders 
& Bandalos, 2001) using the Stata (version 12.1, Stata Corp, College Station, 
Texas, USA) structural equation modelling (SEM) module. Both CRP and IL-6 
can be influenced by acute infections and so we used a sensitivity analysis to 
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 for IL-6) influenced the outcome. Excluding samples with values above 
these thresholds made no material difference to the results and so the data for all 
available samples is presented. For the 6-month timepoint, we examined the 
extent (expressed as a percentage) to which the total observed effects were 
mediated by three putative mechanism variables – change in body mass, change 
in HbA1c, and change in HOMA-IR. This mediation analysis was also conducted 
using the Stata SEM mediation module. The Pearson rank correlation was 
employed to determine the strength of relationships between parameters. As part 
of this collaborative project, the adjusted ANCOVA element of the statistical 




3.3.1 Baseline  
 
Of 1634 patients who were screened by telephone, 593 were enrolled and the 
characteristics of each group were similar at baseline (Table 3.1). Approximately 
90 % of potential samples were available for the assessment of inflammatory 
markers (Figure 3.1). As reported in detail previously (Andrews et al., 2011), 
HbA1c was reduced similarly in both intervention groups compared to usual care 
with no difference  between  intervention  arms.  Briefly, HbA1c was reduced  by  
-0.28 % (-0.46 to -0.10) and -0.26 % (-0.44 to -0.08) in the diet group compared 
to usual care at 6 and 12 months, respectively. This was similar to the reduction 
seen in the diet plus physical activity group of -0.33 % (-0.51 to -0.14) and -0.21 
% (-0.39 to -0.02) at 6 and 12 months. Measures of insulin resistance followed a 
similar pattern to the changes in HbA1c with both intervention arms being 
different  to usual care but  not to  each  other.  Log HOMA-IR  was  reduced  by  
-0.26 (-0.37 to -0.15) and -0.24 (-0.37 to -0.12) in the diet group compared to 
usual care at 6 and 12 months, respectively. This was not different to the 
reduction seen in the diet plus physical activity group compared to usual care of  
-0.24 (-0.35 to -0.13) and -0.16 (-0.29 to -0.04) at 6 and 12 months. The change 
in weight was not different between intervention arms but both diet and diet plus 
physical activity groups were different to usual care at 6 and 12 months. Weight 
was reduced by -2.70 kg (-3.94 to -1.47) and -2.80 kg (-4.05 to -1.55) and -2.31 
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kg (-3.55 to -1.07) and -2.54 kg (-3.80 to -1.28) in diet and diet plus physical 
activity versus usual care at 6 and 12 months, respectively. The diet plus physical 
activity group increased their step count from 6399 (SD 3056) to 7680 (SD 2818) 
and 7621 (SD 2778) at 6 and 12 months, respectively.   
 
Table 3.1: Summary statistics at baseline. Unless otherwise indicated, values 
represent means (SD). The mean shown is the back-transformed mean of the log 












































Male sex (%) 
 
158 (64 %) 
 
165 (66 %) 
 
62 (63 %) 
Age (years) 60 (10) 60 (10) 60 (11) 
Smoker 24 (10 %) 16 (7 %) 8 (8 %) 
White 239 (96 %) 232 (94 %) 96 (97 %) 
Median (IQR) time since diagnosis (days) 186 (152-225) 194 (151-233) 185 (148-232) 





) 31.5 (5.7) 31.6 (5.6) 32.3 (5.9) 
Diabetes medication (%) 98 (40 %) 95 (39 %) 35 (35 %) 
Antihypertensive agents (%) 168 (68 %) 139 (57 %) 58 (59 %) 
Lipid-lowering drugs (%) 162 (65 %) 150 (61 %) 63 (64 %) 
HbA1c (%) 6.64 (0.93) 6.69 (0.99) 6.72 (1.02) 
Systolic blood pressure (mmHg) 133 (15) 133 (15) 135 (14) 
Diastolic blood pressure (mmHg) 79 (8) 79 (8) 80 (9) 















) 249 (1.3) 242 (1.3) 255 (1.3) 
Adiponectin (μg.ml-1) 5.0 (1.7) 4.8 (1.7) 5.0 (1.7) 





Figure 3.1: Trial profile  
 
3.3.2 Inflammatory markers at 6 months  
Adjusted CRP, IL-6 and sICAM-1 fell in both intervention arms in comparison 
to usual care. The reductions in CRP and sICAM-1 were statistically significant 
but not different between arms. Although the reduction in IL-6 in the diet and 
diet plus activity group just fell short of being statistically significant according 
to the 95 % confidence interval, both groups achieved a significant reduction 
similar to the reduction seen in other inflammatory markers. Adiponectin 
increased in both intervention arms relative to usual care, this increase was 
statistically significant but not different between arms. Overall, both 
interventions versus usual care produced similar effects on these markers, with a 
trivial difference between interventions as shown by Table 3.2. The percentage 
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change from baseline to 6 months versus usual care for each inflammatory 
marker is displayed in Figure 3.2. 
 
Table 3.2: Adjusted means for all outcomes at the 6-month time-point. The 
geometric means are adjusted for the baseline value of the outcome, all 
minimisation variables (age, sex, fitness, route into the study, blood pressure), 
and study centre.  The adjusted means are expressed with additional precision to 
better illustrate differences between geometric means expressed as a ratio.  
 





(95 % confidence interval) 
CRP (mg/l) 1.73 1.70 2.18  
     
     
Diet plus activity vs. usual care    -22 (-38 to -3.1) % 
Diet vs. usual care    -21 (-36 to -1.4) % 
Diet plus activity vs. diet    -1.9 (-17 to 16) % 
IL-6 (pg/ml) 2.06 2.11 2.29  
     
     
Diet plus activity vs. usual care    -7.8 (-19 to 4.4) % 
Diet vs. usual care    -10 (-21 to 1.9) % 
Diet plus activity vs. diet    2.5 (-6.7 to 13) % 
sICAM-1 (ng/ml) 236.7 235.4 249.7  
     
     
Diet plus activity vs. usual care    -5.8 (-9.7 to -1.6) % 
Diet vs. usual care    -5.2 (-9.2 to -1.1) % 
Diet plus activity vs. diet    -0.6 (-3.7 to 2.7) % 
Adiponectin (μ /ml) 5.53 5.45 5.12  
     
     
Diet plus activity vs. usual care    6.5 (0.8 to 13) % 
Diet vs. usual care    8.2 (2.3 to 14) % 
Diet plus activity vs. diet    -1.5 (-5.5 to 2.8) % 
 




Figure 3.2: Percentage change from baseline to 6 months versus usual care for 
each inflammatory marker in the diet and diet plus activity arms. Data shown 




We have examined the mediating effect of body mass, HbA1c and HOMA-IR and these 
are presented in a Table 3.3. The change in body mass had the biggest effect on 
adiponectin mediating ~60 % of the changes. It also had large impact on CRP mediating 
almost half of the total effect. The impact on sICAM-1 and IL-6  was less pronounced 
with the change in body mass only mediating ~30 % and ~20 % of the changes in those 
markers, respectively. Changes in HOMA-IR mediated ~30 % of the changes in all 
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Table 3.3: Mediation of total effects at 6 months by three putative mechanism 
variables. The percentage shown is the mean proportion of the total effect from 
Table 3.2 mediated by the mechanism variable.   
 
Outcome ∆ Body Mass ∆ Hba1c ∆ HOMA-IR 
CRP 


















































The strength of relationships between changes in parameters is displayed in 
Table 3.4. Changes in weight were positively correlated with the changes in 
several parameters such as blood pressure (systolic and diastolic), waist 
circumference, HbA1c, TAG, glucose, insulin, HOMA-IR, sICAM-1, CRP and 
inversely correlated with changes in HDL cholesterol, adiponectin and activity. 
Changes in HbA1c were positively correlated with the changes in weight, waist 
circumference, total cholesterol, TAG, glucose, HOMA-IR, sICAM-1, CRP and 
inversely correlated with changes in HOMA-β and adiponectin. Changes in 
glucose were positively correlated with the changes in weight, waist 
circumference, HbA1c, TAG, insulin, HOMA-IR, HOMA-β, sI AM-1, CRP and 
inversely correlated with changes in HDL cholesterol and adiponectin. Changes 
in CRP were positively correlated with the changes in weight, waist 
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Table 3.4: Pearson rank correlation between changes in parameters. ** denotes a correlation at the 0.01 level (2-tailed) * denotes a correlation at 
the 0.05 level (2-tailed). Sys BP= Systolic blood pressure, Dia BP= Diastolic blood pressure, Waist cir= Waist circumference, HbA1c= Glycated 
haemoglobin, Total chol= Total cholesterol, LDL chol= Low-density lipoprotein, HDL chol= High-density lipoprotein, TAG= Triacylglycerol, 
HOMA-IR= Homeostasis model assessment of insulin resistance, HOMA-β= Homeostasis model assessment of β-cell function. 
 
 Sys BP Dia BP Weight Waist cir HbA1c Total chol LDL chol HDL chol TAG Glucose Insulin HOMA-IR HOMA-β Activity sICAM-1 IL-6 CRP Adiponectin 
Sys BP                   
Dia BP .704
**





                 
Waist .024 -.013 .574
**
                


















 .052 .021 .040 .888
**
             








            



























          








         












        
HOMA-β -.037 -.079 .017 -.020 -.232
**








       
Activity .064 -.034 -.125
**
 -.078 -.069 .014 .029 .040 -.007 -.046 -.048 -.064 .003      
















 -.019     
IL-6 .000 .011 -.006 -.027 .051 -.024 -.006 -.081 -.008 .088
*
 -.019 .023 -.045 .016 .165
**
    










 .040 -.085 .135
**






   


















 .046 .001 .014 -.004 -.072  
Chapter 3                                                                                                    Study 1                                                                                                    
69 
 
3.3.5 Changes in inflammatory markers at 12 months  
The effects for CRP and adiponectin were weakened at 12 months and were no 
longer statistically different to usual care; although this was mainly due to 
improvements in the usual care group. Effects for sICAM-1 remained. IL-6 
concentrations decreased further in the diet arm and were statistically significant 
as shown in Table 3.4.  
 
Table 3.4: Adjusted means for all outcomes at the 12-month time-point. The 
geometric means are adjusted for the baseline value of the outcome, all 
minimisation variables (age, sex, fitness, route into the study, blood pressure), 
and study centre.  The adjusted means are expressed with additional precision to 
better illustrate differences between geometric means expressed as a ratio.  
 
 





(95 % confidence interval) 
CRP (mg/l) 1.57 1.60 1.73  
     
     
Diet plus activity vs. usual care    -7.6 (-26 to 16) % 
Diet vs. usual care    -9.6 (-28 to 13) % 
Diet plus activity vs. diet    2.2 (-13 to 20) % 
IL-6 (pg/ml) 1.95 2.03 2.24  
     
     
Diet plus activity vs. usual care    -9.3 (-21 to 3.8) % 
Diet vs. usual care    -13 (-24 to -0.8) % 
Diet plus activity vs. diet    4.5 (-5.3 to 15) % 
sICAM-1 (ng/ml) 232.3 235.0 250.5  
     
     
Diet plus activity vs. usual care    -6.2 (-10 to -2.1) % 
Diet vs. usual care    -7.3(-11 to -3.3) % 
Diet plus activity vs. diet    1.2 (-2.0 to 4.4) % 
Adiponectin (μ /ml) 5.59 5.56 5.31  
     
     
Diet plus activity vs. usual care    4.6 (-3.5 to 13) % 
Diet vs. usual care    5.2 (-2.8 to 14) % 













These results from Early ACTID show that motivational unsupervised diet and 
diet plus physical activity interventions in patients with newly-diagnosed type 2 
diabetes lead to reductions in CRP, IL-6 and sICAM-1 with an increase in 
adiponectin. There was no greater benefit from adding physical activity advice 
to dietary advice. Approximately half of the observed effect for the primary 
outcome (CRP) was explained by the change in weight. It is noteworthy that a 
relatively modest 2-3 % decrease in weight led to a fall in circulating CRP of 
approximately 20 %. These results are the first to show that simple diet and 
diet/physical activity interventions can be integrated into real-world health care 
settings and generate beneficial changes in various inflammatory markers in 
early type 2 diabetes.  
 
Both intervention arms experienced changes in CRP, IL-6, sICAM-1 and 
adiponectin that were greater than usual care after 6 months. However, over the 
following 6 months, the changes in CRP and adiponectin in the usual care arm 
were relatively greater than the intervention arms so that there were no longer 
any differences when compared to usual care at 12 months. This was not the 
case for sICAM-1, which remained different in both intervention arms when 
compared to usual care at 12 months. Importantly, during the first 6 months of 
Early ACTID, there were no changes to medication whereas between 6 and 12 
months medication was adjusted to target pre-defined clinical outcomes. As 
discussed previously, there was a greater increase in diabetes medication use in 
the usual care arm of Early ACTID than either intervention arm (Andrews et al., 
2011). Diabetes medication such as metformin has an established effect on 
inflammatory markers such as CRP (Dandona et al., 2004). Thus, for CRP and 
adiponectin, conventional treatment appears to catch up with diet and diet plus 
physical activity advice when medication is adjusted according to fixed 
protocols (Andrews et al., 2011). However, conventional treatment was not as 
effective as diet and diet plus physical activity advice at improving sICAM-1 
after 12 months. 
 
The lack of additional effect from physical activity was surprising but similar to 
that reported for other outcomes in Early ACTID such as HbA1c (Andrews et 
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al., 2011). Other studies show that supervised exercise can have a much greater 
effect on inflammatory markers than those reported in the present study 
(Xydakis et al., 2004; Balducci et al., 2010; Jorge et al., 2011; Kadoglou et al., 
2013). However, Early ACTID is a pragmatic trial designed to test the benefit 
from giving advice on physical activity in addition to diet in a real-world, 
community-based setting in the first year after diagnosis. Thus, these results 
show the effect from this additional advice and not the effect of physical activity 
per se. This advice led to a significant but modest increase in physical activity 
(Andrews et al., 2011). As a result of the energetics of physical activity and 
other factors such as substitution, a reasonably large change in a given 
behaviour might not translate into a large change in energy expenditure 
(Thompson et al., 2012). Patients in the diet plus physical activity arm increased 
their step count by approximately 1300 steps per day (Andrews et al., 2011). An 




 would equate to walking 
approximately 1000 m with an energy cost of ~50 kcal per day (Thompson et 
al., 2006). Thus, our results show that this change in physical activity has no 
additional benefit than dietary advice on the various inflammatory markers 
included in the present study. Investing in strategies to increase physical activity 
further may have yielded greater improvements but of course with a greater 
financial cost.  
 
Since weight loss in these patients was responsible for much of the change in 
CRP and adiponectin in both intervention arms then, arguably, the primary 
focus for these outcomes should be the achievement of weight loss through any 
means. In support of this contention, one small study found that plasma 
adipokines are disturbed in obese but not non-obese patients with type 2 
diabetes (Hansen et al., 2010). Furthermore, studies have shown that adiposity 
and not differences in physical activity explain variation in circulating markers 
of inflammation (Dixon et al., 2013). Our data supports this as changes in 
weight were correlated with changes in adiponectin, sICAM-1 and CRP while 
changes in activity were not. Exercise without pronounced weight loss does not 
change concentrations of CRP (Church et al., 2010; Stewart et al., 2010; 
Thompson et al., 2010; Fisher et al., 2011). Thus, although weight loss was 
relatively modest in diet and diet plus physical activity arms during the first 6 
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months, this was sufficient to produce beneficial changes in CRP and 
adiponectin. The lack of any further weight loss over the following 6 months 
may explain why there was no further improvement at 12 months in either 
intervention arm for CRP and adiponectin.  
 
In contrast to the findings for CRP and adiponectin, the change in sICAM-1 was 
sustained over 12 months in diet and diet plus physical activity arms. This is 
similar to the sustained changes in HbA1c, fasting insulin and fasting glucose 
reported previously (Andrews et al., 2011). It is also noteworthy that the change 
in weight was a less important mediator of the change in sICAM-1 than for CRP 
and adiponectin. Measurement of sICAM-1 independently predicts the risk of 
cardiovascular disease and stroke in people with Type 2 Diabetes (Shai et al., 
2006; Kanai et al., 2008). Thus, diet and diet plus physical activity is more 
effective than conventional treatment at targeting inflammatory markers 
associated with vascular risk in patients with type 2 diabetes (Shai et al., 2006; 
Kanai et al., 2008).  
 
Two of the strengths of Early ACTID are (i) it purposefully targeted patients 
with newly-diagnosed type 2 diabetes and (ii) there was no change in 
medication over the first six months in order to better elucidate the impact of 
lifestyle intervention. It is noteworthy that average  RP was in the ‘moderate’ 
risk category according to established thresholds for CRP (Pearson et al., 2003; 
Ridker et al. 2003) and naturally the findings may have been different in 
patients with more established diabetes and/or higher baseline values. We 
should also highlight that whilst the changes in inflammatory measures were 
statistically significant, the size of the effects were small to modest. However, it 
is also important to highlight that this was accomplished with a modest change 
to lifestyle achieved without supervision and in a community-based setting.  
 
The findings from this pragmatic research will help improve clinical practice 
and future patient care. We have shown that a modest reduction in weight 
resulting from diet alone or diet combined with increase physical activity has 
led to tangible positive changes in markers of inflammation. The increase in 
moderate to vigorous physical activity achieved between baseline and 6 months 
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in the diet plus activity group was modest (10 min per day compared to 3 min 
per day for the diet arm). This was likely to be too small to separate the relative 
importance of physical activity compared to changes in energy balance and their 
separate impact on metabolic and inflammatory health outcomes.  
 
Our results indicate that motivational, unsupervised, community-based diet and 
diet plus physical activity interventions can be integrated into real-world health 
care settings and generate beneficial changes in various markers of 
inflammation in patients with newly-diagnosed type 2 diabetes. Once 
adjustments to medication were permitted (i.e., after 6 months), usual care was 
equally effective at improving CRP and adiponectin but not sICAM-1. Thus, 
diet and diet plus physical activity advice were more effective at improving 
markers of vascular risk than conventional drug therapy. Alternative models 
carefully designed to investigate the effect of exercise on inflammatory markers 
and metabolic control independent of changes in energy balance may be useful 












Exercise counteracts short-term overfeeding and 
reduced physical activity independent of any net 
attenuation of energy imbalance in healthy young men. 
 
4.1 Introduction 
Western lifestyles are typified by chronically low levels of physical activity and 
excessive caloric intake, resulting in positive energy balance (Hill & Wyatt, 
2005; Uauy & Diaz, 2005) and an accumulation of triacylglycerol within 
adipocytes. Adipose tissue is not just a site of energy storage and acts as an 
endocrine organ capable of secreting growth factors and adipokines (Rajala & 
Scherer, 2003) with implications for metabolic control via adipocyte insulin 
resistance and subsequent elevations in blood lipids (Khan et al., 2006). This 
provides one mechanism for the established link between energy imbalance, 
obesity and insulin resistance (Horowitz, 2007). 
 
Intermittent and/or sustained periods of overconsumption and/or under-activity 
are necessarily responsible for net positive energy balance. Numerous studies 
have examined overfeeding of varied duration and composition, with the 
resultant positive energy balance associated with impaired insulin sensitivity 
(Wang et al., 2001; Cornier et al., 2006; Brons et al., 2009) and marked 
alterations in adipose tissue gene expression (Shea et al., 2009; Alligier et al., 
2012). This in turn impacts the systemic concentration of key adipokines 
involved in the regulation of energy balance, such as leptin (Lammert et al., 
2000; Wang et al., 2001; Brons et al., 2009), adiponectin (Brons et al., 2009) 
and visfatin (Sun et al., 2007). Equally, enforced physical inactivity results in 
impaired insulin sensitivity and other negative health outcomes in previously 
healthy, active individuals (Vukovich et al., 1996; Arciero et al., 1998; Olsen et 
al., 2008).  
 
In contrast to the relative wealth of information in relation to the separate 
influences of overfeeding or physical inactivity, it is remarkable that only two 
studies have explored the combined impact of both factors applied 
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simultaneously. A recent study by Knudsen et al. (2012) demonstrated impaired 
insulin sensitivity after just 3 days of overfeeding (150 % habitual intake) 
combined with restricted step count (≤1 00 steps per day), an effect that 
preceded any measurable change in body composition. Previously, Hagobian & 
Braun (2006) reported similarly rapid metabolic dysregulation in a cohort of 
habitually-active participants provided with 125 % of their habitual intake for 3 
days whilst abstaining from structured exercise. Importantly, however, insulin 
responses were restored to baseline levels by a single bout of moderate-intensity 
exercise, despite additional overfeeding on that day to match for the energy 
expended during exercise. This finding presents the interesting possibility that 
prescribed daily exercise may offset the negative health effects of overfeeding 
plus reduced physical activity independent of any impact on energy 
(im)balance. 
 
Thus, we hypothesised that short-term combined overfeeding and reduced 
physical activity would significantly impair metabolic function but that the 
incorporation of daily physical exercise within the same experimental model 
would prevent these changes (independent of any net effect on energy balance). 
Furthermore, given the potential independent effects of energy balance and 
exercise on adipose tissue function given its role in energy storage (Thompson 
et al., 2012); we hypothesised that changes in the expression of key genes 
within adipose tissue in response to a standardised energy surplus would be 
offset by daily vigorous-intensity exercise. 
 
4.2 Methods 
4.2.1 Approach to the Research Question 
The purpose of this study was to examine whether daily vigorous-intensity 
exercise would offset the metabolic consequences of short-term overfeeding and 
reduced physical activity, independent of any net attenuation of energy 
imbalance. A randomised parallel group design was used for this study 
(registration number: ISRCTN59822195), with participants randomly allocated 
by a third party to experience a fixed energy surplus via seven days of 
overfeeding and restricted physical activity per se (SUR) or with a daily bout of 
physical exercise (SUR+EX). The SUR group reduced their daily activity to 
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≤4000 steps while increasing their habitual energy intake by  0   ( hapter 
2.9). The SUR+EX group adhered to a matched model of overfeeding and 
reduced physical activity except for the introduction of a daily bout of vigorous-
intensity treadmill running (  min warm-up at  0     2max then 4  min at 70  
   2max), with an additional overfeed individually prescribed to account for the 
energy expended during each run and thus standardise the energy surplus (i.e. 
habitual energy intake increased by 75 ± 3 %). The daily step allowance (4000 
steps) was selected to allow some margin of error without exceeding the 5000 
steps per day thought to reflect a sedentary lifestyle (Tudor-Locke et al., 2000). 
 
The extent of overfeeding selected was based on the balance of available 
literature regarding overfeeding in general, along with our preliminary work that 
supported this as a realistic and thus practically achievable target for both 
groups. While previous studies have examined overfeeding of varied nature 
(e.g. mixed, high carbohydrate, high fat, etc.), we elected to overfeed each 
individual according to their habitual diet and thus avoid introducing an 
additional variable at this stage.   Changes in insulin sensitivity and glycaemic 
control (reflected by basal values and incremental Area Under the Curve 
(iAUC) measured at baseline and follow up were the primary outcome 
measures. Other blood measures related to metabolic function, inflammation 
and changes within adipose tissue were secondary outcome measures.  
 
4.2.2 Participants 
Twenty-six healthy, habitually active men completed the study. Participants 
were 25 ± 7 years old (mean ± SD) and had been weight stable (± 3 kg) for at 
least 6 months. Only volunteers who undertook structured vigorous-intensity 
exercise for thirty minutes or more, at least three times a week were included in 
the study, assessed via a self-report questionnaire. Participants completed a 
health questionnaire (Appendix 1) and Physical Activity Readiness 
Questionnaire (PAR-Q; Appendix 3) to determine eligibility and provided 
written and verbal consent consistent with the requirements of the Bath NHS 
Research Ethics Committee, who approved this study (REC reference number : 
07/H0101/234). Individuals who smoked, suffered from a condition known to 
interact with the study measures or took regular medication that may have 
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interfered with the results were excluded from the study. The anthropometric 
and physiological characteristics of those included are presented in Table 4.1.  
Table 4.1: Participant details. Mean ± SD 
Characteristic SUR group (n=14) SUR + EX group (n=12) 
Age (y) 25 ± 7 26 ± 7 
Height (m) 1.80 ± 0.07 1.79 ± 0.05 
Mass (kg) 75.5 ± 8.9 78.2 ± 11.0 
BMI (kg·m
-2
) 23.2 ± 2.5 24.4 ± 2.6 
FMI (kg·m
-2
) 3.3 ± 1.2 3.8 ± 1.1 




) 58.7 ± 5.9 54.9 ± 4.8 
   2max (l·min
-1
) 4.4 ± 0.8 4.3 ± 0.5 
 
4.2.3 Design Summary 
Participants were randomly allocated by a third party to one of two groups for 
the study design of seven days using a block randomisation plan with age 
stratification (18-28 or 29-40 years): 
1) Overfeeding with restricted physical activity (SUR) n=14 
2) Overfeeding with restricted physical activity alongside a daily exercise bout 
(SUR+EX) n=12 
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Typical Baseline
(Energy Balance)




    Energy
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Overfeeding/Reduced Physical 
Activity + Exercise Group (SUR+EX)
Energy
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Figure 4.1: Schematic representation of the planned energy surplus that will be 
induced by the overfeeding and restricted physical activity model. CHO= 
Carbohydrates, PRO= Protein, EtOH= Alcohol, RMR= Resting Metabolic Rate, 
DIT= Diet Induced Thermogenesis, PAEE= Physical Activity Energy 
Expenditure. 
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All participants performed a 30 min bout of running the day before they were 
due to start the trial, either in the morning or at lunch time but no later than 2pm 
in order to control for an acute effect of exercise. Participants recorded their 
step count using a pedometer (Yamax, Japan) for three days leading up to and 
during the whole trial. All participants reduced their steps to ≤ 4000 steps.day-1 
for the duration of the trial. During the intervention, PAEE was estimated using 
individual average step count as combined accelerometry and heart rate 
(Actiheart, CamNtech, Cambridge UK) data proved to be confounded. It 
appears that overfeeding confounds the assumptions underlying the estimation 
of energy expenditure via this method. The average sleeping heart rate (mean ± 








  in the SUR group 








 in the SUR+EX group 
(n=11). This finding has already been reported after long-term overfeeding in 
identical twins by Bouchard et al. (1990). Whilst this effect might appear 
modest, this has a profound impact on estimated PAEE using this methodology. 
As a result, data from the Actiheart was solely used to ensure compliance (i.e., 
presence or absence of structured exercise). The volunteers in the SUR+EX 
group were required to perform 45 min of treadmill running each day at 70 % of 
their maximum oxygen uptake preceded by a 5 min warm-up. Importantly, this 
group received additional prescribed energy intake (Chapter 2.9) to account for 
the energy expended during the exercise. The Excess Post-Exercise Oxygen 
Consumption (EPOC) associated with each exercise bout was taken into 
account when prescribing the overfeeding to the SUR+EX group and was 
estimated as 6.6 % of energy expended during the run based on LaForgia et al. 
(2006). The DIT associated with the extra food prescribed to the SUR+EX 
group compare to the SUR group was also taken into consideration and was 
calculated as 10 % of the energy expended during the run (including EPOC) 
based on Westerterp (2004). Finally, the contribution of RMR towards total 
energy expenditure during each run (50 min) was subtracted from the 
overfeeding calculation as this was already taken into account when prescribing 
the 50 % overfeed. An example of an overfeeding calculation for an individual 
from each group in energy balance (12570 kJ/3000 kcal) at baseline is shown 
below (Table 4.2).  
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Table 4.2: An example of an overfeeding calculation is shown below. EPOC = 
6.6 % of energy expended during run based on LaForgia et al. (2006). DIT = 10 
% of extra energy intake supplied + EPOC based on Westerterp (2004). RMR 
for the duration of the run. 
 
 SUR group SUR+EX group 
Average daily energy intake  12570 kJ  12570 kJ 
50 % overfeeding + 6285 kJ + 6285 kJ 
Energy expended during run n/a + 2933 kJ 
EPOC n/a + 194 kJ 
DIT (additional overfeeding) n/a + 313 kJ 
RMR (during run) n/a - 293 kJ 
   
Total energy intake prescribed 18855 kJ  22002 kJ 
   
Surplus 6285 kJ 6285 kJ 
 
 
Participants abstained from tea/coffee or alcohol the day before each trial. 
During the days leading up to the trial, volunteers exercised as normal and 
consumed their habitual diet. The final exercise bout prescribed under the 
SUR+EX treatment was performed at a standardised time of day specific for 
each participant. This took place at the same time as the running bout each 
individual had performed the day before baseline measures were taken. All 
participants performed this bout of exercise either in the morning or at 
lunchtime but not later in the day. 
 
4.2.4 Laboratory Measurements 
Following an overnight fast (≥ 10 h), participants arrived in the laboratory at 
0700 ± 0.5 h. Body mass was measured to the nearest 0.1 kg using electronic 
scales (Tanita Corporation, Japan). All participants wore the same pair of shorts 
at baseline and follow-up on top of their underwear for body mass 
measurement. Anthropometric measurements were made in triplicate using a 
metallic tape measure (Lufkin, US) before lean and fat mass were measured 
using Dual-Energy X-ray absorptiometry (DEXA) (Discovery, Hologic, 
Bedford, UK) (Chapter 2.2). RMR was estimated by indirect calorimetry from 
expired air samples. Four 5-min samples were collected in Douglas bags, with 





(Compher et al., 2006; Betts et al., 2011). Once four stable values had been 
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collected, the lowest was accepted as RMR. Following the application of a 
topical local anaesthetic (1.5 ml Ametop gel, Smith & Nephew, Hull, England) 
an 18-gauge 1.3 x 45 mm cannula (BD Venflon Pro) was inserted into an 
antecubital vein and a baseline blood sample collected. An adipose tissue 
sample was then collected (Chapter 2.10) before an OGTT was performed 
according to the procedure described in Chapter 2.4. Blood pressure was 
measured in triplicate at the end of each trial (Chapter 2.3). The same protocol 
was used at follow-up.  
 
4.2.5 Calculation of energy surplus (post-intervention) 
The energy surplus induced by the overfeeding and restricted physical activity 
model was quantified retrospectively post-intervention based on the following 
assumptions. For each macronutrient, we assumed that the amount entering the 
system was equal to the amount ingested (i.e. ignoring urinary and faecal 









) were used to calculate the metabolised energy contents of protein, 
alcohol, fat and carbohydrate, respectively (Bender, 2006). We estimated DIT to 
be 21 % for protein, 15 % for alcohol, 2 % for fat and 8 % for carbohydrate 
based on Westerterp (2004). Based on these values, DIT was calculated 
retrospectively post-intervention to be 8.3 ± 0.6 % of energy intake for the 
population who took part in this study. Resting carbohydrate and fat oxidation 
were based on indirect calorimetry measurements collected in a fasted state at 
baseline and follow-up. Where Respiratory Exchange Ratio (RER) was >1, the 
apparently negative rates of lipid oxidation were assumed to reflect 
quantitatively proportional lipid synthesis (Frayn, 1983). The amount of lipid 
synthesised was added to the fat intake of each participant for calculations of 
substrate balance. It was assumed that 1 g of glucose was required to produce 
0.52 g of lipid based on Ferrannini (1988). Any minor PAEE during the 
intervention was calculated as the product of average daily step count and an 







 (Dill, 1965). Exclusive reliance on carbohydrates as a fuel 
source during physical activity was assumed as participants mean RER during 
overfeeding was 0.98 even under fasted and resting conditions at follow-up. The 
energy cost associated with the exercise sessions was based on the indirect 
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calorimetry measurements during participants’ preliminary exercise tests taking 
part in the study. Again, exclusive reliance on carbohydrates as fuel source 
during running was assumed. The overall energy surplus was estimated by 
calculating the sum of the surpluses associated with each macronutrient. The 
calculated energy surplus for all participants is provided in Appendix 4. 
 
4.2.6 Analytical methods 
Blood was analysed for WBC counts, serum CRP, IL-6, Adiponectin, Leptin, 
ALT, Insulin, C-peptide, TAG, Cholesterol, HDL-Cholesterol, NEFA and 
plasma glucose. Adipose tissue was analysed for mRNA (Chapter 2.11, 2.12) 
and protein expression profiles. 
 
4.2.7 Western Blot Analysis 
One ml of organic phase was removed and mixed with 1.5 ml of Isopropanol 
before being inverted several times and incubated for 10 min at room 
temperature. Samples were spun for 10 min at 2500 g, 4
o
C. Supernatants were 
discarded and pellets were washed using a 0.3 M Guanadine HCl in a 95 % 
Ethanol solution and incubated with rotation for 20 min at room temperature. 
Samples were then spun for 10 min at 2500 g, 4
o
C and supernatant removed. 
This wash procedure was repeated 3 times. After the final wash, pellets were 
mixed with 2 ml of 100 % Ethanol and left for 20 min at room temperature 
before being spun for 10 min at 2500 g, 4
o
C. Supernatants were removed and 
the pellet was left to air dry. 400 µl of a 1 % SDS solution was added to the 
pellets before sonication (18 µm) on ice. Protein content was determined by 
BCA protein assay (Thermo Scientific). 20 µg of the protein solution was 
loaded on a SDS-Polyacrylamide gel for electrophoresis alongside Novex® 
sharp protein standard (Life Technologies, UK). This was carried out using a 
modification of the method of Hashimoto et al. (1983), using the discontinuous 
buffer system of Laemmli (Laemmli et al., 1970). 6 % acrylamide Tris-Glycine 
SDS-PAGE slab gels were prepared using the triple-wide mini-vertical 
electrophoresis systems (CBS Scientific, USA). Gels were run at 200 V for about 
1 h until the bromophenyl blue tracking dye had just run off the gel. Proteins were 
then transferred to a nitrocellulose membrane. The nitrocellulose membrane was 
washed in Tris-buffered saline containing Tween-20 (TBS-T) to remove the 
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Ponceau stain. The membrane was blocked using a 5 % (w/v) Marvel (dried 
skimmed milk powder) in TBS-T for 60 min to block non-specific protein sites 
before being washed four times in TBS-T for 15 min at a time. It was then 
incubated with the primary antibody overnight at 4
o
C. The antibody was diluted 
in 1 % BSA in TBS-T: Akt1 (Millipore), Akt2 (Cell Signaling Technology), 
GLUT4 (Holman et al., 1990), AMPK (Cell Signaling Technology), GAPDH 
(Millipore) or 5 % BSA TBS-T: pAKT(Cell Signaling Technology), pAMPK 
(Cell Signaling Technology). The nitrocellulose membrane was then washed six 
times with TBS-T for 5 min at a time and then incubated with a secondary 
antibody for 1 h at room temperature. The secondary antibody was diluted in 5 
% Marvel-TBS-T. Goat anti-rabbit IgG HRP conjugate (Millipore, USA) or 
Goat anti-mouse IgG HRP conjugate (Thermo scientific, USA) were used at a 
1:4000 dilution. Finally, the nitrocellulose was washed six times in TBS-T for 5 
min at a time and developed using ECL or ECL Advance (GE healthcare) 
following the manufacturer’s guidelines. Solutions were mixed in a 1 1 ratio 
and the membrane incubated for 1 min for ECL and 5 min for ECL advance. 
The image was detected by use of a Hamamatsu camera attached to the 
EpiChemi II Darkroom (UVP). 
 
4.2.8 Statistical analysis 
To simplify data analysis and facilitate a more meaningful interpretation of an 
otherwise complex factorial research design (Hopkins et al., 2009 & Matthews 
et al., 1990), serial measurements of glucose, insulin and C-peptide at baseline 
and follow-up were converted into simple summary statistics to illustrate the net 
response of each parameter (i.e. within-subject peak concentrations, time to 
peak and incremental area under curve; Wolever & Jenkins, 1986). Pre-planned 
contrasts were conducted in relation to the absolute group differences both at 
final follow-up and the relative change from baseline. The precise time-course 
of responses within and between trials were analysed using factorial 2- and 3-
way mixed-model analysis of variance (groupxday & groupxdayxtime, 
respectively) irrespective of minor deviations from a normal distribution 
(Maxwell & Delaney, 1990) but with the Greenhouse-Geisser correction applied 
to intra-individual contrasts for ɛ <0.75 and the Huynh-Feldt correction adopted 
for less severe asphericity (Atkinson, 2002). Where significant interactions were 
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observed, multiple t-tests were applied to determine the location of variance 
both between treatments at each time point and between time points within each 
treatment relative to baseline, with both methods subject to a Holm-Bonferroni 
correction (Atkinson, 2002). For all the above statistical approaches, statistical 
significance was set at an alpha level of P≤0.0 . Data are presented in text as 
means and standard deviations (SDs). The table displays 95 % confidence 
intervals (95 % CI) to better illustrate group differences, whereas the variance 
bars on figures are normalised confidence intervals (nCI) that have been 
corrected to remove inter-individual variation (Masson, 2003). For reference, 
the magnitude of these CIs illustrate the change at each time point relative to 
baseline such that, in general, plotted means which CIs do not overlap by more 
than one-half of one side of an interval are likely to be deemed statistically 
different according to conventional significance testing (Masson, 2003). A main 
effect of day denotes an effect of energy surplus (†  Day 1 vs. Day 8 both 
groups), whereas a dayxgroup interaction means there is a mediating effect of 
exercise (*). Statistical analysis for the gene expression data was carried out on 
the ∆ t values, whereas fold changes were used for the Western Blot data. The 
Pearson rank correlation was employed to determine the strength of 






















4.3.1 Induced energy surplus 
The estimated energy surplus induced by the overfeeding and restricted physical 
activity model is summarised in Figure 4.2. These were not statistically different 









the SUR and SUR + EX group, respectively).
 
At baseline, the average energy 




 while the average energy expenditure was 
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Figure 4.2: Schematic representation of the achieved energy surplus induced by 
the overfeeding and restricted physical activity model in SUR group (n=13) and 
SUR+EX group (n=12). Energy intake estimated from diet analysis. RMR 
estimated from indirect calorimetry. DIT was quantified post-intervention as 8.3 
% of energy intake, this was done by calculating the specific DIT associated 
with each macronutrient before the overall DIT was determined. PAEE was 
based on step count and indirect calorimetry (exercise). Energy surplus was 
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4.3.2 Diet composition   
Diet composition before (Table 4.3) and during the intervention (Table 4.4) is 
summarised below. All participants confirmed that all prescribed foods had 
been consumed over the course of the intervention. These were not statistically 
different between groups. 
 
Table 4.3: Habitual diet composition. Mean ± SD 





























Table 4.4: Diet composition during the intervention. Mean ± SD 
Characteristic SUR group (n=13) SUR + EX group (n=12) 
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4.3.3 Physical activity levels 
 
As discussed in the methods, overfeeding has an impact on heart rate. As a 
result, the assumptions underlying the estimation of energy expenditure using 
the Actiheart technology were confounded and step counts were used to 
quantify physical activity levels instead. Average steps significantly decreased 
during the intervention within the SUR and SUR+EX groups from 12562 ± 









, respectively. There was a main effect of day (F=120.0, P<0.001) as shown by 





































Figure 4.3: Schematic representation of the reduction in steps achieved during 
the intervention in SUR group (n=11) and SUR+EX group (n=11). Values are 
means ± n I. † denotes a main effect of day (i.e.  Day 1 vs. Day 8 both groups; 
F=120.0, P<0.001).  
 
 
4.3.4 RMR & RER 
Resting Metabolic Rate (RMR) significantly increased at follow-up in the SUR 




while it remained unchanged in 




. There was a 
main effect of day (F=20.4, P<0.001) and a
 
dayxgroup interaction (F=8.2, 
P=0.009) as shown by Figure 4.4. The RMR values described here were also 
used in Figure 4.2. Respiratory Exchange Ratio (RER; Figure 4.5) significantly 
increased at follow-up in the SUR and SUR+EX group, there was a main effect 
of day (F=54.5, P<0.001).  
























































Figure 4.4: Resting metabolic rate at baseline and follow-up for the SUR group 
(n=13) and the SUR+EX group. Values are means ± nCI. † denotes a main 
effect of day (i.e.: Day 1 vs. Day 8 both groups; F=20.4, P<0.001) * denotes a 
dayxgroup interaction (F=8.2, P=0.009) # denotes values different pre-post 




















































Figure 4.5: Respiratory Exchange Ratio at baseline and follow-up for the SUR 
group (n=13) and the SUR+EX group. Values are means ± nCI. † denotes a 
main effect of day (i.e.: Day 1 vs. Day 8 both groups; F=54.5, P<0.001). Dotted 
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4.3.5 Anthropometric and physiological measures 
Anthropometric and physiological measures pre and post-intervention are 
summarised in Table 4.5. Body mass (balance scales & DEXA), waist and hip 
circumference and lean mass (DEXA) significantly increased post-intervention 
in both groups (P≤0.05 baseline versus follow-up); this increase was different 
between groups (dayxgroup interaction; F>5.9, P≤0.05). Fat mass (Bio-
Impedance) significantly increased post-intervention in the SUR group (P≤0.05 
baseline versus follow-up); this increase was different between groups 
(dayxgroup interaction; F=7.7, P=0.01). Fat mass (Skinfolds & DEXA), lean 
mass (Bio-Impedance), abdominal fat (DEXA) and systolic blood pressure 
significantly increased post-intervention in both groups (P≤0.05 baseline versus 




Chapter 4                                                                                                    Study 2                 
89 
 
Table 4.5: Anthropometric and physiological characteristics measured before and after 7 days of overfeeding and reduced physical activity 
with (SUR+EX; n=12) or without (SUR; n=14) an exercise prescription. (n.b. for DEXA measurements  n=11 & 10, respectively). Mean ± SD. 
Change scores shown with 95 % confidence intervals. * P≤0.05 dayxgroup interaction. # P≤0.05 baseline versus follow-up. † main effect of 
day (i.e.: Day 1 vs. Day 8 both groups; P≤0.0 ). 
 
 
 SUR SUR+EX 
 Baseline Follow-up ∆  95 % CI) Baseline Follow-up ∆  95 % CI) 
Body Mass (kg; Scales)  75.5 ± 8.9 78.2 ± 9.2 # 2.7 (2.0 to 3.3) 78.2 ± 11.0 79.9 ± 11.3 # 1.6 (1.0 to 2.3) * 
Body Mass (kg; DEXA)  71.8 ± 7.8 74.6 ± 8.0 # 2.8 (2.1 to 3.5) 79.0 ± 10.6 80.7 ± 10.8 # 1.7 (1.0 to 2.3) * 
Waist Circumference (cm) 81.7 ± 5.2 84.1 ± 5.0 # 2.4 (1.6 to 3.2) 83.7 ± 7.1 84.8 ± 6.9 # 1.1 (0.6 to 1.6) * 
Hip Circumference (cm) 97.0 ± 6.0 98.7 ± 6.0 # 1.7 (1.2 to 2.3) 98.6 ± 5.5 99.1 ± 5.4 # 0.5 (0.0 to 0.9) * 
Fat Mass (kg; DEXA) 10.5 ± 3.6 10.7 ± 3.4 0.1 (-0.5  o 0.7) † 12.4 ± 4.1 13.0 ± 4.5  0.6  0.1  o 1.1) † 
Fat Mass (kg; Skinfolds) 11.0 ± 3.6 11.8 ± 3.6  0.7  0.3  o 1.1) † 11.1 ± 3.8 11.7 ± 3.7  0.6  0.4  o 0.9) † 
Fat Mass (kg; Bio. Imp.) 11.8 ± 4.0 13.1 ± 4.5 # 1.4 (0.8 to 1.9) 13.8 ± 4.7 14.1 ± 5.0 0.3 (-0.3 to 1.0) * 
Lean Mass (kg; DEXA) 58.2 ± 5.8 60.8 ± 6.4 # 2.6 (1.9 to 3.4) 63.4 ± 7.2 64.5 ± 7.0 # 1.0 (0.1 to 2.0) * 
Lean Mass (kg; Bio. Imp.) 60.6 ± 5.8 61.9 ± 5.6  1.3  0.7  o 1.9) † 61.2 ± 6.8 62.5 ± 6.8  1.3  0.5  o 2.0) † 
Abdominal Fat (g; DEXA) 900 ± 416 932 ± 360 32 (-56  o 119) † 1206 ± 477 1261 ± 479  55  25  o 85) † 
Systolic BP (mmHg) 122 ± 10 128 ± 8  6  1  o 11) † 126 ± 9 128 ± 10 2 (-2  o 6) † 
Diastolic BP (mmHg) 69 ± 9 71 ± 4 2 (-2 to 6) 70 ± 7 70 ± 7 0 (-4 to 4) 
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4.3.6 Insulin, C-peptide & Glucose responses to OGTT 
 
Serum Insulin 
The serum insulin concentrations in response to the OGTT were significantly 
greater at follow-up for the SUR group but not for the SUR+EX group as shown 
in Figure 4.6. There was a main effect of day (P<0.001) and a dayxtimexgroup 
interaction (P=0.003). The insulinaemic response following the OGTT was 
significantly greater at follow-up for the SUR group increasing their 2 h insulin 
iAUC. The 2 h insulin iAUC of the SUR+EX group was unaffected as shown in 
Figure 4.7. There was a main effect of day (P=0.001) and a dayxgroup 
interaction (P=0.002). 
 
There was also a main effect of day (P<0.001) and a dayxgroup interaction 
(P<0.001) for the serum insulin peak concentration during the 2 h OGTT with 
the SUR group increasing their peak concentration while the serum insulin peak 
concentration for the SUR+EX group was unaffected as shown in Figure 4.8. 
The individual serum insulin peak time for the SUR group was unaffected (from 
46 ± 20 to 45 ± 14 min) while serum insulin peaked earlier at follow-up for the 



















































































Figure 4.6: Serum insulin concentrations in response to the OGTT before and 
after a week of overfeeding and reduced physical activity (Panel A; SUR group) 
or after a week of overfeeding and reduced physical activity + exercise (Panel 
B; SUR+EX group). Values are means ± nCI. * denotes a dayxtimexgroup 
interaction (F=5.04, P=0.003) # denotes values different pre-post (P≤0.0 ) † 


































































Figure 4.7: Insulinaemic responses during the 2 h OGTT for the SUR and 
SUR+EX group. Values are means ± nCI. * denotes a dayxgroup interaction 
(F=11.59, P=0.002) # denotes values different pre-post within SUR group 































































Figure 4.8: Serum Insulin peak concentration during the 2 h OGTT for the SUR 
and SUR+EX group. Values are means ± nCI * denotes a dayxgroup interaction 
(F=18.01, P<0.001) # denotes values different pre-post within SUR group 












The serum C-peptide concentrations in response to the OGTT were significantly 
greater at follow-up for the SUR group but not for the SUR+EX group as shown 
in Figure 4.9. There was a main effect of day (P<0.001) and a dayxtimexgroup 
interaction (P=0.06). C-peptide response following the OGTT was significantly 
greater at follow-up for the SUR group while the 2 h C-peptide iAUC of the 
SUR+EX group decreased as shown in Figure 4.10. There was a dayxgroup 
interaction (P=0.002). 
 
The insulin data is also presented with n=8 in both group and with 5 time points 
during the OGTT (every 30 min) to enable comparison with the C-peptide data 

























































































































































         Figure 4.9: Serum C-peptide & insulin concentrations in response to the OGTT 
before and after a week of overfeeding and reduced physical activity (Panel A; 
C-peptide; SUR group, n=8), (Panel C; insulin; SUR group, n=8) or after a 
week of overfeeding and reduced physical activity + exercise (Panel B; C-
peptide; SUR+EX group, n=8), (Panel D; insulin; SUR+EX group, n=8). Values 
are means ± nCI * denotes a dayxtimexgroup interaction (F=2.92, P=0.06). ** 
denotes a dayxtimexgroup interaction (F=6.63, P=0.003) # denotes values 
different pre-post (P≤0.0 ) † denotes a main effect of day (i.e.  Day 1 vs. Day 8 
both groups; F=20.2, P<0.001) ††denotes a main effect of day (i.e.  Day 1 vs. 



































































Figure 4.10: C-peptide responses during the 2 h OGTT for the SUR group 
(n=8) and the SUR+EX group (n=8). Values are means ± nCI. # denotes values 




























































Figure 4.11: Insulinaemic responses during the 2 h OGTT for the SUR group 
(n=8) and the SUR+EX group (n=8). Values are means ± nCI * denotes a 
dayxgroup interaction (F=16.09, P=0.001) # denotes values different pre-post 
within SUR group (P=0.004) † denotes a main effect of day (i.e.: Day 1 vs. Day 










The glycaemic response following the OGTT was unaffected in both groups as 
























































Figure 4.12: Plasma glucose concentrations in response to the OGTT before and 
after a week of overfeeding and reduced physical activity (Panel A; SUR group) or 
after a week of overfeeding and reduced physical activity + exercise (Panel B; 
SUR+EX group). Values are means ± nCI.  
 
 


























































Figure 4.13: Glycaemic responses during the 2 h OGTT for the SUR and 























































Figure 4.14: Plasma glucose peak concentration during the 2 h OGTT for the 
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The Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) increased at follow-up in both groups; there was a dayxgroup trend 
(F=3.5, P=0.07) and a main effect of day (F=14.3, P=0.001). The Homeostasis Model Assessment of β-cell function (HOMA-β) increased at 
follow-up in the SUR group (P≤0.05 pre-post within SUR group); there was a dayxgroup interaction (F=4.9, P=0.04). The Matsuda Index or 
Composite Index (ISI comp) decreased at follow-up in the SUR group (P≤0.05 pre-post within SUR group); there was a dayxgroup interaction 
(F=4.9, P=0.04) as shown in Table 4.6. 
 
Table 4.6: HOMA-IR, HOMA- β and Composite Index values at baseline and follow-up. Mean ± SD. Change scores shown with 95 % confidence 
intervals. * P ≤ 0.05 dayxgroup interaction # P ≤ 0.0  baseline versus follow-up † main effect of day (i.e.  Day 1 vs. Day 8 both groups; P=0.001). 
 
 
 SUR SUR+EX 
 Baseline Follow-up ∆  95 % CI) Baseline Follow-up ∆  95 % CI) 
HOMA-IR 0.79 ± 0.67 1.54 ± 0.85  0.75  0.30  o 1.20) † 0.95 ± 0.58 1.20 ± 0.61 0.25 (-0.08  o 0.59) † 
HOMA-β  %) 63± 53 119± 73 # 57 (23 to 91) 60± 33 74± 33 14 (-9to 37) * 
Insulin Sensitivity Index 
(comp) 
11.9 ± 4.2 6.2 ± 2.5 # 5.6 (3.4to 7.8) 10.8 ± 5.9 8.9 ± 4.2 1.8 (-1.4 to 5.0) * 




4.3.7 Fasted Blood measurements 
 
Serum adiponectin concentrations significantly increased at follow-up within the 
SUR and SUR+EX group; there was a main effect of day (P<0.001) and a 
dayxgroup interaction (P≤0.05) as shown by Figure 4.15. Serum leptin 
concentrations significantly increased at follow-up within the SUR and SUR+EX 






















































































Figure 4.15: Serum Adiponectin concentrations at baseline and follow-up for the 
SUR and SUR+EX group. Values are means ± nCI * denotes a dayxgroup 
interaction (F=4.17, P≤0.0 ) # denotes values different pre-post within SUR and 
SUR+EX group (P<0.001 & P=0.03, respectively) † denotes a main effect of day 




































          
Figure 4.16: Serum Leptin concentrations at baseline and follow-up for the SUR 
and SUR+EX group. Values are means ± nCI. † denotes a main effect of day 
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Total serum cholesterol concentrations significantly increased at follow-up in the 
SUR group while they remained unchanged in the SUR+EX group; there was a 
main effect of day (P=0.005) and a dayxgroup interaction (P=0.03) as shown by 
Figure 4.17. HDL cholesterol concentrations increased in both groups at follow-
up; there was a main effect of day (P=0.002) as shown by Figure 4.18. LDL 
cholesterol concentrations increased at follow-up within the SUR group but 
decreased within the SUR+EX group, there was a main effect of day (P=0.002) 
and a dayxgroup interaction (P≤0.0 ) as shown by Figure 4.19. Triglyceride 
concentrations increased in both groups at follow-up; there was a main effect of 
day (P=0.003) as shown by Figure 4.20. Non-esterified fatty acids concentrations 
decreased at follow-up; there was a main effect of day (P<0.001) as shown by 
Figure 4.21. Serum ALT activity (Figure 4.22) increased in both groups at 



































































Figure 4.17: Total serum cholesterol concentrations at baseline and follow-up 
for the SUR and SUR+EX group. Values are means ± nCI. * denotes a 
dayxgroup interaction (F=5.73, P=0.03) # denotes values different pre-post 
within SUR group (P=0.006) † denotes a main effect of day (i.e.  Day 1 vs. Day 
















































Figure 4.18: Serum HDL cholesterol concentrations at baseline and follow-up 
for the SUR and SUR+EX group. Values are means ± nCI.  † denotes a main 





















































 Figure 4.19: LDL cholesterol at baseline and follow-up for the SUR and 
SUR+EX group. Values are means ± nCI. * denotes a dayxgroup interaction 
(F=4.34, P≤0.0 ) † denotes a main effect of day (i.e.: Day 1 vs. Day 8 both 












































Figure 4.20: Serum triglycerides (TAG) concentrations at baseline and follow-
up for the SUR and SUR+EX group. Values are means ± nCI.  † denotes a main 

















































Figure 4.21: Serum NEFA concentrations at baseline and follow-up for the SUR 
and SUR+EX group. Values are means ± nCI.  † denotes a main effect of day 









































Figure 4.22: Serum ALT activity at baseline and follow-up for the SUR group 
(n=13) and the SUR+EX group. Values are means ± nCI. † denotes a main effect 
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Whole blood white blood cell count significantly increased at follow-up in the 
SUR group while it remained unchanged in the SUR+EX group; there was a 
main effect of day (P=0.01) and a dayxgroup interaction (P=0.03) as shown by 
Figure 4.23. CRP concentrations were not affected as shown by Figure 4.24. 














































Figure 4.23: Whole blood white blood cell count at baseline and follow-up for 
the SUR and SUR+EX group. Values are means ± nCI. * denotes a dayxgroup 
interaction (F=5.38, P=0.03) # denotes values different pre-post within SUR 
group (P=0.008) † denotes a main effect of day (i.e.  Day 1 vs. Day 8 both 

















































Figure 4.24: Serum CRP concentrations at baseline and follow-up for the SUR 







































Figure 4.25: Serum IL-6 concentrations at baseline and follow-up for the SUR 














4.3.8 Adipose tissue Gene Expression 
Expression of SREBP1c, FAS and GLUT4 was significantly up-regulated in the 
SUR group (P≤0.01 baseline versus follow-up); there was a main effect of day 
(F>9.8, P<0.01) and a dayxgroup interaction (F>5.2, P≤0.05). Expression of 
IRS2 was significantly down-regulated in the SUR group (P<0.001 baseline 
versus follow-up); there was a main effect of day (F=11.8, P=0.003) and a 
dayxgroup interaction (F=17.8, P<0.001). Expression of VISFATIN was 
significantly down-regulated in the SUR group (P=0.02 baseline versus follow-
up); there was a dayxgroup interaction (F=6.2, P=0.02). Expression of PDK4 and 
HSL was significantly down-regulated in the SUR and SUR+EX groups (P≤0.05 
baseline versus follow-up); there was a main effect of day (F>25.4, P<0.001) and 
a dayxgroup interaction (F>5.3, P≤0.05). There was a main effect of day in the 
expression changes of ADIPONECTIN, LEPTIN, PPARγ, AMPK and Apelin 
(F>5.4, P≤0.0 ). Individuals with one or both samples outside the detectable 
limit (Ct>35) were excluded from the analysis. Four genes were expressed at 
very low levels; TNFα was undetectable in 9   of samples; IL-18 was 
undetectable in 32 % of samples; IL-6 was undetectable in 39 % of samples and 
Apelin was undetectable in 50 % of samples. Gene expression data is presented 
below (Figure 4.26). Enough RNA could not be obtained from some smaller 
biopsies to carry out gene expression analysis on those samples, as a result n=10 








Figure 4.26 : Mean fold change in the expression of several key genes measured in adipose tissue at baseline and follow-up for the SUR group (n=10) 
and the SUR+EX group (n=12). Data normalised to PPIA= Peptidylprolyl isomerase A. SREBP-1c= Sterol regulatory element binding protein 1c, 
PDK4= Pyruvate dehydrogenase kinase isozyme 4, FAS= Fatty acid synthase, PPARγ= Peroxisome proliferator-activated receptor gamma, TNFa= 
Tumor necrosis factor alpha (SUR, n=9; SUR+EX, n=10), GLUT4= Glucose transporter type 4, IRS2= Insulin receptor substrate 2, LPL= Lipoprotein 
lipase, HSL= Hormone-sensitive lipase. IRS1= Insulin receptor substrate 1, IL18= Interleukin-18 (SUR, n=6; SUR+EX, n=8), IL6= Interleukin-6 (SUR, 
n=4; SUR+EX, n=6), AMPK= AMP-activated kinase (SUR, n=5; SUR+EX, n=6). Values are means ± nCI. * P≤0.0  dayxgroup interaction. # P≤0.05 
baseline versus follow-up. † main effect of day (i.e.  Day 1 vs. Day 8 both groups; P≤0.0 ). 
SUR
SUR+EX
Chapter 4  Study 2 
109 
 
4.3.9 Western Blots Analysis 
The protein ratio between pAMPK and AMPK was significantly down-
regulated in the SUR group (P=0.001 baseline versus follow-up); there was a 
dayxgroup interaction (F=11.3, P=0.005). None of the other proteins measured 
(GLUT4, pAMPK, AMPK, pAKT, AKT1& 2) or ratios (pAKT/AKT1 & 
pAKT/AKT2) were significantly impacted by the overfeeding and restricted 
physical activity model. Protein expression data is presented below (Figure 
4.27). A subset of samples representative of the overall group (mean response to 
the OGTT was very similar to the group mean) were analysed (SUR group, n=7; 
SUR+EX, n=8).  
 
 
Figure 4.27 : Mean fold change in the expression of several key proteins 
measured in adipose tissue at baseline and follow-up for the SUR group (n=7) 
and the SUR+EX group (n=8). Data normalised to GAPDH= Glyceraldehyde 3-
phosphate dehydrogenase. GLUT4= Glucose transporter type 4, pAMPK= 
phospho 5' AMP-activated protein kinase, AMPK= 5' AMP-activated protein 
kinase, pAKT= phospho Protein Kinase B, AKT1= RAC-alpha 
serine/threonine-protein kinase, AKT2= RAC-beta serine/threonine-protein 
kinase. Values are means ± nCI. * P≤0.0  dayxgroup interaction. # P≤0.05 
baseline versus follow-up. † main effect of day (i.e.  Day 1 vs. Day 8 both 

















The combination of short-term overfeeding and reduced physical activity had a 
dramatic impact on insulin sensitivity and adipose tissue gene expression. We 
demonstrated that 7 days of positive energy balance induced a state of marked 
insulin insensitivity in healthy individuals, with significantly altered expression 
patterns of several key genes and proteins within adipose tissue involved in 
nutritional homeostasis, metabolism and insulin action. Notably, the inclusion 
of a daily vigorous-intensity exercise bout largely prevented these changes from 
taking place independent of any net effect on energy imbalance.  
 
Combining reduced physical activity with overfeeding represents an 
experimental model to investigate the benefits of exercise independent of 
energy balance. We successfully maintained a comparable energy surplus 
between the SUR and SUR+EX groups. Importantly, the SUR+EX group 
expended ~700 kcal through daily exercise which was accounted for in the 
prescribed overfeeding. The SUR group experienced an increase in fasted 
insulin concentrations and a ~2-fold increase in the insulinaemic response to the 
OGTT whereas there was no such change in SUR+EX group. The greater 
insulin response to the OGTT reflects greater insulin secretion as indicated by 
the C-peptide response to the OGTT which provides a more accurate assessment 
of β-cell function than peripheral insulin levels as it overcomes the issue of 
hepatic insulin clearance (Cobelli et al., 2007). Brief periods of positive energy 
balance have been shown to lead to impaired insulin sensitivity whether this is 
achieved through decreased physical activity (Vukovich et al., 1996; Arciero et 
al., 1998; Hamburg et al., 2007; Sonne et al., 2010), through overfeeding 
(Wang et al., 2001; Cornier et al., 2006; Brons et al., 2009) or both (Knudsen et 
al., 2012; Hagobian and Braun, 2006). Hagobian and Braun (2006) showed that 
a single 60-minute bout of exercise performed after 3 days of overfeeding and 
detraining partially restored the insulinaemic response to feeding. To our 
knowledge, the present study is the first to demonstrate that metabolic 
dysfunction resulting from a profound short term energy surplus can be mostly 
prevented by concurrent daily vigorous-intensity exercise. 
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Given that energy surplus is a major factor leading to obesity and resultant 
metabolic disturbances, it is surprising that so few studies have focused on 
changes in the expression patterns of key genes in adipose tissue during a bout 
of energy surplus in healthy individuals considering it is a major site for energy 
storage (Shea et al., 2009; Alligier et al., 2012). This is in contrast to the large 
amount of research that has been dedicated to investigating the development of 
insulin resistance within skeletal muscle (Vukovich et al., 1996; Majer et al., 
1998; Schrauwen-Hinderling et al., 2005; Krogh-Madsen et al., 2006; Steinberg 
et al., 2006; Lessard et al., 2007; Plomgaard et al., 2007; Tsintzas et al., 2007; 
Alibegovic et al., 2010; Jensen et al., 2006, 2011). We elected to focus on 
expression changes within adipose tissue and seventeen genes involved in a 
variety of biological processes such as energy homeostasis (AMPK, LEPTIN, 
APELIN), glucose metabolism (IRS1&2, PDK4, GLUT 4, ADIPONECTIN), 
lipid metabolism (ADIP N  TIN, SR BP1c, FAS, PPARγ, LPL, HSL, 
 ISFATIN) and inflammatory pathways (TNFα, IL18, IL ) were selected. The 
overfeeding and reduced physical activity protocol adopted here dramatically 
impacted on the expression of these genes. Seven out of seventeen tested genes 
were differentially-expressed between the two groups. Crucially, the addition of 
a daily vigorous-intensity exercise bout mostly prevented alterations to the 
expression patterns of these genes independent of any net effect on energy 
imbalance. 
 
Few studies have examined the impact of overfeeding and/or reduced physical 
activity on adipose tissue and this is surprising given its role in energy storage 
and metabolic control. AMPK plays a role in cellular energy homeostasis and 
increases glucose transport and fatty acid oxidation while switching off other 
pathways such as lipogenesis and gluconeogenesis. In the current study, AMPK 
mRNA in adipose tissue was down-regulated in both groups, more so in the 
SUR group. This was confirmed at the protein level and the ratio between 
pAMPK and AMPK was significantly down-regulated in the SUR group. This 
would be likely to reduce glucose uptake plus decrease fatty acid oxidation and 
both fasting and exercise have been shown to activate AMPK in adipose tissue 
(Daval et al., 2006). Recently, AMPK has become a potential therapeutic target 
for the treatment of obesity and Type 2 Diabetes (Pedersen, 2007) and thus it is 
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particularly noteworthy that exercise prevented the changes to AMPK in 
adipose tissue even in the context of a profound energy surplus.  
Expression of PDK4 in adipose tissue decreased in both groups but more so in 
the SUR group, highlighting a switch of oxidative fuel from fatty acids to 
glucose. PDK4 is a mitochondrial protein that is a member of the pyruvate 
dehydrogenase kinase family, a group of enzymes that inhibit the pyruvate 
dehydrogenase complex (PDC) by phosphorylating one of its subunits (Rowles 
et al., 1996). Expression of this gene is regulated by glucocorticoids, retinoic 
acid and insulin (Kwon & Harris, 2004). Our data support the role of insulin 
since there was an inverse correlation between changes in insulin iAUC and 
changes in the expression of PDK4 (r=-0.62; P=0.002). There was also an 
inverse correlation between changes in insulin iAUC and changes in the 
expression of IRS2 (r=-0.56; P=0.007). IRS2 mRNA was down-regulated in the 
SUR group in response to the intervention but was not affected in the SUR+EX 
group. IRS2 is a cytoplasmic protein that mediates the effects of insulin and 
various cytokines (Sun et al., 1995). The changes in PDK4 and IRS2 reported 
here are in agreement with transcriptome analysis conducted on abdominal 
subcutaneous fat samples from lean and obese men following short-term 
overfeeding (Shea et al., 2009). We suggest that these changes within adipose 
tissue may be a secondary response to the marked hyperinsulinaemia induced by 
overfeeding.  
SREBP-1c is a transcription factor that regulates the expression of the lipogenic 
enzymes FAS (Minehira et al., 2003). Overfeeding and reduced activity 
significantly increased the expression of both SREBP-1c and FAS transcripts in 
the SUR group and changes in SREBP-1c and FAS were correlated (r=0.63; 
P=0.002). Minehira et al. (2003) made a similar finding in humans using a 





) during the intervention and so it is likely that this 
would have rapidly saturated liver and muscle glycogen stores. The SUR group 
had little capacity for carbohydrate oxidation as a result of restricted physical 
activity thermogenesis and thus it is unsurprising that SREBP-1c and FAS are 
up-regulated in the SUR group as SREBP-1c has been linked with de novo 
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lipogenesis (DNL) which has been shown to take place in adipose tissue 
(Strawford et al., 2004; Roberts et al., 2009; Collins et al., 2011); thus 
providing a route for disposal of excess glucose. Our calculations suggest that 
the increase in RMR in the SUR group may be explained by DNL; by removing 
the estimated energy cost of this process (Acheson et al., 1988), RMR at follow-









 in SUR and SUR+EX groups, respectively). Collectively, our results 
indicate that combined overfeeding and reduced physical activity favours net 
lipogenesis (↑SR BP-1c, ↑FAS, ↓HSL) but not when the same energy surplus 
occurs alongside daily vigorous intensity exercise. 
 
Leptin is a hormone that is predominantly expressed in the adipose tissue. Our 
results suggest that leptin is regulated at the post-transcriptional level as mRNA 
levels are not affected by the intervention while serum levels increased 1.7-fold 
in the SUR group and 1.3-fold in the SUR+EX group. The best known effect is 
that adipocyte-derived leptin acts on the hypothalamus to centrally suppress 
feeding and fatty acid metabolism (Baranova, 2008). Leptin and insulin 
compete for the same signaling molecules, in particular, JAK2/STAT-3 and 
phosphoinositide 3-kinase (PI3K; Baranova, 2008). As a result, an increase in 
leptin reduces insulin efficiency (Benomar et al., 2005). Overfeeding studies 
consistently showed an increase in serum leptin concentrations following 
overfeeding (Joosen et al., 2006; Brons et al., 2009).  
 
Like leptin, adiponectin is synthesized exclusively in adipocytes (Baranova, 
2008). In patients with type 2 diabetes compared with subjects without diabetes, 
low adiponectin concentrations correlate strongly with insulin resistance (Weyer 
et al., 2001). Adiponectin has been shown to increase insulin sensitivity in 
rodents by administrating recombinant adiponectin to insulin-resistant rodents 
(Yamauchi et al., 2001). Our data shows a slight down-regulation of 
adiponectin at the mRNA level in both groups but an increase at the protein 
concentration level, more so in the SUR group. An increase in circulating 
adiponectin seems counter-intuitive considering our participants gained weight 
as a result of the intervention. Ukkola et al. (2008) showed that serum 
adiponectin significantly decreased in response to 100 days of overfeeding. A 
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more comparable study is the one conducted by Brons et al. (2009) where 
subjects consumed a high-fat, high calorie diet for five days. They noticed an 
increase in fasting levels of plasma adiponectin in response to this diet. 
Adiponectin increases both hepatic and peripheral insulin sensitivity (Fasshauer 
& Paschke, 2003). Brons et al. (2009) hypothesised that the increase in 
adiponectin may explain the lack of the otherwise expected development of 
overt peripheral insulin resistance. This increase of circulating adiponectin 
points towards an acute response to the overfeeding perhaps in an attempt to 
improve insulin sensitivity.  
 
Our post-intervention calculations show that carbohydrate and fat contributed 
approximately 20 % and 50 % towards the overall energy surplus, respectively. 
There was a non-significant tendency for positive carbohydrate balance (i.e., 
intake – oxidation – conversion to lipid) to be greater in the SUR than SUR+EX 








 in SUR and SUR+EX 
groups, respectively; P=0.24). The current experiment was designed to induce a 
matched energy surplus with or without exercise and not to account for the route 
of disposal for each macronutrient. Inevitably, the SUR+EX oxidised more 
carbohydrate as a result of daily vigorous-intensity exercise where carbohydrate 
was the primary substrate but, because the overfeeding was based on their usual 
diet, the surplus for individual macronutrients was not matched. It is possible 




 greater carbohydrate balance 
between groups could explain differences in insulin sensitivity at follow-up. 
However, research shows that exercise enhances insulin action even when 
expended energy and carbohydrate are replaced (Stephens et al., 2007). Based 
on our observations, we cannot know the fate of the surplus carbohydrate. Some 
possibilities for disposal of surplus carbohydrate not stored as glycogen include: 
excretion (although this is likely to be minor; Acheson et al., 1988), adaptive 
thermogenesis (e.g., fidgeting), and an under-estimation of DNL. Recent work 
by Hodson et al. (2013) indicates that DNL takes place after meals within the 
adipose tissue of healthy humans whereas we have based our calculations on 
only fasting measures. Furthermore, we should point out that our calculations do 
not take into account protein and alcohol metabolism as these would also have 
been oxidised (Appendix 4). We can therefore assume that we are under-
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estimating the amount of excess macronutrients that have been converted into 
fat via DNL. Future studies replacing individual macronutrients and more 
carefully accounting for their fate would help understand the importance of each 
macronutrient in regulating insulin sensitivity and adipose tissue metabolism.  
 
Profound short-term macronutrient imbalances also have the capacity to 
confound prediction of energy imbalances based on observed changes in mass. 
In the present study, the SUR group gained 2.7 kg and the SUR+EX group 
gained 1.6 kg. This may be related to differences in glycogen storage. Glycogen 
is stored alongside water but the ratio is unclear and is likely to vary under 
different conditions (Appendix 5; Olsson & Saltin,1970; Sherman et al., 1982; 
Piehl Aulin et al., 2000). Interestingly, a study by Horton et al. (1995) showed 
that 7 days of CHO overfeeding led to a ~30 % greater weight gain than 
matched fat overfeeding, which is very similar to the greater weight gain 
observed in the SUR group in the present study. Thus, in the short-term, a given 
energy or nutrient imbalance will not necessarily translate into a proportional 
change in mass. 
 
In summary, our study shows that short-term overfeeding combined with 
reduced physical activity induces a state of insulin resistance, hyperinsulinaemia 
and altered expression of several key genes within adipose tissue. The addition 
of daily vigorous-intensity exercise mostly prevented these changes independent 
of any net effect on energy imbalance. Whether this is facilitated by regular 
glycogen turnover or some other consequence of muscle contraction per se 
remains to be explored. These results demonstrate that exercise has a profound 















Caloric restriction combined with moderate or vigorous-
intensity exercise provide similar positive changes in 
metabolic control when energy expenditure and caloric 
deficit are matched. 
 
5.1 Introduction 
In Chapter 4, we demonstrated that a daily bout of vigorous-intensity exercise 
prevented most of the metabolic changes induced by seven days of overfeeding 
and reduced physical activity independent of any net effect on energy 
imbalance. Although we have shown that vigorous-intensity exercise can offer 
substantial benefits in the context of an energy surplus, it is still unclear whether 
exercise-induced changes in the context of an energy deficit are specific to the 
characteristics of the exercise (such as duration and intensity). Whether exercise 
training programmes that differ in intensity and duration also differ in their 
ability to improve metabolic health remains uncertain.  
 
Whilst some studies suggest that vigorous high-intensity exercise can further 
improve glucose control and insulin action compared to moderate-intensity 
exercise (Seals et al., 1984; Kang et al., 1996; Swain & Franklin, 2006), others 
have shown that moderate-intensity exercise can provide the same benefits 
(Oshida et al., 1989; Braun et al., 1995; Houmard et al., 2004;  ’Donovan et 
al., 2005). To complicate matters further, there is much debate about whether 
the effect of exercise on metabolic control is independent of changes in energy 
balance. In order to determine whether vigorous-intensity exercise provides 
further health benefits than moderate-intensity exercise, it is crucial to control 
energy status during the intervention (Braun & Brooks, 2008). It is also 
important to prioritise health outcomes when investigating the optimum 
intensity, duration and frequency of a type of exercise as conclusions may vary 
depending on the health outcome in question (Haskell, 2001). 
 
Houmard et al. (2004) showed that total exercise duration was the key 
determinant in improving insulin action in the Studies of a Targeted Risk 
Reduction Interventions through Defined Exercise (STRRIDE) study. In 




STRRIDE, sedentary, overweight/obese participants (n=154) were randomly 
assigned to either a control or an exercise group for six months. The exercise 
arm was further split into three different categories: 1) low-volume/moderate-
intensity group (~12 miles walking/week at 40-55 %    2 peak) 2) low-
volume/high-intensity group (~12 miles jogging/week at 65-80 %    2 peak) 3) 
high-volume/high-intensity group (~20 miles jogging/week at 65-80 %    2 
peak). Insulin sensitivity was shown to improve in all three groups but the low-
volume/moderate-intensity and high-volume/high-intensity groups elicited 
greater improvements in insulin sensitivity than the low-volume/high-intensity 
group. The authors concluded that total exercise duration (regardless of exercise 
intensity) was the key factor in improving insulin sensitivity. Importantly, 
energy balance was not controlled during the intervention as there was no 
mention of any dietary assessment.  ’Donovan et al. (2005) investigated the 
effect of exercise intensity on insulin resistance by comparing moderate and 
high-intensity training of equal energy cost in sixty-four previously sedentary 
men who were randomly allocated to either: 1) a non-exercise group 2) a 
moderate-intensity group 3) a high-intensity group. Participants were instructed 
to maintain their normal dietary habits. They concluded that moderate-intensity 
exercise is as effective as high-intensity exercise when 400 kcal are expended 
per session.  
 
There is a strong scientific rationale for combining hypocaloric diets with 
regular physical aerobic exercise as the most effective treatment of obesity 
(Hsueh & Buchanan, 1994; Brochu et al., 2000; Poirier & Despres, 2001). The 
combination of caloric restriction alongside increased physical activity is more 
ecologically valid than studies looking at diet or physical activity alone. It is 
unclear whether variation in exercise intensity will lead to different metabolic 
responses. A study by Nicklas et al. (2009) investigated whether varying 
exercise intensity concurrent with caloric restriction affected abdominal fat loss 
and risk factors of cardiovascular disease. In a randomised controlled trial of 
equal energy deficit, 112 overweight and obese postmenopausal women were 
assigned to one of three groups for the study duration of 20 weeks: 1) caloric 
restriction alone 2) caloric restriction plus moderate-intensity exercise 3) caloric 
restriction plus vigorous-intensity exercise. The average weight loss for all 




participants was 12 ± 5 kg, they found that there was no difference in abdominal 
fat loss or improvements of metabolic markers across treatment groups. Roberts 
et al. (2006) also combined short-term diet manipulation with daily vigorous 
aerobic exercise (45-60 minutes at 70-85 %    2max) in a 3-week intervention in 
middle-aged obese men (n=31). Participants were placed on a high-fibre, low-
fat diet where food was provided ad libitum. After 3 weeks, significant 
reductions (P<0.05) were achieved for all serum lipids, fasting glucose and 
insulin as well as C-reactive protein. It is uncertain whether these improvements 
were the result of the increased physical activity or the weight loss/negative 
energy balance. These findings highlight the importance of carefully controlling 
energy balance when investigating whether exercise intensity has an impact on 
metabolic outcomes and inflammatory markers.  
 
The purpose of the present study was therefore to investigate whether caloric 
restriction alongside vigorous-intensity exercise would further improve 
metabolic control in inactive and overweight/obese men and postmenopausal 
women over the course of a three-week intervention relative to moderate-
intensity exercise. We hypothesised that caloric restriction alongside vigorous-
intensity exercise would further improve metabolic markers and the expression 
of key genes within adipose tissue (a major site for energy storage) during a 
period of negative energy balance compared to moderate-intensity exercise 




5.2.1 Overview of experimental design 
 
The purpose of this study was to examine whether caloric restriction combined 
with moderate or vigorous-intensity exercise would further improve metabolic 
control and markers of inflammation in inactive and overweight/obese men and 
postmenopausal women over the course of a three-week intervention. The study 
duration was based on a similar protocol used by Roberts et al. (2006) which 
reduced markers of inflammation in obese middle-aged men following a three-
week intervention. A randomised parallel group design was used for this study, 
with participants randomly allocated by a third party to experience a fixed 










induced by caloric restriction and increased 
physical activity via either moderate (MOD) or vigorous (VIG) physical 
exercise. Volunteers in both groups were asked to reduce their caloric intake by 
under-consuming their habitual diet (Chapter 2.9) in order to create a caloric 






In addition, participants in the MOD group increased 
their physical activity by walking on a treadmill five times per week at 50 % of 
their maximum oxygen uptake while participants in the VIG group increased 
their physical activity by walking on a treadmill five times per week at 70 % of 







per session for both groups) above rest through increased 
physical activity. 
 
Changes in insulin sensitivity and glycaemic control reflected by basal values 
and incremental Area Under the Curve (iAUC) measured at baseline and follow 
up were the primary outcome measures. Other blood measures related to 
metabolic control, inflammation and changes within adipose tissue were 
secondary outcome measures.  
 
5.2.2 Participants 




) men (n=24) and 
postmenopausal women (n=14) completed the present study. Participants were 
45-64 years old with a mean age of 52 ± 5 years (mean ± SD) and had been 
weight stable (± 3 kg) for at least 6 months. Women were required to have been 
postmenopausal in order to take part in the study (no menstruation for at least a 
year; Witteman et al., 1989). To be eligible, participants were required to report 
no participation in regular structured exercise and that they did not do >30 
minutes of moderate-intensity exercise, accumulated in 10 minutes bouts, on 
most days of the week. Habitual physical activity was assessed via a physical 
activity questionnaire (Appendix 2). Participants completed a health 
questionnaire (Appendix 2) and Physical Activity Readiness Questionnaire 
(PAR-Q; Appendix 3) to determine eligibility and provided written and verbal 
consent consistent with the requirements of the Bath NHS Research Ethics 
Committee, who approved this study (REC reference number: 08/H0101/194). 
Specifically, individuals who smoked, suffered from a condition known to 




interact with the study measures or took regular medication that may have 
interfered with the results were excluded from the study. All participants 
confirmed they adhered to the exercise training by filling out an exercise log 
and attending a weekly supervised exercise session. They also confirmed to 
have only consumed the prescribed foods over the course of the intervention. 
The anthropometric and physiological characteristics of those included are 
presented in Table 5.1.  
 
Table 5.1: Participant details. Mean ± SD 
Characteristic MOD group (n=20) VIG group (n=18) 
Age (y) 53 ± 6 50 ± 4 
Height (m) 1.71 ± 0.10 1.71 ± 0.12 
Mass (kg) 90.0 ± 13.6 89.5 ± 16.6 
BMI (kg·m
-2
) 30.7 ± 2.4 30.3 ± 2.7 
Fat Mass Index (kg·m
-2
) 11.2 ± 2.1  10.7 ±  2.2 




) 31.7 ± 4.2 31.3 ± 4.9 
   2 max (l·min
-1
) 2.9 ± 0.6  2.9 ± 0.8 
PAL (TEE/REE) 1.57 ± 0.17 1.59 ± 0.17 
 
 
5.2.3 Design Summary 
Participants were randomly-allocated by a third party to one of two groups for 
the study period of three weeks using block randomisation: 
1) Caloric restriction with vigorous-intensity exercise (VIG) n=20 
2) Caloric restriction with moderate-intensity exercise (MOD) n=18 
This resulted in 13 males and 7 females in the MOD group and 11 males and 7 
females in the VIG group.  
The experimental design is summarised below (Figure 5.1) 






Figure 5.1: Schematic representation of the energy deficit induced by the 
caloric restriction and increased physical activity model. 
 
 
In the month prior to the three-week intervention, participants recorded their 
food and fluid intake for one week as described in Chapter 2.9, which was used 





 from caloric restriction alone. This was achieved by subtracting 20950 
kJ from their recorded total weekly energy expenditure (assessed by the 
Actiheart during the diet recall week). The dietary caloric restriction was based 
on participants’ energy expenditure as overweight and obese individuals have 
been shown to under-report food intake (Macdiarmid & Blundell, 1998).  Based 
on this, participants recorded diets were scaled in order to induce the desired 
energy deficit during the intervention. This was achieved by multiplying the 
weight of all individual foods by the desired energy intake over the recorded 
week energy input. Participants repeated this one-week diet three times during 
the intervention. Participants underwent a maximal oxygen uptake test in order 
to determine the correct speed and gradient required for them to achieve either 
 0      2 max for the M D group or 70      2 max for the  IG group 
( hapter 2. ). A corresponding Heart Rate (HR) at this gradient and speed was 
estimated from the relationship between HR and      2 max. Energy 
expenditure at the desired intensity was utilised to calculate a set distance (km) 




required to expend 1676 kJ
 
above resting energy expenditure. In order to 
account for post-exercise oxygen consumption, measured oxygen consumption 
was adjusted by an extra 5.4 % for the MOD group and by 6.4 % for the VIG 
group (Gore & Withers, 1990). Participants were asked to complete this 
distance at predicted HR below  0      2max for the M D group or at least 70 
     2max for the VIG group. Exercise took place in the Sports Training Village 
fitness suite at the University of Bath. In addition, one supervised exercise 
session per week was performed in the Exercise Physiology Laboratory. 
Assuming a linear relationship between speed and energy expenditure when 
walking at a set gradient (Franklin, 2000), participants were then able to adjust 
the speed in order to achieve the target heart rate and intensity.  
 
Participants abstained from tea/coffee or alcohol the day before each trial. 
During the days leading up to the trial, volunteers followed their normal 
lifestyle and consumed their habitual diet. The final exercise bout prescribed 
was performed 48 hours before follow-up measurements were collected. 
 
5.2.4 Trial Days 
Following an overnight fast (≥10 h), participants arrived in the laboratory at 
0700 ± 0.5 h. Body mass was measured to the nearest 0.1 kg using electronic 
scales (Tanita Corporation, Japan). All participants wore the same light clothing 
at baseline and follow-up for body mass measurement. Anthropometric 
measurements were made in triplicate using a metallic tape measure (Lufkin, 
US) before lean and fat mass were measured using Dual-Energy X-ray 
Absorptiometry (DEXA) (Discovery, Hologic, Bedford, UK) (Chapter 2.2). 
Following the application of a topical local anaesthetic (1.5 ml Ametop gel, 
Smith & Nephew, Hull, England) an 18-gauge 1.3x45 mm cannula (BD 
Venflon Pro) was inserted into an antecubital vein and a baseline blood sample 
collected. An adipose tissue sample was then collected (Chapter 2.10) before an 
OGTT was performed according to the procedure described in Chapter 2.4. 
Blood pressure was measured in triplicate at the end of each trial (Chapter 2.3). 
The same protocol was used at follow-up.  
 
 




5.2.5 Analytical methods 
Blood was analysed for WBC counts, serum CRP, IL-6, Adiponectin, Leptin, 
ALT, Insulin, TAG, Cholesterol, HDL-Cholesterol, NEFA and plasma glucose. 
Adipose tissue was analysed for mRNA (Chapter 2.11, 2.12). 
 
5.2.6 Statistical analysis 
To simplify data analysis and facilitate a more meaningful interpretation of an 
otherwise complex factorial research design (Hopkins et al., 2009 & Matthews 
et al., 1990), serial measurements of glucose and insulin at baseline and follow-
up were converted into simple summary statistics to illustrate the net response 
of each parameter (i.e. within-subject peak concentrations, time to peak and 
incremental area under curve; Wolever & Jenkins, 1986). Pre-planned contrasts 
were conducted in relation to the absolute group differences both at final 
follow-up and the relative change from baseline. The precise time-course of 
responses within and between trials were analysed using factorial 2- and 3-way 
mixed-model analysis of variance (groupxday & groupxdayxtime, respectively) 
irrespective of minor deviations from a normal distribution (Maxwell & 
Delaney, 1990) but with the Greenhouse-Geisser correction applied to intra-
individual contrasts for ɛ <0.75 and the Huynh-Feldt correction adopted for less 
severe asphericity (Atkinson, 2002). Where significant interactions were 
observed, multiple t-tests were applied to determine the location of variance 
both between treatments at each time point and between time points within each 
treatment relative to baseline, with both methods subject to a Holm-Bonferroni 
correction (Atkinson, 2002). For all the above statistical approaches, statistical 
significance was set at an alpha level of P≤0.0 .  
 
Data are presented in text as means and standard deviations (SDs). The 
confidence intervals displayed in tables are standard 95 % confidence intervals 
(95 % CI) to better illustrate group differences whereas the variance bars on 
figures are normalised confidence intervals (nCI) that have been corrected to 
remove inter-individual variation (Masson, 2003). For reference, the magnitude 
of these CIs illustrate the change at each time point relative to baseline such 
that, in general, plotted means whose CIs do not overlap by more than one-half 
of one side of an interval are likely to be deemed statistically different according 




to conventional significance testing (Masson, 2003). A main effect of day 
denotes an effect of energy surplus (†  Day 1 vs. Day 21 both groups), whereas 
a dayxgroup interaction means there is a mediating effect of exercise (*). 
Statistical analysis for the gene expression data was carried out on the ∆ t 
values. The Pearson rank correlation was employed to determine the strength of 
relationships between parameters. For CRP and IL-6, the mean and standard 
deviation of the change (∆) were calculated using all data points. Any change 
score that was over 3 SD away from the mean were excluded from analysis as 
this would likely have been due to an acute inflammatory response. This is 




5.3.1 Anthropometric and physiological measures 
Anthropometric and physiological measures pre and post-intervention are 
summarised in Table 5.2. Body mass, waist & hip circumference, fat mass 
(DEXA), abdominal fat (DEXA), systolic and diastolic blood pressure 
significantly decreased post-intervention in both groups; there was a main effect 
of day (P<0.001) as shown in Table 5.2. Lean mass (DEXA) was not affected 
by the intervention in either group.  




Table 5.2: Anthropometric and physiological characteristics measured before and after 3 weeks of caloric restriction with moderate-intensity 
physical exercise (MOD; n=20) or vigorous-intensity physical exercise (VIG; n=18) (n.b. waist and hip measurements n=19 in MOD group;  
blood pressure measurements  n=17 in  IG group). Mean ± SD.  hange scores shown with 9   confidence intervals. † main effect of day 
(i.e.: Day 1 vs. Day 21 both groups; F>23.2,  P<0.001). 
 
 MOD VIG 
 Baseline Follow-up ∆  95% CI) Baseline Follow-up ∆  95% CI) 
Body Mass (kg)  90.0 ± 13.6 87.6 ± 13.3  -2.4  1.7  o 3.1) † 89.5 ± 16.6 87.1 ± 16.6  -2.4  1.9  o 2.9) † 
Waist Circumference (cm) 104.7 ± 6.8 102.9 ± 6.5  -1.8 (0.9  o 2.7) † 101.0 ± 10.4 98.8 ± 10.5  -2.2  0.9  o 3.4) † 
Hip Circumference (cm) 111.0 ± 5.9 109.3 ± 5.0  -1.6  0.7  o 2.8) † 110.6 ± 6.2 108.2 ± 5.0  -2.4  1.4  o 3.5) † 
Fat Mass (kg; DEXA) 32.3 ± 5.6 30.5 ± 5.0  -1.8  0.9  o 2.8) † 30.9 ± 5.4 29.0 ± 5.1  -1.9  1.2  o 2.6) † 
Lean Mass (kg; DEXA) 54.2 ± 11.4 53.5 ± 11.0  -0.7 (-0.4 to 1.8) 54.8 ± 14.7 54.5 ± 14.9  -0.3 (-1.1 to 0.5)  
Abdominal Fat (kg; DEXA) 4.8 ± 1.4 4.4 ± 1.3 -0.4  4.2  o 5.5) † 4.4 ± 1.1 3.9 ± 1.0 -0.4  3.8  o 4.9) † 
Systolic BP (mmHg) 128 ± 13 121 ± 15  -7  3  o 10) † 135 ± 11 128 ± 13  -7  2  o 12) † 
Diastolic BP (mmHg) 80 ± 12 75 ± 10  -5  1  o 8) † 85 ± 9 79 ± 9  -6  3  o 9) † 
 
 




5.3.2 Insulin & Glucose responses to OGTT 
 
Serum Insulin 
The serum insulin concentrations in response to the OGTT were significantly 
reduced at follow-up for both groups as shown in Figure 5.2. There was a main 
effect of day (P=0.001). The insulinaemic response following the OGTT was 
significantly reduced at follow-up for both groups with a decrease in 2 h iAUC; 
and there was a main effect of day (P=0.005) as shown by Figure 5.3. There 
also was a main effect of day (P=0.009) for the serum insulin peak 
concentration of both groups following the 2 h OGTT as shown by Figure 5.4. 














































































Figure 5.2: Serum insulin concentrations in response to the OGTT before and 
after 3 weeks of caloric restriction and increased physical activity (Panel A: 
MOD group, n=15; Panel B   IG group, n=14).  alues are means ± n I. † 



































































Figure 5.3: Insulinaemic responses during the 2 h OGTT for the MOD group 
(n=14) and the VIG group (n=15). Values are means ± nCI. † denotes a main 

























































Figure 5.4: Serum insulin peak concentration during the 2 h OGTT for the 
MOD group (n=14) and the VIG group (n=14). Values are means ± nCI. † 















The glycaemic response following the OGTT was unaffected in both groups as 
shown by Figure 5.5. There was a dayxgroup interaction (P=0.04) for the iAUC 
of the glycaemic response following the OGTT as shown by Figure 5.6. There 
also was a dayxgroup interaction (P=0.05) for the plasma glucose peak 
concentration following the 2 h OGTT as shown in Figure 5.7. The individual 








































































Figure 5.5: Plasma glucose concentrations in response to the OGTT before and 
after 3 weeks of caloric restriction and increased physical activity (Panel A: 



































































Figure 5.6: Glycaemic responses during the 2 h OGTT for the MOD group 
(n=16) and the VIG group (n=12). Values are means ± nCI. * denotes a 
























































Figure 5.7: Plasma glucose peak concentration during the 2 h OGTT for the 
MOD group (n=16) and the VIG group (n=14). Values are means ± nCI. * 









The Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) decreased at follow-up in both groups; there was a main effect of day 
(P=0.001). The Homeostasis Model Assessment of β-cell function (HOMA-β) decreased at follow-up in both groups; there was a main effect of 
day (P=0.001). The Matsuda Index or Composite Index (ISI comp) increased at follow-up in both groups; there was a main effect of day 
(P=0.007). Data is summarised in Table 5.3. 
 
Table 5.3: HOMA-IR (MOD, n=16; VIG, n=18), HOMA- β (MOD, n=16; VIG, n=18) and Composite Index (MOD, n=15; VIG, n=11) values at 
baseline and follow-up. Mean ± SD. Change scores shown with 95% confidence intervals. † main effect of day (i.e.  Day 1 vs. Day 21 both 
groups; F>8.6, P<0.01). 
 
 
 MOD VIG 
 Baseline Follow-up ∆  95% CI) Baseline Follow-up ∆  95% CI) 
HOMA-IR 1.98 ± 1.06 1.65 ± 0.82  -0.33 (-0.17  o 0.82) † 2.36 ± 2.18 1.41 ± 1.45 -0.95  0.44  o 1.46) † 
HOMA-β  %) 99 ± 58 76 ± 33  -22 (-4  o 48) † 84 ± 44 52 ± 19 -31  13  o 50) † 
Insulin Sensitivity Index 
(comp) 
5.6 ± 3.6 6.1 ± 2.6  0.5 (-1.0  o 2.1) † 5.9 ± 3.3 8.1 ± 3.5 2.2  1.2  o 3.3) † 




5.3.3 Fasted Blood measurements 
 
Serum adiponectin and leptin concentrations significantly decreased at follow-up 
in both groups; there was a main effect of day (P=0.002 & P<0.001, 
respectively) as shown by Figure 5.8 & 5.9. Serum cholesterol, HDL cholesterol, 
LDL cholesterol & TAG concentrations significantly decreased at follow-up in 
both groups; there was a main effect of day (P=0.006, P=0.05, P=0.02 & 
P=0.002, respectively) as shown by Figures 5.10, 5.11, 5.12 & 5.13, respectively. 
Serum NEFA concentrations were unaffected in both groups (Figure 5.14). 
Serum ALT activity decreased at follow-up in both groups; there was a main 
effect of day (P=0.01) as shown by Figure 5.15. Whole blood WBC & serum 
CRP decreased at follow-up in both groups; there was a main effect of day 
(P<0.001 & P=0.001, respectively) as shown by Figure 5.16 & 5.17, 









































































Figure 5.8: Serum Adiponectin concentrations at baseline and follow-up for the 
MOD group and the VIG group. Values are means ± n I. † denotes a main effect 










































Figure 5.9: Serum Leptin concentrations at baseline and follow-up for the MOD 
group and the VIG group. Values are means ± nCI. † denotes a main effect of 

























































Figure 5.10: Total serum cholesterol concentrations at baseline and follow-up 
for the MOD group and the VIG group. Values are means ± nCI. † denotes a 











































Figure 5.11: Serum HDL cholesterol concentrations at baseline and follow-up 
for the MOD group and the VIG group. Values are means ± nCI. † denotes a 






























































Figure 5.12: LDL cholesterol at baseline and follow-up for the MOD group and 
the VIG group. Values are means ± nCI. † denotes a main effect of day (i.e.  Day 









































Figure 5.13: Serum triglycerides (TAG) concentrations at baseline and follow-
up for the MOD group and the VIG group. Values are means ± nCI. † denotes a 























































Figure 5.14: Serum NEFA concentrations at baseline and follow-up for the 












































Figure 5.15: Serum ALT activity at baseline and follow-up for the MOD group 
and the VIG group. Values are means ± nCI. † denotes a main effect of day (i.e.  



















































Figure 5.16: Whole blood white blood cell count at baseline and follow-up for 
the M D group and the  IG group.  alues are means ± n I. † denotes a main 














































Figure 5.17: Serum CRP concentrations at baseline and follow-up for the MOD 
group (n=19) and the  IG group (n=17).  alues are means ± n I. † denotes a 
main effect of day (i.e.: Day 1 vs. Day 21 both groups; F=14.5, P=0.001). Two 



















































Figure 5.18: Serum IL-6 concentrations at baseline and follow-up for the MOD 
group (n=19) and the VIG group (n=17). Values are means ± nCI. ). Two 



































5.3.4 Adipose tissue Gene Expression 
 
Expression of SREBP1c & FAS was significantly down-regulated in both 
groups; there was a main effect of day (F>10.1, P<0.01). Expression of PDK4 & 
HSL was significantly up-regulated in both groups; there was a main effect of 
day (F>4.8, P≤0.0 ). Expression of APELIN was significantly up-regulated in 
the MOD group (n=5); there was a dayxgroup interaction (F=5.5, P=0.03). 
Individuals with one or both samples outside the detectable limit (Ct>35) were 
excluded from the analysis. Two genes were expressed at very low levels; 
APELIN was undetectable in 29 % of samples; IL-18 was undetectable in 17 % 
of samples. Gene expression data is presented below (Figure 5.19). Adipose 
tissue biopsies were collected from a subset of participants, as a result n=12 in 
both groups. 
 





Figure 5.19: Mean fold change in the expression of several key genes measured in adipose tissue at baseline and follow-up for the MOD group (n=12) 
and the VIG group (n=12). Data normalised to PPIA= Peptidylprolyl isomerase A. SREBP-1c= Sterol regulatory element binding protein 1c, PDK4= 
Pyruvate dehydrogenase kinase isozyme 4, FAS= Fatty acid synthase (MOD, n=11), PPARγ= Peroxisome proliferator-activated receptor gamma, 
TNFa= Tumor necrosis factor alpha, GLUT4= Glucose transporter type 4, IRS2= Insulin receptor substrate 2, LPL= Lipoprotein lipase, HSL= 
Hormone-sensitive lipase. IRS1= Insulin receptor substrate 1, IL18= Interleukin-18 (MOD, n=8), IL6= Interleukin-6 (MOD, n=10; VIG, n=11), 
AMPK= AMP-activated kinase, APELIN (MOD, n=5). Values are means ± nCI. * P≤0.0  dayxgroup interaction. # P≤0.05 baseline versus follow-up. † 









The current study assessed the impact of caloric restriction combined with either 
moderate or vigorous-intensity exercise on metabolic control and inflammatory 
markers in inactive and overweight/obese men and post-menopausal women, 
with caloric restriction and exercise energy expenditure carefully matched 
between groups. We demonstrated that three weeks of caloric reduction and 
increased physical activity improved fasting measures of metabolic control and 
inflammation, responses to an OGTT and expression of several key genes 
within adipose tissue. These positive changes were not affected by exercise 
intensity. 
 
In order to investigate whether vigorous-intensity exercise offers added benefits 
compared to moderate-intensity exercise in improving metabolic control and 
inflammatory markers in an inactive and overweight/obese population, we used 
a model where caloric restriction and physical exercise energy expenditure were 
carefully matched, as their combination has been successfully used in several 
other studies for similar purposes (You et al., 2004; Roberts et al., 2006; 
Nicklas et al., 2009). We successfully induced a standardised negative energy 
balance, resulting in a weight loss of 2.4 ± 1.4 kg and 2.4 ± 1.1 kg in the MOD 
and VIG group, respectively. Our data suggest that after three weeks of caloric 
restriction and increased physical exercise, improvements in insulin sensitivity 
and metabolic control were evident. Interestingly, the majority of these changes 
were independent of exercise intensity. Short-term negative energy balance 
impacts metabolic control whether that is induced through caloric restriction 
alone (Weiss et al., 2006; Fontana et al., 2007; Lagerpusch et al., 2011) or 
exercise alone (Oshida et al., 1989; Kang et al., 1996; Tjonna et al., 2008).  
 
A review of epidemiological data by Swain & Franklin (2006) examined a 
number of epidemiologic studies and clinical trials that investigated the value of 
moderate versus vigorous-intensity aerobic exercise (without caloric restriction) 
in improving cardiovascular health and reducing the risk of coronary heart 
disease.  Importantly, only experiments where energy expenditure was 
controlled were examined. They concluded that if the total energy expenditure 
of exercise is held constant, exercise performed at a vigorous intensity appears 




to further reduce the risk of cardiovascular disease compared to moderate-
intensity exercise. In contrast,  ’Donovan et al. (2005) suggested that 
moderate-intensity exercise is as effective as high-intensity exercise in 
improving insulin sensitivity in sedentary men when 1676 kJ are expended per 
session. Interestingly, an earlier article published by the same group (the latter) 
using the same cohort suggested that changes in coronary heart disease risk 
factors are influenced by exercise intensity after greater improvements in lipid 
profiles were detected following high-intensity exercise ( ’Donovan et al., 
2005). A more similar study to the current one observed that the combination of 
caloric restriction and increased physical activity (independent of intensity) 
produced similar weight loss and changes in lipids, glucose and insulin 
metabolism across treatment groups (Nicklas et al. 2009). The present study 
confirms the earlier findings made by Nicklas et al. (2009) but also provides 
novel insight to the area by providing information about the adipose tissue 
metabolism of inactive and overweight/obese individuals facing a period of 
negative energy balance induced by caloric restriction and increased physical 
exercise.  
 
Although the benefits of caloric restriction combined with increased physical 
activity on human health are well documented, little is known about the impact 
on the transcriptome of adipose tissue during energy deficit in humans. The 
adipose organ is a major site for energy storage and one of the main tissue being 
impacted during a bout of negative energy balance (Capel et al., 2009; 
Bouchard et al., 2010). Seventeen genes involved in a variety of biological 
processes such as energy homeostasis (AMPK, LEPTIN, APELIN), glucose 
metabolism (IRS1&2, PDK4, GLUT 4, ADIPONECTIN), lipid metabolism 
(ADIPONECTIN, SREBP1c, FAS, PPARγ, LPL, HSL,  ISFATIN) and 
inflammatory pathways (TNFα, IL18, IL ) were selected part of this 
investigation. All are involved in various metabolic processes and are expressed 
in adipose tissue. The caloric restriction and increased physical activity protocol 
adopted here significantly impacted the expression of some of these genes.  
Expression of PDK4 in adipose increased in both groups, highlighting a switch 
of oxidative fuel from glucose to fatty acids by the adipose tissue. PDK4 is a 




mitochondrial protein that is a member of the pyruvate dehydrogenase kinase 
family, a group of enzymes that inhibit the pyruvate dehydrogenase complex 
(PDC) by phosphorylating one of its subunits (Rowles et al., 1996). Expression 
of this gene is regulated by glucocorticoids, retinoic acid and insulin (Kwon & 
Harris, 2004). During starvation, the activation of PDK4 results in a switch of 
oxidative fuel use from glucose to fatty acids (Wu et al., 2000; Tsintzas et al., 
2006; Jeoung et al., 2006). The decrease in systemic triglycerides and the 
increase in non-esterified fatty acids reported in the present study further 
confirm this. A study by Hilderbrandt et al. (2003) showed PDK4 to be up-
regulated in rat muscle following exercise, highlighting the important function 
of PDK4 post-exercise and the gradual transition from carbohydrate to non-
esterified fatty acid metabolism. Chokkalingam et al. (2007) demonstrated that 
insulin can rapidly suppress PDK4 gene expression in skeletal muscle in healthy 
humans. The model used in the present study decreased HOMA-IR, HOMA-β 
and the insulinaemic response to a standard glucose load, whilst increasing ISI 
similarly in both groups, potentially favouring a switch to fatty acid metabolism. 
As a result, lipolysis was being up-regulated (↑ HSL mRNA) in both groups. 
Changes in HSL mRNA and protein levels have been shown to be correlated 
(Jocken et al., 2007) and major determinants of the maximum lipolytic capacity 
of human adipocytes (Large et al., 1998). HSL plays a central part in lipid 
metabolism as it catalyses the hydrolysis of triglycerides and diglycerides 
(Holm et al., 2000). This up-regulation in HSL could also reflect an increase in 
lipolysis to ensure that adipose is carrying out its primary role (i.e.: to liberate 
NEFA for metabolism by other tissues). HSL protein expression has been 
shown to be up-regulated during very-low-calorie diet in obese females (Stich et 
al., 1997). 
SREBP-1c was downregulated to a similar degree in both groups in the present 
study. SREBP-1c is a transcription factor that regulates the expression of the 
lipogenic enzyme FAS (Minehira et al., 2003) and our data support this as there 
was a strong positive correlation between changes in the expression of SREBP-
1c and changes in the expression of FAS (r=0.77; P>0.001). SREBP-1c 
mediates the effects of insulin and glucose on the regulation of key genes 
associated with glucose metabolism; there was an inverse correlation between 




changes in insulin iAUC and changes in the expression of SREBP-1c (r=-0.47; 
P=0.03). Tsintzas et al. (2006) showed that SREBP-1c mRNA was down-
regulated 2.5 fold in skeletal muscle following forty-eight hours of starvation in 
healthy males. Conversely, carbohydrate overfeeding increased SREBP-1c 
mRNA by 25 % and 43 % in the adipose tissue of overweight and lean 
participants, respectively (Minehira et al., 2004). The combination of caloric 
reduction and increased physical activity favoured an increase in lipolysis 
(↓SR BP-1c, ↓FAS, ↑HSL) independent of exercise intensity. 
 
Several markers of inflammation such as  RP (∆=-0.58 ± 1.14 and -0.54 ± 0.44 
for the MOD and VIG group, respectively), ALT and whole blood WBC were 
similarly reduced in both groups following the intervention. The decrease in 
CRP is consistent with the findings reported by Roberts et al. (2006) using a 
similar protocol in men with diabetes. Campbell et al. (2009) achieved a 10 % 
reduction in CRP following a year-long exercise intervention of moderate-
intensity in 115 postmenopausal, overweight or obese, middle-aged, sedentary 
women. Interestingly, they showed that only participants who decreased body 
fat by 2 % or more experienced a significant reduction in CRP. Imayama et al. 
(2012) concluded that a reduction in weight ≥     was necessary to reduce 
inflammatory biomarkers (CRP, IL-6 & serum amyloid A) in overweight and 
obese postmenopausal women induced either by caloric restriction, exercise or a 
combination, irrespectively. This highlights the importance of weight loss or 
deficit per se on these parameters (Church et al., 2010). 
 
We cannot refute the possibility that an intervention over a longer period might 
have resulted in a different pattern of results between the moderate and vigorous 
intensity groups. Longitudinal studies are required to confirm that these findings 
apply to more permanent lifestyle changes. The current model being a 
combination of caloric restriction and increased physical activity; we are unable 
to dissociate the benefits derived from each component. Further work is 
required in order to understand the long-term impact of negative energy balance 
on adipose tissue and other metabolic health markers.  
 




To conclude, this experiment shows that short-term caloric restriction combined 
with either vigorous or moderate-intensity physical exercise improves insulin 
sensitivity, lipid profiles and markers of inflammation. The expression of 
several key genes in adipose tissue of sedentary and overweight/obese men and 
postmenopausal women was also positively altered when energy expenditure 
and caloric deficit were matched. These results confirm the positive effects of 
combined caloric restriction and increased exercise in sedentary overweight 
men and women. The benefits of increased physical exercise combined with 
caloric restriction were independent of exercise intensity 









Throughout the work in this thesis, I have attempted to use several study designs 
to address the question of whether physical activity (including structured 
exercise) is associated with reduced concentrations of blood inflammatory 
markers and whole-body metabolic improvements and whether this is achieved 
through its impact on energy balance, body weight/fat mass or physical activity 
per se. Specifically, Chapter 3 addressed the question of whether a lifestyle 
intervention combining dietary advice with increased physical activity would 
further improve inflammatory markers compared to dietary advice alone and 
usual care in patients with newly diagnosed type 2 diabetes. Chapter 4 
investigated whether daily vigorous-intensity exercise would counteract the 
metabolic changes induced by short-term overfeeding and reduced physical 
activity independent of any net attenuation of energy imbalance in healthy young 
men. Chapter 5 aimed to determine whether caloric restriction combined with 
vigorous-intensity exercise would further improve metabolic control and 
inflammatory markers compared to moderate-intensity exercise in middle-aged, 
overweight/obese men and postmenopausal women. 
 
A summary of the results of all three experimental chapters is outlined below. 
 
Chapter 3: Diet or diet plus physical activity provide similar positive 
changes in inflammation in patients with newly-diagnosed type 2 diabetes 
compared to usual care: The Early ACTID randomised controlled trial 
 Motivational unsupervised diet and diet plus physical activity 
interventions in patients with newly-diagnosed type 2 diabetes lead to 
reductions in CRP, IL-6 and sICAM-1 with an increase in adiponectin. 
 There was no greater benefit from adding physical activity advice to 
dietary advice. 
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 Approximately half of the observed effect for the primary outcome 
(CRP) was explained by the change in weight. 
 A relatively modest 2-3 % decrease in weight led to a fall in circulating 
CRP of approximately 20 %. 
 
Chapter 4: Exercise counteracts short-term overfeeding and reduced 
physical activity independent of any net attenuation of energy imbalance in 
healthy young men 
 The combination of short-term overfeeding and reduced physical activity 
induced a state of insulin resistance, hyperinsulinaemia and altered 
expression of several key genes within adipose tissue. 
 The inclusion of a daily vigorous-intensity exercise bout largely 
prevented these changes from taking place independent of any net effect 
on energy imbalance. 
 Exercise has a profound effect on physiological function even in the face 
of a considerable energy surplus. 
 
Chapter 5: Caloric restriction combined with moderate or vigorous-
intensity exercise provide similar positive changes in metabolic control 
when energy expenditure and caloric deficit are matched 
 Three weeks of caloric restriction combined with either vigorous or 
moderate-intensity physical exercise improved insulin sensitivity, lipid 
profiles and markers of inflammation. 
 The expression of several key genes in adipose tissue of sedentary and 
overweight/obese men and postmenopausal women was also positively 
altered when energy expenditure and caloric deficit were matched. 
 These results confirm the positive effects of combined caloric restriction 
and increased exercise in sedentary overweight men and women.  
 The benefits of increased physical exercise combined with caloric 
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6.2 Impact of increased physical activity on inflammatory markers and 
metabolic control 
Epidemiological studies suggest that physical activity is beneficial in reducing 
markers of inflammation and reducing the risk of developing chronic diseases 
such as the metabolic syndrome and T2D (Rennie et al., 2003; Fischer et al., 
2007; Demakakos et al., 2010). Several studies have investigated whether 
physical activity combined with dietary advice further improves metabolic and 
inflammatory markers compared to dietary advice alone. A study in patients 
with T2D found that diet alone conferred the same benefits as diet combined 
with exercise (Giannopoulou et al., 2005). Conversely, another study with the 
same population suggests that diet combined with exercise is more beneficial 
than diet alone in improving insulin resistance (Yokoyama et al., 2004). 
Importantly, both studies reported similar weight losses between groups. 
Findings from studies in overweight/obese participants are equally ambiguous. 
While Larson-Meyer et al. (2006) suggested that diet alone or diet combined 
with exercise similarly improved insulin resistance. Nicklas et al. (2004) 
showed that diet-induced weight loss resulted in greater reductions in 
inflammatory markers compared to exercise alone or exercise plus diet. 
Importantly, the diet group experienced a much greater weight loss. In Chapter 
3, our findings suggest that diet combined with exercise confers the same 
positive changes to inflammatory markers as diet alone. Interestingly, the 
reduction observed in inflammatory markers in Chapter 3 over a year-long 
intervention are similar to those observed in Chapter 5 following a 3-week 
intervention. Both studies resulted in a similar change in body weight, 
suggesting that weight/fat loss might be the driving factor influencing 
improvements in inflammatory markers. Findings in Chapter 5 demonstrate that 
benefits derived from exercise (in combination with caloric restriction) are 
independent of exercise intensity when energy expenditure and caloric deficit 
are matched. Exercising at higher intensity for less time is equally beneficial to 
metabolic control and markers of inflammation than exercising for longer 
duration at a lower intensity. Whether physical activity positively impacts 
metabolic control and inflammatory markers through a change in weight or fat 
mass remains unclear.  
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6.3 Association between exercise and energy balance 
Exercise and physical activity make a major contribution to total energy 
expenditure and therefore overall energy balance. Western lifestyles are 
characterised by chronically low levels of physical activity and excessive 
caloric intake, resulting in positive energy. In order to investigate the benefits 
from exercise, it is critical to control energy balance in order to tease apart the 
effects of energy balance from exercise/physical activity. Numerous studies 
have examined overfeeding of varied duration and composition, with the 
resultant positive energy balance associated with impaired insulin sensitivity 
(Wang et al., 2001; Cornier et al., 2006; Brons et al., 2009) and marked 
alterations in adipose tissue gene expression (Shea et al., 2009; Alligier et al., 
2012). In Chapter 4, we demonstrated that a daily bout of vigorous-intensity 
exercise mostly prevented the negative health effects induced by 7 days of 
overfeeding and reduced physical activity. Critically, this was independent of 
any impact on energy (im)balance. Whether this is facilitated by regular 
glycogen turnover or some other consequence of muscle contraction per se 
remains to be explored. These results demonstrate that exercise has a profound 
effect on physiological function even in the face of a considerable energy 
surplus. Although the benefits of exercise in the context of an energy surplus are 
evident, it remains unclear whether increased physical activity in the context of 
a caloric deficit confers similar benefits.  
 
6.4 Association between weight loss/gain and key genes within adipose 
tissue 
Given that positive energy balance is a major factor leading to obesity and 
resultant metabolic disturbances, it is surprising that so few studies have 
focused on changes in the expression patterns of key genes in adipose tissue 
during an energy surplus or deficit in healthy individuals considering it is a 
major site for energy storage. We elected to focus on expression changes within 
adipose tissue and seventeen genes involved in a variety of biological processes 
such as energy homeostasis, glucose metabolism, lipid metabolism and 
inflammatory pathways. In Chapter 4, the impact of the overfeeding and 
reduced physical activity model had a dramatic impact on the expression of key 
genes in adipose tissue as shown by the amplitude of the changes reported. For 
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example, FAS and PDK4 were regulated ~4-fold in the SUR group. In 
comparison, the same genes were regulated ~2-fold in Chapter 5. Although 
applied in opposite directions, the actual energy imbalances were similar in both 
these studies resulting in a weight gain of 2.7 kg in SUR group in Chapter 4 
versus a weight loss of -2.4 kg on average in Chapter 5. One consideration in 
the interpretation of these studies is that the study design in Chapter 5 lasted 
over a three-week period unlike the methods employed in Chapter 4 which was 
very acute (1 week); this could explain why some of the changes seen at the 
mRNA level are less pronounced. Also, participants in Chapter 5 had an 
average fat mass of ~32 kg compared to ~11.5 kg in Chapter 4. This could also 
potentially explain the reduction in the amplitude of the gene expression 
changes seen Chapter 5. Interestingly, the same genes that were up-regulated 
(SREBP1c & FAS) and down-regulated (PDK4 & HSL) in Chapter 4 by a 
period of positive energy balance were down-regulated (SREBP1c & FAS) and 




Changes in the activity levels of participants within the diet plus activity arm in 
Chapter 3 were modest (10 min per day compared to 3 min per day for the diet 
arm). Although it was not the purpose of this study, future interventions with a 
greater increase in physical activity combined with diet are required to establish 
whether it would result in greater improvements in inflammatory markers (dose 
response).  
 
As discussed throughout, due to the general inverse association between body 
weight and physical activity, it is difficult to tease out the independent role of 
changes in physical activity or weight on metabolic and inflammatory markers. 
Findings in Chapter 4 bring new evidence to demonstrate that exercise might be 
beneficial independent of energy balance. Even though participants in the 
SUR+EX groups experience a dramatic estimated energy surplus over the course 
of the week (~66000 kJ), the addition of a daily bout of vigorous-intensity 
exercise bout prevented/restored most of the metabolic changes seen in the SUR 
group. This demonstrates that in the short-term at least, exercise can prevent 
Chapter 6  General Discussion 
152 
 
health outcomes from worsening even in the face of an energy surplus. 
However, it is possible that these findings would not hold in the long term or in a 
different population. 
 
The model used in Chapter 5 combined restricted caloric intake with increase 
physical activity. As it is an extreme short-term intervention, future research 
should focus on examining whether the improvements in metabolic control and 
inflammatory markers reported here hold in the long term. The study design 
used in Chapter 5 does not enable us to conclude whether the same benefits 
would have been achieved through caloric restriction alone.  
 
Changes in the expression of several genes measured in adipose tissue in 
Chapter 4 & 5 give us an indication of how metabolism and inflammation are 
regulated during periods of positive and negative energy balance, respectively. 
We cannot conclude that the changes reported at the mRNA level would 
translate to changes at the protein level (apart from AMPK).  
 
6.6 Future work 
More studies designed to investigate the benefits of exercise independent of 
changes in energy balance on inflammatory markers and metabolic control are 
needed in order to clarify the benefits of physical activity. Findings in Chapter 4 
suggest that exercise per se can have independent effects, future studies 
exploring the role played by specific macronutrients is required to confirm this. 
Analysis of skeletal muscle glycogen content and mRNA would be useful in 
answering some of the remaining questions. More longitudinal studies are 
required to confirm whether the findings made in Chapter 4 & 5 apply to a more 
permanent lifestyle change. Chapter 3 suggests that more work is needed to get 
patients to become more active if we are to examine the independent effect of 
exercise on inflammatory markers in people with type 2 diabetes. An inter-
disciplinary approach targeting behavioural changes should be part of future 
strategies aimed at improving the health of patients newly diagnosed with type 2 
diabetes.  Future studies where energy balance is carefully controlled are 
required in order to clarify the impact of exercise on metabolic control and 
inflammation. 




Based on the results from this thesis, there is reasonable evidence that exercise 
per se can have independent (i.e., independent of energy balance) effects on 
metabolic control and inflammation although this is in the context of an extreme 
short-term intervention. Whether exercise contributes towards the health benefits 
reported during a bout of negative energy balance is less convincing.  
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your suitability for our research study 
 








3. Are you taking non-prescription medicine/drugs (e.g. aspirin)? If 




4. Have you been diagnosed as having any form of chronic or 





5. Do you have a current illness or have you had an illness in the last 
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7. How many times do you undergo structured vigorous exercise 










9. Has your doctor ever said that you have a heart condition and that 




































Please answer the following questions in order for us to determine 
your suitability for our research study 
 
1. Date of birth 
 
 
2. Height and weight 
 
 




4. Are you taking non-prescription medicine/drugs (e.g. aspirin)? If 
so, please list 
 
 
5. Is your doctor currently prescribing drugs (e.g. water pills) for 




6. Have you been diagnosed as having any form of chronic or 




7. If you are female, are you post-menopausal (no menstruation for 
at least one year)? 
 
 
8. If you are female, are you on hormone replacement therapy? 
 
 
9. Do you have a current illness or have you had an illness in the last 
6 weeks (e.g. cold or flu)? 





10. Do you or have you ever smoked? Please provide details. 
 
 
11. Has your weight been stable in the last 6 months? 
 
 
12. Has your doctor ever said that you have a heart condition and 
that you should only do physical activity recommended by a doctor? 
 
 
13. Has your doctor ever said that you have a heart arrhythmia? 
 
 




15. Do you feel pain in your chest when you do physical activity? 
 
 




17. Do you have a bone or joint problem (back, knee or hip) that 




18. Do you undergo structured vigorous exercise (i.e., that makes 




19. Do you accumulate more than 30 minutes of exercise, in bouts of 
10 minutes or more (including walking, household and garden 
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20. Have your physical activity patterns changed in the last year (if 



























WEIGHT WEIGHT AVERAGE EI
DAY1 DAY8 WEIGHT AVERAGE PRO CHO FAT ALC PRO CHO FAT ALC 
(kg) (kg) (kg) (kJ/day) % % % % (kJ/day) (kJ/day) (kJ/day) (kJ/day)
PARTICIPANT 13 65.1 67.9 66.5 13513 11.8 56.4 31.7 0.0 1600 7621 4278 0
PARTICIPANT 9 75.8 78.0 76.9 11740 15.1 49.6 30.0 4.7 1775 5824 3521 551
PARTICIPANT 8 82.7 87.9 85.3 17284 13.2 61.6 25.1 0.4 2280 10638 4331 60
PARTICIPANT 7 82.0 84.3 83.2 12557 14.3 45.8 39.8 0.0 1792 5748 4997 0
PARTICIPANT 2 92.3 94.8 93.6 17791 14.7 53.8 30.2 1.4 2612 9566 5367 256
PARTICIPANT 4 74.2 75.9 75.1 12511 14.7 49.0 29.5 6.9 1837 6133 3691 863
PARTICIPANT 3 68.7 71.4 70.1 15976 11.4 48.6 39.8 0.0 1828 7766 6351 0
PARTICIPANT 25 76.6 79.7 78.2 16810 17.3 53.7 28.9 0.0 2903 9030 4851 0
PARTICIPANT 18 81.2 84.6 82.9 15800 14.8 50.1 34.0 1.0 2334 7916 5374 160
PARTICIPANT 2_4 77.5 78.5 78.0 13576 14.0 48.5 34.9 2.8 1898 6577 4732 376
PARTICIPANT 2_2 73.4 78.2 75.8 14267 17.4 58.7 24.2 0.0 2475 8369 3448 0
PARTICIPANT 2_6 54.1 56.2 55.2 7073 21.7 61.9 16.5 0.0 1536 4379 1166 0
PARTICIPANT 2_7 77.4 79.5 78.5 12662 19.5 45.7 33.2 1.8 2470 5784 4201 222
AVERAGE 75.5 78.2 76.842 13966 15.4 52.6 30.6 1.5 2103 7335 4331 191
WEIGHT WEIGHT AVERAGE EI
DAY1 DAY8 WEIGHT AVERAGE PRO CHO FAT ALC PRO CHO FAT ALC 
(kg) (kg) (kg) (kJ/day) % % % % (kJ/day) (kJ/day) (kJ/day) (kJ/day)
PARTICIPANT 16 82.4 82.7 82.6 11430 17.7 44.3 33.7 4.3 2020 5067 3857 488
PARTICIPANT 15 76.7 79.5 78.1 14020 11.8 51.0 34.4 2.6 1653 7153 4820 358
PARTICIPANT 1 82.9 84.4 83.7 14585 13.8 52.2 30.6 3.2 2014 7616 4466 471
PARTICIPANT 19 98.9 100.8 99.9 12926 23.1 49.3 27.6 0.0 2991 6370 3571 0
PARTICIPANT 23 72.8 73.1 73.0 12566 12.5 56.6 27.2 3.7 1573 7110 3418 462
PARTICIPANT 21 73.0 74.9 74.0 13475 13.6 51.6 33.3 1.4 1831 6950 4490 183
PARTICIPANT 6 82.8 86.1 84.5 12478 13.3 44.7 37.2 4.5 1660 5578 4641 562
PARTICIPANT 22 65.2 65.6 65.4 9536 12.4 47.3 31.1 9.1 1178 4512 2965 872
PARTICIPANT 24 90.1 91.4 90.8 13722 20.0 42.9 35.6 1.5 2747 5887 4878 207
PARTICIPANT 2_2 62.6 64.5 63.6 11753 16.9 37.7 39.5 6.0 1985 4430 4642 699
PARTICIPANT 2_3 86.1 88.8 87.5 15721 18.1 52.4 29.3 0.0 2841 8235 4605 0
PARTICIPANT 2_8 65.3 66.4 65.9 13358 15.8 44.5 40.0 0.0 2116 5939 5342 0
AVERAGE 78.2 79.9 79.042 12964 15.7 47.9 33.3 3.0 2051 6237 4308 359
SUR GROUP
SUR+EX GROUP
These calculations are based on the average weight of participants during the intervention. Baseline diet 
information is derived from the diet analysis (Chapter 2.9). DIT was estimated as 21 % for protein, 15 % for alcohol, 
2 % for fat and 8 % of Energy Intake (EI) based on Westerterp (2004). Protein and Alcohol surpluses were estimated 
by subtracting DIT from EI. These calculations do not take into account protein and alcohol metabolism. Fat 
surpluses were estimated as EI-DIT-FAT oxidised (RMR)+FAT generated via DNL. Carbohydrate surpluses were 
estimated as EI-DIT-CHO oxidised (RMR)-CHO converted into FAT- CHO oxidised through daily steps and run. The 
overall average energy surplus for each group was estimated by calculating the sum of the surpluses associated with 
each macronutrient (Chapter 4.2.5).
 
 





EI minus minus minus minus plus
% OF during DIT SURPLUS DIT SURPLUS DIT RMR OX DNL SURPLUS
 intervention PRO PRO PRO ALC ALC ALC FAT FAT FAT FAT FAT 
(kJ/day) (kJ/day) (kJ/day) (kJ/day) (kJ/day) (kJ/day) (kJ/day) (kJ/day) (kJ/day) (kJ/day) (kJ/day) (kJ/day)
PARTICIPANT 13 1.5 20269 2400 504 1896 0 0 0 6417 128 0 2224 8513
PARTICIPANT 9 1.5 17611 2663 559 2104 826 124 702 5281 106 842 0 4334
PARTICIPANT 8 1.5 25926 3420 718 2701 91 14 77 6497 130 0 2730 9097
PARTICIPANT 7 1.5 18836 2688 564 2123 0 0 0 7495 150 0 824 8169
PARTICIPANT 2 1.5 26686 3918 823 3095 384 58 327 8051 161 0 1372 9262
PARTICIPANT 4 1.5 18767 2755 579 2176 1295 194 1101 5536 111 936 0 4490
PARTICIPANT 3 1.5 23965 2742 576 2166 0 0 0 9526 191 2114 0 7222
PARTICIPANT 25 1.5 25215 4355 914 3440 0 0 0 7277 146 0 820 7952
PARTICIPANT 18 1.5 23701 3501 735 2765 239 36 203 8061 161 0 93 7992
PARTICIPANT 2_4 1.5 20363 2847 598 2249 564 85 479 7099 142 4175 0 2782
PARTICIPANT 2_2 1.5 21400 3713 780 2933 0 0 0 5172 103 823 0 4246
PARTICIPANT 2_6 1.5 10609 2304 484 1820 0 0 0 1748 35 582 0 1131
PARTICIPANT 2_7 1.5 18993 3706 778 2927 332 50 283 6302 126 3510 0 2666
AVERAGE 1.5 20949 3155 662 2492 287 43 244 6497 130 999 620 5989
EI minus minus minus minus plus
% OF during DIT SURPLUS DIT SURPLUS DIT RMR OX DNL SURPLUS
 intervention PRO PRO PRO ALC ALC ALC FAT FAT FAT FAT FAT 
(kJ/day) (kJ/day) (kJ/day) (kJ/day) (kJ/day) (kJ/day) (kJ/day) (kJ/day) (kJ/day) (kJ/day) (kJ/day) (kJ/day)
PARTICIPANT 16 1.78 20346 3595 755 2840 869 130 738 6865 137 3378 0 3349
PARTICIPANT 15 1.70 23834 2810 590 2220 608 91 517 8194 164 0 1378 9408
PARTICIPANT 1 1.74 25379 3505 736 2769 820 123 697 7771 155 1246 0 6369
PARTICIPANT 19 1.80 23267 5384 1131 4253 0 0 0 6429 129 2272 0 4028
PARTICIPANT 23 1.75 21990 2753 578 2175 809 121 688 5981 120 4396 0 1466
PARTICIPANT 21 1.73 23312 3168 665 2503 317 48 269 7767 155 747 0 6865
PARTICIPANT 6 1.78 22211 2954 620 2334 999 150 850 8260 165 2081 0 6013
PARTICIPANT 22 1.79 17070 2108 443 1665 1560 234 1326 5307 106 4027 0 1174
PARTICIPANT 24 1.76 24151 4835 1015 3820 365 55 310 8586 172 6321 0 2093
PARTICIPANT 2_2 1.74 20450 3454 725 2729 1217 183 1034 8078 162 2813 0 5104
PARTICIPANT 2_3 1.75 27512 4971 1044 3927 0 0 0 8058 161 4687 0 3209
PARTICIPANT 2_8 1.71 22842 3618 760 2858 0 0 0 9134 183 3822 0 5130



























minus minus minus minus minus OVERALL
DIT RMR OX Lipid conv Steps Run SURPLUS ENERGY
CHO CHO CHO CHO CHO CHO CHO SURPLUS
(kJ/day) (kJ/day) (kJ/day) (kJ/day) (kJ/day) (kJ/day) (kJ/day) (kJ/day)
PARTICIPANT 13 11432 915 5563 1802 542 0 2610 13019
PARTICIPANT 9 8737 699 6795 0 653 0 589 7729
PARTICIPANT 8 15957 1277 7096 2212 536 0 4836 16712
PARTICIPANT 7 8621 690 7617 668 635 0 -988 9305
PARTICIPANT 2 14349 1148 8318 1111 667 0 3105 15788
PARTICIPANT 4 9200 736 6321 0 627 0 1515 9282
PARTICIPANT 3 11649 932 5723 0 493 0 4502 13889
PARTICIPANT 25 13546 1084 8284 0 481 0 3697 15089
PARTICIPANT 18 11874 950 9128 75 622 0 1099 12060
PARTICIPANT 2_4 9866 789 4072 0 290 0 4714 10225
PARTICIPANT 2_2 12553 1004 7766 0 554 0 3229 10408
PARTICIPANT 2_6 6569 526 4824 0 409 0 810 3762
PARTICIPANT 2_7 8676 694 5025 0 817 0 2140 8016
AVERAGE 11002 880 6656 451 564 0 2451 11176
minus minus minus minus minus OVERALL
DIT RMR OX Lipid conv Steps Run SURPLUS ENERGY
CHO CHO CHO CHO CHO CHO CHO SURPLUS
(kJ/day) (kJ/day) (kJ/day) (kJ/day) (kJ/day) (kJ/day) (kJ/day) (kJ/day)
PARTICIPANT 16 9019 722 4810 0 704 2732 52 6979
PARTICIPANT 15 12160 973 7136 1117 550 2665 -280 11864
PARTICIPANT 1 13253 1060 6188 0 618 3151 2235 12070
PARTICIPANT 19 11466 917 6936 0 596 3281 -264 8018
PARTICIPANT 23 12442 995 2966 0 515 2908 5058 9387
PARTICIPANT 21 12024 962 7221 0 547 2916 378 10015
PARTICIPANT 6 9928 794 5416 0 712 3210 -204 8993
PARTICIPANT 22 8076 646 2273 0 476 2560 2121 6286
PARTICIPANT 24 10361 829 2853 0 691 3327 2661 8883
PARTICIPANT 2_2 7708 617 3419 0 470 2602 600 9467
PARTICIPANT 2_3 14411 1153 4978 0 536 3616 4128 11265
PARTICIPANT 2_8 10155 812 3739 0 374 2652 2578 10566

















WEIGHT WEIGHT WEIGHT AVERAGE SURPLUS SURPLUS SURPLUS SURPLUS WEIGHT WEIGHT WEIGHT WEIGHT
DAY1 DAY8 DIFF WEIGHT FAT FAT CHO CHO CHANGE CHANGE CHANGE GAIN
(kg) (kg) (kg) (kg) (g/day) (g/week) (g/day) (g/week) 1g:2.7g ratio 1g:3.3g ratio 1g:4g ratio (FAT+CHO)
PARTICIPANT 13 65.1 67.9 2.8 66.5 228 1598 166 1163 4303 5001 5815 2761
PARTICIPANT 9 75.8 78.0 2.2 76.9 116 814 37 262 971 1129 1312 1076
PARTICIPANT 8 82.7 87.9 5.2 85.3 244 1708 308 2155 7972 9265 10773 3862
PARTICIPANT 7 82.0 84.3 2.3 83.2 219 1533 -63 -440 -1628 -1892 -2200 1093
PARTICIPANT 2 92.3 94.8 2.5 93.6 248 1739 198 1383 5118 5947 6916 3122
PARTICIPANT 4 74.2 75.9 1.7 75.1 120 843 96 675 2497 2902 3374 1518
PARTICIPANT 3 68.7 71.4 2.7 70.1 194 1356 287 2006 7421 8624 10028 3361
PARTICIPANT 25 76.6 79.7 3.1 78.2 213 1493 235 1647 6094 7082 8235 3140
PARTICIPANT 18 81.2 84.6 3.4 82.9 214 1500 70 489 1811 2104 2447 1990
PARTICIPANT 2_4 77.5 78.5 1.0 78.0 75 522 300 2100 7771 9031 10501 2622
PARTICIPANT 2_2 73.4 78.2 4.8 75.8 114 797 205 1438 5322 6185 7192 2235
PARTICIPANT 2_6 54.1 56.2 2.1 55.2 30 212 52 361 1335 1552 1805 573
PARTICIPANT 2_7 77.4 79.5 2.1 78.5 71 500 136 953 3528 4100 4767 1454
AVERAGE 75.5 78.2 2.8 76.8 161 1124 156 1092 4040 4695 5459 2216
WEIGHT WEIGHT WEIGHT AVERAGE SURPLUS SURPLUS SURPLUS SURPLUS WEIGHT WEIGHT WEIGHT WEIGHT
DAY1 DAY8 DIFF WEIGHT FAT FAT CHO CHO CHANGE CHANGE CHANGE GAIN
(kg) (kg) (kg) (kg) (g/day) (g/week) (g/day) (g/week) 1g:2.7g ratio 1g:3.3g ratio 1g:4g ratio (FAT+CHO)
PARTICIPANT 16 82.4 82.7 0.3 82.6 90 799 3 23 85 99 115 822
PARTICIPANT 15 76.7 79.5 2.8 78.1 252 2245 -18 -125 -462 -537 -624 2120
PARTICIPANT 1 82.9 84.4 1.5 83.7 171 1520 142 996 3684 4281 4978 2516
PARTICIPANT 19 98.9 100.8 1.9 99.9 108 961 -17 -118 -435 -506 -588 844
PARTICIPANT 23 72.8 73.1 0.3 73.0 39 350 322 2253 8338 9690 11267 2603
PARTICIPANT 21 73.0 74.9 1.9 74.0 184 1638 24 168 622 723 841 1807
PARTICIPANT 6 82.8 86.1 3.3 84.5 161 1435 -13 -91 -336 -390 -454 1344
PARTICIPANT 22 65.2 65.6 0.4 65.4 31 280 135 945 3496 4063 4724 1225
PARTICIPANT 24 90.1 91.4 1.3 90.8 56 499 169 1186 4387 5098 5928 1685
PARTICIPANT 2_2 62.6 64.5 1.9 63.6 137 1218 38 267 989 1150 1337 1485
PARTICIPANT 2_3 86.1 88.8 2.7 87.5 86 766 263 1839 6804 7907 9194 2605
PARTICIPANT 2_8 65.3 66.4 1.1 65.9 138 1224 164 1148 4249 4938 5742 2373
AVERAGE 78.2 79.9 1.6 79.0 121 1078 101 708 2618 3043 3538 1786
SUR GROUP
SUR+EX  GROUP
We are assuming that fat isn't stored with  water being hydrophobic and  a change in the stromal vascular fraction of the adipose tissue is unlikely  
within a week. Overall, we are probably underestimating the fat surplus as it's likely that less fat has been oxidised throughout the week taking into 
account that the RER values were collected after an overnight fast and it's also likely that more fat has been synthesised through DNL for the same 
reason. Overall, we are probably overestimating the CHO surplus as it's likely that more CHO has been oxidised throughout theweek seeing as the 
RER values were collected after an overnight fast and it's also likely that more CHO has been converted into fat through DNL for the same reason. 
The CHO utilised  for the ~4000 steps is probably an underestimation. This spreadsheet presents 3 possible weight gains  associated with the CHO 
surplus calculated.  The first one is  based  on a previously commonly accepted muscle glycogen to water ratio of 1.0 g:2.7 g (Sherman et al., 1982).  
The second one is based on a convertion factor of 4.3 on the assumption of 77 % water content (Piehl Aulin et al., 2000). The third one is based on 
the upper limit  of 3-4 g of water bound with each gram of glycogen suggested by Olsson & Saltin (1970). The final column shows the weight change 
that could be expected based on the weekly fat and CHO surpluses (without any water associated). These assumptions do not take into account 
protein and alcohol metabolism.
 
 
